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Summary 
In this study, a novel strategy for systematic applications in synthetic biology aiming 
the transfer of metabolic capacities from a donor to an acceptor organism was elucidated. As 
a model system, it was chosen the butyrate fermentation of Clostridium difficile, which has 
not been studied in details before.  In order to succeed, individual enzymes, thiolase (EC 
2.3.1.9), β-hydroxybutyryl-CoA dehydrogenase (EC 1.1.1.157), crotonase (EC 4.2.1.17), 
butyryl-CoA dehydrogenase with its two electron transferring flavoprotein subunits (EC 
1.3.99.2), phosphate butyryltransferase (EC 2.3.1.19) and butyrate kinase (EC 2.7.2.7), were 
initially produced in E. coli in order to demonstrate their functional production, followed by 
an initial characterization in vitro. Substrate specificity, stability and kinetic parameters were 
established in order to address their capability for the synthesis of various metabolic 
intermediates in volatile fatty acid biosynthetic pathways. In this context, novel enzyme tests 
for phosphate butyryl-transferase and butyrate kinase were developed and a facile method 
for testing of bi-forking butyryl-CoA dehydrogenase in the physiological reaction was 
established. Using the latter assay, evidence was obtained for a bi-forking butyryl-CoA 
dehydrogenase in C. difficile, which could allow energy conservation aided by reduced 
ferredoxin, an ability lacking in the most intensively studied pathway of C. acetobutylicum. 
The impact of such enzymes, and of the second rate limiting one (3-hydroxybutyryl-CoA 
dehydrogenase), in butan-1-ol-forming recombinant strains is discussed. 
Successively, the enzyme encoding genes were assembled in a synthetic operon in 
order to create an artificial metabolic pathway module, which was expressed from a single 
plasmid and enabled the formation of the predicted product, butyrate. Two different butyrate 
metabolic pathway modules, pASG.wt_BUTD and pASG.wt_BUTAC, were constructed, which 
contained the butyrate fermentation genes (thia1, hbd, crt2, pbt and buk) from C. difficile, but 
differed in the origin of the butyryl-CoA dehydrogenase/ETF complex genes. These genes 
were either from C. difficile (pASG.wt_BUTD) or C. acetobutylicum (pASG.wt_BUTAC).  
The recombinant butyrogenic pathways were analyzed in vivo by a combination of 
enzymes activity measurements in cell free extracts and analysis of the fermentation 
process: substrate uptake, biomass-, product- and by-product- formations were established in 
order to understand the mass flows in the process. Only the recombinant strains were 
capable to produce butyrate with a maximum concentration of 3.1 and 3.7 mM, respectively. 
While growth characteristics, substrate consumption and product yields were rather similar 
in the recombinant strains, the butyryl-CoA dehydrogenase of different origin and sub-class 
caused remarkable different kinetics of butyrate formation, which are discussed with regard 
to their potential applications in solventogenis. 
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Zusammenfassung 
Die vorliegende Arbeit stellt die Entwicklung eines neuartigen Modellsystems dar, 
welches die Implementierung kompletter Stoffwechselmodule in geeignete 
Akzeptororganismen zur systematischen Anwendung in der synthetischen Biologie erlaubt. Das 
bisher wenig untersuchte butyrogene Stoffwechselmodul aus Clostridium difficile wurde hierzu 
in Escherichia coli transferiert, bestehend aus den individuellen Enzymen Thiolase (EC 
2.3.1.9), β-Hydroxybutyryl-CoA-Dehydrogenase (EC 1.1.1.157), Crotonase (EC 4.2.1.17), 
Butyryl-CoA-Dehydrogenase einschließlich der zwei Elektronen transferierenden Flavoprotein-
Untereinheiten (EC 1.3.99.2), Phosphotransbutyrylase (EC 2.3.1.19) sowie Butyratkinase (EC 
2.7.2.7). Die Enzyme wurden zunächst einzeln in E. coli produziert, funktionell getestet und in 
vitro charakterisiert. Die dabei erhaltenen kinetischen Parameter sowie Daten zur 
Substratspezifität und Stabilität gaben Aufschluss über die Fähigkeit der Enzyme zur 
Produktion von Intermediaten innerhalb von Modulen zur Produktion kurzkettiger Fettsäuren. 
In diesem Kontext wurden neue Aktivitätstests für Phosphotransbutyrylase und Butyratkinase 
etabliert. Im Zuge der Entwicklung einer vereinfachten Methode zur Messung der verzweigten 
Butyryl-CoA-Dehydrogenase in der physiologischen Reaktionsrichtung konnte die Annahme 
erhärtet werden, das C. difficile entgegen dem intensiv untersuchten C. acetobutylicum mithilfe 
dieses Enzyms zur Energiekonservierung mit reduziertem Ferredoxin fähig ist. Der potentielle 
Einfluss derartiger Enzyme bei der Produktion von Butan-1-ol in rekombinanten Stämmen wird 
in diesem Kontext diskutiert. 
Zur Konstruktion des kompletten artifiziellen Stoffwechselmoduls wurden die Gene für 
oben erwähnte Enzyme erfolgreich zu einem synthetischen Operon assembliert, resultierend in 
den Expressionsplasmiden pASG.wt_BUTD und pASG.wt_BUTAC, welche sich lediglich in der 
Herkunft des Butyryl-CoA-Dehydrogenase/ETF-Komplexes unterscheiden. Die Gene für den 
besagten Komplex stammten entweder aus C. difficile (pASG.wt_BUTD) oder C. 
acetobutylicum (pASG.wt_BUTAC). 
Die rekombinanten Butyrogenen Stoffwechselmodule wurden in vivo untersucht durch 
Kombinationen aus Enzymtests in zellfreien Extrakten und die Analyse des 
Fermentationsprozesses im Bezug auf Substrataufnahme, Biomasse-, Produkt- sowie 
Nebenproduktbildung zum Verständnis des Massenflusses innerhalb des Systems. Tatsächlich 
waren lediglich die rekombinanten Stämme zur Butyrat-Produktion fähig, mit maximalen 
Konzentrationen von 3,1 bzw. 3,7 mM im Medium. Während keine großen Unterschiede 
zwischen den beiden rekombinanten Stämmen bezüglich Wachstum, Substratverbrauch und 
Produktausbeute beobachtet werden konnten, hatte die Herkunft der jeweiligen Butyryl-CoA-
Dehydrogenase dramatische Auswirkungen auf die Kinetik der Produktbildung, eine 
Beobachtung, die besonders im Bezug auf den potentiellen Einsatz in der biotechnologischen 
Lösemittelproduktion diskutiert wird. 
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1. Introduction 
1.1. Clostridia 
1.1.1. Clostridium difficile 
Clostridia are strict anaerobic, spore-forming rods (bacilli), typically rod-shaped, 
occurring mainly in soil, but also in the intestines of humans and animals [1]. The genus 
Clostridium includes human pathogenic species causing botulism, tetanus gas gangrene and 
the like [1]. Clostridial endospores are heat resistant and can survive in the environment for 
years despite desiccation and exposure to disinfectants. There are many reports on viable 
spores being found on clothing, hospital furniture and equipment. Thus, these spores 
contribute to exogenous exposure of humans via the fecal-oral route (food-borne diseases like 
botulism or C. difficile-associated diarrhea) or wound infections (tetanus). Spores and toxins 
can survive ingestion and vegetative cells capable of growth and toxin production can 
proliferate in the intestine or wound tissues [2].  
Clostridium difficile is a species of Gram-positive bacteria of the genus Clostridium 
that causes diarrhea, colitis and other intestinal disease when competing bacteria are wiped 
out by antibiotics (Antibiotic-Associated Diarrhea, AAD) [2-5]. Approximately 15% to 20% 
of cases of AAD are caused by C. difficile [6, 7], which is, therefore, an emerging human 
pathogen in hospitalized environments. Originally isolated in 1935, C. difficile was initially 
thought to be a component of normal gut flora, and was not identified as a pathogen until the 
1970s, when colitis associated with clindamycin treatment was further investigated [2]. 
Pathogenic strains of C. difficile cause diarrhea and colitis via toxin production [8]. Two 
major toxins have been identified: toxin A is a 308 kDa enterotoxin, and toxin B is a 269 kDa 
cytotoxin. Both toxins are capable of stimulating production of proinflammatory cytokines 
that have been implicated in the pathogenesis of pseudomembranous colitis [7, 8].  
In the mid-2010th, there are 14 clostridia genomes at different sequencing stages, but 
only three, C. acetobutylicum ATCC 824 (cluster I, subcluster Ib), the non-motile 
C. perfringens strain 13 (cluster I, subcluster Ib) and the sporogeneous C. tetani E88 (cluster 
I, subcluster Ie), have been annotated and made public by NCBI [9]. The genomes of 
C. difficile strain 630 (cluster XI) and C. botulinum Hall strain A (ATCC 3502) (cluster I, 
subcluster Id) have been sequenced and all gaps closed [9, 10].  The putative open reading 
frames sequences for C. difficile can be downloaded from the Sanger center [9-11]. The 
genome of C. difficile strain 630 consists of a circular chromosome of 4,290,252 bp and a 
plasmid, pCD630, of 7,881 bp. The chromosome encodes 3,776 predicted coding sequences 
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(CDSs); in common with other low GC content Gram-positive bacteria, the chromosome has 
a strong coding bias, with 82.1% of the CDSs encoded on the leading strand. The plasmid 
carries 11 CDSs, none of which has any obvious function. Reciprocal FASTA analysis 
against four annotated clostridial genomes, C. acetobutylicum [12], C. botulinum [13], 
C. perfringens [14], and C. tetani [15], showed that about 913 (25%) of C. difficile CDSs are 
shared with all the sequenced clostridia, whereas 2,065 (56%) are unique to C. difficile 
(Fig.1.1) [9, 10]. The conserved clostridial CDSs mainly encode essential functions, whereas 
the C. difficile unique CDSs encode many accessory functions and mobile elements [10]. The 
availability of genomic information for a range of C. difficile strains affords researchers the 
opportunity to better understand not only the evolution of these organisms but also their basic 
physiology and biochemistry [16]. 
 
  
 
 
 
 
  
  
 
Fig.1.1: The number of putative orthologous genes in different clostridia; C. acetobutylicum, C. tetani, 
C. perfringens strain 13, C. botulinum, and C. difficile. For comparison, the number of putative 
orthologous genes between Bacillus subtilis, B. halodurans and the B. anthracis Ames strain is shown. 
In every Venn diagram, the genome on top was used as a reference for determining the number of 
putative orthologs. For comparing the bottom genomes of each Venn diagram, the genome on the right-
hand side was used as a reference [9, 15].  
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Data in figure (1.1) show that generally three different given clostridia share between 
850 and 950 proteins. This number is lower than the ~1,550 proteins shared between Bacilli, 
(perhaps) reflecting the heterogeneity of the Clostridium genus [9]. The first comparison of 
putative orthologous pairs among C. tetani, C. perfringens, and C. acetobutylicum was done 
by Brueggemann and co-workers and they observed that orthologous genes were defined as 
best–best matches having >30% amino acid identity over >60% of the length of both 
genes [15]. Paredes and co-workers noted that the solventogenic species C. acetobutylicum 
and the pathogen C. botulinum share the highest number of putative orthologous pairs (1,565), 
even though they belong to different phylogenetic subclusters. In general, C. botulinum shares 
the highest number of putative orthologs with any other analyzed clostridial species, 
regardless of their pathogenicity or phylogenetic classification [9]. 
 
1.1.2. Butyrate pathway in clostridia  
Anaerobic bacteria produce crotonyl-CoA, which is the precursor of butyrate, either 
by amino acid fermentation e.g. from glutamate, lysine, threonine and methionine or by 
synthesis from two acetyl-CoA molecules derived from glucose or glutamate and other amino 
acids via e.g. 3-methylasparate pathway [17].  
The metabolic pathway of glucose in acidogenic clostridia has several possible end-
products including butyrate and acetate in addition to CO2, H2 and lactate as by-products. 
There are six enzymes involved the conversion of acetyl-CoA to butyrate (Fig.1.2): Thiolase 
(EC 2.3.1.9) [18-23], β-hydroxybutyryl-CoA dehydrogenase (EC 1.1.1.157) [24-27], 
crotonase (EC 4.2.1.17) [25, 28-32], butyryl-CoA dehydrogenase/ETF complex (EC 1.3.99.2) 
[25, 33-37], phosphate butyryltransferase (EC 2.3.1.19) [38-42] and butyrate kinase (EC 
2.7.2.7) [43-47]. The butyrate biosynthetic pathway starts with condensation of two molecules 
of acetyl-CoA by thiolase to acetoacetyl-CoA which is reduced to β −hydroxybutyryl-CoA 
involving a dedicated dehydrogenase. Then, water is eliminated via crotonase and the 
resulting crotonyl-CoA is reduced to butyryl-CoA by the butyryl-CoA dehydrogenase 
complex composed of three individual polypeptides. Butyryl-CoA is further converted by 
phosphate butyryltransferase and the butyrylphosphate thus formed is subsequently used for 
substrate phosphorylation of ADP, mediated by butyrate kinase. 
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Fig.1.2: The butyrate biosynthetic pathway in clostridia fermentations of glucose.  
 
1.1.3. Energy conservation by butyryl-CoA dehydrogenase 
In bacteria, there are two basic mechanisms by which redox reactions are coupled to 
energy conservation: substrate level phosphorylation (SLP) and electron transport coupled to 
phosphorylation (ETP). The majority of organisms use oxygen as the terminal acceptor, but 
anaerobic bacteria are able to use other electron acceptors such as nitrate, nitrite, sulfate, 
carbon dioxide, fumarate, the substrate itself or a derivative thereof to respire [17]. Many 
redox processes cause proton extrusion from the cytoplasm and therefore contribute to an 
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electrochemical potential which enables energy conservation in a respiratory-like process for 
that fermentation cannot be completely separated from a membrane electron transport [48]. 
 Recently, NADH-dependent reduction of crotonyl-CoA to butyryl-CoA in butyrate 
synthesis via electron bifurcation butyryl-CoA dehydrogenase/ETF complex and ferredoxin 
has been shown (Fig.1.3) [17, 33]. The reduction of crotonyl-CoA (E0= -10 mV) with NADH 
(E0= -320 mV) is highly exergonic and occurs spontaneously. However, the reduction of 
ferredoxin (E0= -410 mV) with NADH is endergonic and the process cannot occur [17, 33]. 
Therefore, the only possibility to reduce ferredoxin is to drive its endergonic reduction by the 
exergonic reduction of crotonyl-CoA, which makes the overall reaction exergonic (∆G0= -40 
kJ.mol-1) [17].  In the coupled reactions, BCD/ETF complex bifurcates the two electrons from 
NADH; one electron proceeds to the more positive electron acceptor butyryl-CoA 
dehydrogenase and finally to crotonyl-CoA, and the other is transported to the more negative 
acceptor ferredoxin (Fd  Fd-). The next NADH delivers the second electron to complete 
the reduction of crotonyl-CoA to butyryl-CoA and Fd- [17, 33]. 
 
Fig.1.3: Li and co-worker proposed the mechanism of endergonic ferredoxin reduction with NADH 
coupled to exergonic crotonyl-CoA reduction with NADH catalyzed by the butyryl-CoA 
dehydrogenase/ETF complex from C. kluyveri [33].  
 
The reduced ferredoxin generated by BCD/ETF gets reoxidized by the membrane-
bound ferredoxin:NAD oxidoreductase complex (Rnf-CDGEAB), which utilizes the 
exergonic ferredoxin oxidation to establish a proton motive force across the cell membrane 
[17, 33]. Thereby, additional energy conservation via V-type ATPases is possible [49]. Such a 
system has been proposed to improve the ATP yield in the fermentation of glutamate via 3-
methylaspartate up to 0.9 mol ATP per mol glutamate in Clostridium tetanomorphum: 5 mol 
glutamate yield 3 mol ATP via SLP and 1.5 ATP equivalents (6 * 0.25) by the formation of 6 
NADH via Rnf [17].  
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Furthermore, there are two other mechanisms to reoxidize reduced ferredoxin, either 
by NADP:ferredoxin oxidoreductase (FPR, EC 1.18.1.2), which couples the oxidation of 
reduced ferredoxin with NADP+ reduction, or ferredoxin-hydrogenase (Hyd, EC 1.12.7.2) 
which couples hydrogen production with ferredoxin oxidation. Based on the genome-derived 
data from different clostridia, there is at least one system to reoxidize reduced ferredoxin 
present in species (Figure 1.4). Some organisms such as C. difficile and C. kluyveri contain all 
of the three systems.  
 
Fig.1.4: Genome analysis for genes encoding proteins capable to reoxidize reduced ferredoxin in different 
clostridia. There is in each arrow the name and the accession number for individual genes. The 
direction of arrow indicates the open reading frame direction. Linked arrows show that these genes are 
clustered in one operon. The arrow length correspond to the genes sizes. 
 
 
1.1.4. Comparative analysis of butyrate biosynthetic genes in clostridia 
The arrangement of homologous butyrate biosynthetic pathway genes in the genome 
of C. difficile 630, C. acetobutylicum, C. kluyveri DSM555, C. botulinum AATCC3502 and 
C. perfringens 13 are shown in figure (1.5). The data shows that there are 5 genes (hbd, crt, 
bcd, etfB and etfA) encoding for 3-hydroxybutryl-CoA dehydrogenase, crotonase, 
butyryl−CoA dehydrogenase and the two electron transfer flavoprotein subunits, respectively. 
They are clustered together in one operon in those species. Moreover, some species like 
C. difficile and C. botulinum have the gene encoding for thiolase (thia) clustered in the above 
operon and this indicates that in these two species the genes encoding enzymes capable of 
converting acetyl-CoA to butyryl-CoA are transcribed under a single regulator.  Also the 
analysis shows that the genes encoding for phosphate butyryl-transferase (pbt) and butyrate 
kinase (buk) are transcribed in another operon. This of course signalizes the ability to switch 
between acid and alcohol production, since the butyryl-CoA is the precursor in both acid and 
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alcohol so the organism should separate the control of butyryl-CoA production and its 
subsequent conversation to acid or alcohol. In the case of C. kluyveri the lack of pbt-buk 
operon is compensated by another gene (cat3, accession number CKL_3595) encoding for 
abroad substrate specificity: acetate-CoA transferase that affords the formation of butyrate 
and caproate [50]. It is worth mentioning that some of these enzymes are found in the 
clostridia genomes in paralogs, which do, however, not cluster and were, therefore, omitted 
from the overview figure1.5.     
 
Fig.1.5: The arrangement of homologous butyrate biosynthetic pathway genes in different clostridia. 
There is in each arrow the gene name plus the gene accession number. The direction of arrow indicates 
the open reading frame direction. Linked arrows show that these genes are transcript in one operon; 
however the unlinked genes are not clustered. The arrow sizes are corresponding to the genes sizes. 
 
1.2. Escherichia coli 
 Escherichia coli is a species of Gram negative, rod-shaped, facultative anaerobic, non-
sporulating bacterium that is commonly found in the lower intestine of warm-blooded 
organisms. E. coli was discovered by German pediatrician and bacteriologist Theodor 
Escherich in 1885 [51], and is now classified as part of the Enterobacteriaceae family of       
γ-proteobacteria [52].  Most E. coli strains are harmless, part of the normal flora of the gut and 
can benefit their host by producing vitamin K2. However, some E. coli strains such as 
serotype O157:H7 can cause serious food poisoning in humans [53].  
 
1.2.1. Advantages of using E. coli  
 E. coli has been the most widely used prokaryotic host for mass-production of 
recombinant proteins of pharmaceutical and industrial purposes. This remarkable 
microorganism has numerous desirable characteristics as a production host such as fast cell 
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growth, easy genetic manipulation, straightforward high cell density cultivation (HCDC) and 
capacity to hold over 50% of foreign protein in total protein expression [54, 55]. These 
features have facilitated the production of recombinant proteins and non-protein bio-
molecular products such as amino acids, primary and secondary metabolites with high 
productivities [54, 56-64].  In addition, HCDC has the added advantage of increased cost 
effectiveness, reduced culture volume, enhanced downstream processing, reduced wastewater, 
lower production costs and a reduced investment in equipment. The effectiveness of HCDC 
can be further improved by employing a host strain optimized by various strategies. The most 
popular approaches used are the use of different promoters to regulate expression levels, 
different host strains, co-expression of various proteins (e.g. chaperones), reduction of culture 
temperature and secretion of proteins into the periplasm or culture medium [55, 65].  
 
1.2.2. Different metabolic pathways transferred into E. coli  
 Because clostridia are more difficult to transform, sensitive to oxygen, exhibit 
complex fermentation kinetics and can form spores, they are more difficult to engineer. 
Synthetic biology promises to simplify and expedite the design and engineering of metabolic 
pathways for the bioconversion of various feedstocks to desired fuels and chemicals. For that, 
several groups have recently applied synthetic biology approaches to the synthesis of desired 
fuels and chemicals in a well-studied, robust host organism such as E. coli [56-59, 66, 67], see 
table (1.1). 
 
Table.1.1: Some metabolic pathways transferred into E. coli [68] 
Source Transferred genes Substrate Major-Product Titer Reference 
C. acetobutylicum thiA, hbd, crt, bcd-
etfB-etfA, and adhe1 Glucose Butan-1-ol 
1.2g/L 
0.5g/L 
[57] 
[59] 
Methanococcus 
jannaschii CimA, leuABCD Glucose 
1-Propanol & 
1-Butanol  
3.5g/L 
0.5g/L [69] 
Different organisms  Combinatorial of different genes Glucose Isopropanol 4.9g/L [64] 
Zymomonas mobilis pdc, adhA, and adhB Xylose Ethanol 40g/L [70] 
Bacillus subtilis yhfR and nudF Glucose Isopentenol 0.11g/L [71] 
Different organisms  dhaB1, pduP, phaC1 Glycerol poly(3-hydroxypropionate) 1.42g/L [72] 
C. acetobutylicum 
 
Ralstonia eutropha 
hbd, thl, ptb and buk 
+ 
bktB, phaA and phaB 
Glucose 
(R)- 3-
Hydroxybutyrate &  
(S)-(3HB) 
2.92g/L 
&  
2.08g/L 
[60] 
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1.2.3. Metabolic pathway design in E. coli 
 The analysis of metabolic activities in bacteria is a useful tool for the generation and 
development of novel strains with desired growth and production properties. Several methods 
are available for the evaluation and understanding of the metabolic pathways: Biochemical 
methods to measure metabolite concentrations and enzyme activity [56, 57, 59, 66, 69, 73], 
mathematical models to analyze metabolic fluxes through the various pathways [74-78], 
proteomic studies to identify expressed proteins [79-83], and molecular biology methods to 
detect and analyse gene expression [80, 84-86]. A combination of various methods is required 
to obtain a comprehensive understanding of metabolic activities. In particular high-throughput 
methods provide substantial amount information on global gene expression and, thereby offer 
routes to system biological approaches, but do not always reflect the actual activity of the 
individual components.  
 Biochemical methods can provide additional data measuring either metabolite 
concentrations or enzyme activities. These measurements were used to analyze the metabolic 
differences between E. coli K (strain JM109) and E. coli B (BL21) to solve the growing 
behavior puzzle between these strains. It was established that when growing at high glucose 
concentration (20-40 g/L), E. coli B (BL21) grew faster, to higher densities and produced less 
acetate than E. coli K (JM109). The metabolite analyses showed that E. coli B (BL21) had a 
higher internal concentration of isocitrate and a lower concentration of pyruvate. In regard to 
the enzymatic activity, isocitrate dehydrogenase and isocitrate lyase highly active in E. coli B 
(BL21) compared with almost no detectable activity of isocitrate lyase in E. coli K (JM109)  
[87].   
 Regarding the transferred pathway activities in E. coli, Fischer and co-worker 
developed another application for the determination of the intracellular pathway intermediates 
to assess the heterologous butyrate and butan-1-ol pathway activities in recombinant E. coli 
strains. They observed that there are a two rate-limiting steps mediated by two individual 
enzymes, 3-hydroxybutyryl-CoA dehydrogenase and butyryl-CoA dehydrogenase/ ETF 
complex, and increasing the expression level of these enzymes alleviated the bottleneck in 
this pathway [66]. Other groups were satisfied by measuring the enzyme activities in cell free 
extracts obtained from recombinant E. coli strains harboring butanol-forming genes from 
clostridia in addition to measure butan-1-ol concentration in the culture. They also observed 
that butyryl-CoA dehydrogenase/ ETF complex is a rate-limiting enzyme in this pathway [57, 
59]. 
Introduction  
-10- 
 
 Regarding mathematical methods, Lequeux group applied a dynamic metabolic flux 
analysis on E. coli cultivations shifting from carbon limitation to nitrogen limitation and vice 
versa and they observed a lag phase after switching the limiting substrate from nitrogen to 
carbon accompanied with an increase in maintenance energy requirement. However, this lag 
phase did not occur upon C- to N-limitation switch [88].  
 
1.2.4. Fatty acid oxidation in E. coli 
Fatty acids and their derivatives play essential roles in a number of cellular processes, 
including cell signaling, transcriptional control, membrane syntheses and protein 
modification. Thus, fatty acid metabolism is tightly regulated to allow the cells to adapt 
quickly to environmental changes. E. coli can uptake and utilize long-chain fatty acids (C12 to 
C18) as a sole carbon and energy source [89-91]. In contrast, it cannot uptake but utilize the 
medium-chain fatty acids (C6 to C11), and neither uptake nor utilize short-chain fatty acids (C4 
and C5) [89, 90].  
The uptake and utilization of fatty acids occurs by means of proteins encoded by the 
fad regulon genes. The fad regulon encoded proteins are essential for fatty acids transport, 
activation and β-oxidation. Exogenous fatty acids are transported into the cell by the outer-
membrane-bound fatty acid transport protein FadL and activated by the inner-membrane-
associated acyl-CoA synthetase FadD yielding acyl-CoA thioesters. Then, the activated fatty 
acids are catabolized to acetyl-CoA via β-oxidation mediated by the acyl-CoA dehydrogenase 
encoded by fadE and the tetrameric enzyme complex encoded by fadB and fadA. Acetyl-CoA 
is subsequently used to generate energy and precursors required for cell maintenance [92]. 
 
1.3. Aim of investigation 
In the recent years, several metabolic pathways were transferred into E. coli for the 
bioconversion of various feedstocks to desired fuels and chemicals using common metabolic 
pathway engineering pathways. These ways started with transferring the metabolic pathway 
genes into E. coli using more than one expression plasmid with different antibiotic resistances 
and sometimes different regulators. Then, the transferred metabolic pathway in E. coli was 
analyzed using either biochemical, mathematical, proteomic or genomic methods. Our goal 
was to design a new strategy for the evaluation and understanding of the transferred metabolic 
pathways in E. coli. The novel strategy must allow i) rapid recombinant production of 
dedicated enzymes in a functional state for individual testing, ii) systematic assembly of 
individually characterized enzyme-encoding genes to yield functional metabolic pathway 
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modules and iii) the tailor-made design of technical microbes for different applications from 
these metabolic modules. 
The target genes for introduction in E. coli were chosen from the genome sequenced 
human pathogen Clostridium difficile. The butyrate formation by this organism has not yet 
been studied on the enzyme level and recent findings suggest that the butyrate pathway might 
be crucial for general understanding of clostridial metabolism and might be of particular 
importance in understanding of the remarkable metabolic versatility of C. difficile.  
In order to test the capability of a recently developed novel combinatorial cloning system for 
these applications, we decided to transfer the capability to form butyrate from Clostridium 
difficile to Escherichia coli, which naturally lacks the ability to convert glucose to butyric 
acid. In a systematic approach, thiolase (EC 2.3.1.9), β-hydroxybutyryl-CoA dehydrogenase 
(EC 1.1.1.157), crotonase (EC 4.2.1.17), butyryl-CoA dehydrogenase/ ETF complex (EC 
1.3.99.2), phosphate butyryltransferase (EC 2.3.1.19) and butyrate kinase (EC 2.7.2.7) were 
first produced in E. coli and functionally tested in vitro. Substrate specificity, stability and 
kinetic parameters were established in order to address their capability for the synthesis of 
various metabolic intermediates in volatile fatty acid biosynthetic pathways. Then, the 
individual genes were combined in order to yield a synthetic metabolic pathway module, 
which was introduced into the host cells. The transferred pathway was analyzed by measuring 
the enzyme activities in cell free extracts and analysis of the fermentation process: substrate 
uptake, biomass-, product- and by-product formations were established in order to understand 
the mass flows in the process. 
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2. Materials 
2.1. Chemicals, biochemicals and reagents 
 Unless otherwise stated, all chemicals were purchased from Sigma-Aldrich 
(Taufkirchen, Germany), VWR International GmbH (Darmstadt, Germany) or Roth 
(Karlsruhe, Germany) and were of highest available quality.  
 
2.2. Chemicals synthesis 
 
2.2.1. Chemical synthesis of Butyryl-phosphate  
Butyryl-phosphate was prepared according to Uede [93] with slight adaptations: To a 
mixture of 2.39 mL of phosphoric acid (85%) and 18.37 mL butyric acid,  34.19 mL butyric 
anhydride were added dropwise and allowed to stir overnight at room temperature. Then, 1.7 
g of solid LiOH was added for product precipitation at room temperature for additional 3 h. 
The colourless precipitate was vacuum-filtered through a glass filter of F-porosity and washed 
two times with 50 mL of methanol. The remaining 5.36 g of lithium butyryl phosphate was 
dried under vacuum and stored as crystalline powder at -20°C. The purity of the product was 
93.6% as determined enzymatically with recombinant butyrate kinase.  
 
2.2.2. Chemical synthesis of CoA-esters  
Acetyl-CoA and butyryl-CoA were prepared and purified as previously described [94, 95].  
 
2.3. Media and plates 
All media were freshly prepared and immediately autoclaved at 121°C for 20 min.  
 
Lysogenic-Broth (LB medium), per liter 
Trypton 10.0 g 
Yeast extract 5.0 g 
NaCl 5.0 g 
Distilled water 800 mL 
The medium was adjusted to pH 7.0 with NaOH (1 M) prior autoclaving.  
 
LB-agar  
Solid media were prepared by addition of the required amount of agar to the 
previously prepared LB-media (1.5% w/v) prior autoclaving. The temperature was adjusted to 
55°C in a water-bath prior addition of antibiotic or indicator solutions.  
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Mineral medium (M9 medium)  
M9 medium consists of a M9 salt solution, which is complemented with compounds 
listed in table (2.1) prior use. 
 
Ten-fold M9 salts (per liter), adjusted to pH 7.4 
Na2HPO4 60 g 
KH2PO4 30 g 
NH4Cl  10 g 
NaCl 5 g 
 
Table.2.1: Composition of one liter M9.  
Ten-fold M9 salts (100 mL) were diluted with 900 mL distilled water and 
autoclaved.  The following solutions were used for completing the medium just prior use. 
Component  Stock solution volume End Conc. Sterilization 
MgSO4 1.0 M 1.0 mL 1.0 mM Autoclaving 
CaCl2 0.1 M 1.0 mL 0.1 mM Autoclaving 
Thiamine-HCl. 2 H2O 1.0 M 1.0 mL 1.0 mM Filtration 
Glucose  1.0 M 20 mL 20 mM Filtration 
FeSO4 0.2 M 250 µL 50 µM Filtration 
Carbenicillin 100 mg/mL 500 µL 50 µg/ mL Filtration 
Chloramphenicol  50 mg/mL 680 µL 34µg/ mL Filtration 
 
2.4. Bacterial strains and plasmids used in the study  
Bacterial strains and plasmids used in this study are show in table (2.2 and 2.3). 
 
Table.2.2: Bacterial strains  
Strains Genotypes Source 
E. coli, DH5α-cells 
(Cloning strain) 
F- φ80lacZ∆M15 ∆(lacZYA-argF)U169 recA1 endA1 
hsdR17(r
k
-
, m
k
+) phoA supE44 thi-1 gyrA96 relA1 λ- 
Invitrogen, 
Darmstadt, 
Germany 
E. coli, RosettaTM pLysE-cells 
(Expression strain) 
F
- 
ompT hsdS
B 
(r
B
- 
m
B
-
) gal dcm (DE3) pLysE /RARE 
[argU argW ileX glyT leuW [proL] (Cam
r
)  
Merck, 
Darmstadt, 
Germany 
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Table.2.3: Original plasmids  
Plasmids Special characteristics Reference 
pENTRY-IBA51 Kanr : Cloning vector 
IBA, Göttingen, 
Germany 
pCFUSE-IBA11 Ampr : Fusion vector 
pNFUSE-IBA11 Ampr : Fusion vector 
pASG-IBAwt1  Ampr : Expression vector 
pASG-IBA3 Ampr : Expression vector 
pASG-IBA5 Ampr : Expression vector 
Ampr , Ampicillin resistance gene; Camr , Chloramphenicol resistance gene; Kanr , Kanamycin resistance 
gene  
 
2.5. Oligonucleotides  
Synthetic oligonucleotides were custom synthesized by MWG Biotech (Ebersberg, 
Germany). List of primers used in the current work are presented in the appendix. 
 
2.6. Molecular biology kits and enzymes 
GeneJET™ PCR purification kit, GeneJET™ plasmid purification kit, Phusion™ 
DNA Polymerase, cloning enzymes (LguI, Esp3I, T4-DNA ligase) and restriction enzymes 
(XbaI, HindIII, EcoRV, NlaIII, HinfI) were purchased from Fermentas-GmbH (Fisher 
Scientific, Schwerte, Germany). 
 
3. Methods 
3.1. DNA Manipulations  
3.1.1. PCR Amplification  
Synthetic oligonucleotides were designed based on the genome-derived sequences of 
individual genes according to the instructions of the Stargate™ supplier (IBA, Göttingen, 
Germany), (Table.2.4). The LguI recognition site was introduced into the primers to allow the 
insertion of the PCR product into the cloning vector pENTRY-IBA51. Genomic DNA from 
C. difficile (DSM 1296T) and C. acetobutylicum (DSM 792T) were used as templates. Target 
gene amplification was performed using the PhusionTM DNA polymerase (Fisher Scientific, 
Schwerte, Germany). The PCR products were analyzed by either agarose gel electrophoresis 
or chip electrophoresis (MCE-202 MultiNA, Shimadzu Deutschland, Duisburg, Germany). 
Afterwards, the amplified fragments were purified with the PCR purification kit according to 
the manufacturer instructions.  
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Composition of a standard PCR mixture (100 µL final volume)  
Template (10 ng/µL) 
Primer mix (10 µM each)  
5x HF buffer 
10 mM dNTPs 
Phusion™ DNA Polymerase 
Sterilized distilled water 
10 
5.0 
20 
2.0 
0.5 
62.5 
µL 
µL 
µL 
µL 
µL 
µL 
 
PCR program  
Initial denaturation 
Denaturation 
Annealing 
Extension 
Final extension 
98 °C 
98 °C 
     55-60 °C 
72 °C 
72 °C 
           2 min 
         10 sec 
         20 sec                     30 cycles 
        (30 sec/ 1kb) 
           5 min 
 
3.1.2. Genes cloning  
The PCR fragments were cloned into the dedicated entry vector pENTRY-IBA51 using 
site-specific overhangs created by digest both the PCR fragment and the cloning vector with 
LguI and re-ligated with T4ligase in one-step reaction at 30 °C for one hour.  
Standard cloning reaction mixture (50 µL final volume) 
PCR product  (10 ng/ µL) 10 µL 
pENTRY-IBA51  (25 ng/ µL) 1.0 µL 
Buffer Tango  10x 5.0 µL 
DTT (10 mM) 5.0 µL 
ATP (10 mM) 2.5 µL 
LguI (5 U/µL) 1.0 µL 
T4ligase (5 U/µL) 1.0 µL 
Sterilized distilled water 24.5  µL 
 
The resulting ligation mixture containing pE-GOI (pENTRY carry the Gene Of Interest) was 
transformed into chemically ultra-competent E. coli DH5α-cells [96]. After addition of 5 µL 
of ligation mixture to 70 µL of competent E. coli cells on ice, binding of DNA by the cells 
was allowed for 10 to15 min. Then, the cells were heat-shocked at 42°C for 30 sec. The cells 
were immediately placed back on ice and adjusted to 1 mL with LB-medium (4°C). In order 
to allow establishing kanamycin resistance, the cells were grown at 37°C for one hour prior 
plating on LB-agar with kanamycin (50 µg/mL) and X-Gal (25 µg/mL).  The plates were 
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incubated at 37°C over night. Afterwards white colonies were picked in order to inoculate 2 
mL of LB-medium with kanamycin (50 µg/mL) over night for plasmid mini-preparation. 
 
3.1.3. Small scale plasmid DNA purification 
Plasmids were isolated from 1.5 mL of an overnight culture using GeneJET™ plasmid 
purification kit according to the supplier instructions.  
 
3.1.4. Determination of DNA concentration 
DNA concentration was determined using a NanoDrop 1000 UV/Vis 
spectrophotometer (PeQlab Biotechnologie GmbH, Germany) at 260 nm against elution 
buffer. An absorbance of one unit equals 50 µg per mL of double-stranded DNA.  
 
3.1.5. Restriction digests of plasmid 
The plasmid identity was confirmed by restricts-fragment-length-polymorphism-
(RFLP) studies with suitable endonucleases (Endonuclease digests were performed at 5 to 20 
fold over-digestion). The obtained fragments were analyzed by either agarose gel or chip 
electrophoresis.  
 
Standard restriction digests of plasmid (final volume of 20 µL) 
Plasmid (pE-GOI)  (50 ng/µL) 5.0 µL 
Appropriate Buffer  10x 2.0 µL 
Restriction enzyme (10 U/µL) 0.5 µL 
Sterilized distilled water 12.5 µL 
 
3.1.6. DNA agarose gel electrophoresis  
PCR products and RFLP-analyses of purified plasmids were analyzed by 
electrophoresis in mini agarose gels (80*20*4 mm) followed by ethidium bromide staining.  
Therefore, low melting agarose was suspended in Tris: Acetate: EDTA (TAE) buffer and 
molten in a microwave. The gels were then poured into suitable casting moulds and stored 
after solidification at 4°C up to two weeks. After removal of the comb, the gels were placed 
into a horizontal electrophoresis chamber and loaded with samples completed with TriTrack 
DNA loading Dye (5:1 v/v). Electrophoresis was carried out at 170 V for 10 to 15 min using 
suitable Fast RulerTM standards for size estimation (Fisher scientifice, Schwerte, Germany). 
The gels were stained with ethidium bromide solution (0.5 µg/ mL) for 10 to 20 min, washed 
two times with deionised water and the location of DNA was visualized with UV light. 
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TAE buffer pH 8.4 
 Stock solution (50x) Concentration in (1x) 
Tris 2.0 M 40 mM 
Acetic acid 1.0 M 20 mM 
EDTA 0.05 M 1 mM 
 
3.1.7. Chip electrophoresis 
In the later stages of the work, a chip electrophoresis (MCE-202 MultiNA, Shimadzu 
Deutschland, Dusisburg, Germany) was available in our laboratory, which almost entirely 
replaced gel electrophoresis in DNA fragments analysis. This system provides fully automatic 
analysis of multiple samples on an array of four individual electrophoresis chips for multiple 
uses in combination with an online detection of CyBR-Gold-mediated DNA fluorescence 
detection. For DNA analysis, three polyampholyte running buffer systems are available 
depend on fragment size (up to 500, up to 1500 and up to 3500 bp). The analysis was 
performed according to the manufacturer instructions.  
 
3.1.8. DNA sequencing  
Custom sequencing of DNA was performed by Eurofins MWG Operon-Biotech 
(Ebersberg, Germany). Standard vector-derived primers and internal primers were used for 
the complete sequencing of DNA templates using dye-terminator chemistry [97].  
 
3.1.9. Expression plasmid generation 
Genes originally cloned in pENTRY-IBA51 vector and confirmed by DNA sequencing 
were subsequently used in sub-cloning experiments (either generation of expression or fusion 
plasmids). Therefore, both the donor plasmid (pE-GOI) and the acceptor vector were digested 
with Esp3I and re-ligated with T4-Ligase simultaneously at 37°C for one hour. Three different 
expression vectors (pASG-IBAwt1, pASG-IBA3, and pASG-IBA5) were used in the current 
study.  The resulting recombinant plasmid was transformed into E. coli DH5α-cells and then 
plated on LB-agar plates containing carbenicillin (50 µg/ mL) and X-Gal (25 µg/ mL). The 
plates were incubated at 37°C over night.  Afterwards white colonies were picked for plasmid 
mini-preparation. 
Standard transfer reaction mixture (final volume of 50 µL) 
Donor plasmid (pE-GOI) (50 ng/ µL) 1.0 µL 
Acceptor vector (expression or fusion) (25 ng/ µL) 1.0 µL 
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Buffer Tango  10x 5.0 µL 
DTT (10 mM) 5.0 µL 
ATP (10 mM) 2.5 µL 
Esp3I (10 U/µL) 0.5 µL 
T4 ligase (5 U/µL) 1.0 µL 
Sterilized distilled water 34 µL 
 
3.1.10. Fusion cloning of multiple genes 
In order to construct several genes together for stepwise built-up of polycistronic 
operons, a fusion strategy was employed, which successively allow Esp3I mediated transfers 
of genes into dedicated fusion vectors. Two types of fusion vectors were employed (pNFUSE-
IBA11 and pCFUSE-IBA11), in which the first provides upstream position of the inserted GOI 
in the final fusion vector with a ribosomal binding site (RBS) as an intergenic region, and the 
second provides downstream position. Afterwards, pair-wise back-insertion of two DNA 
fragments individually harbored by these two vectors was assembled into pENTRY.  
Repetition of transfer into fusion vector and re-integration in the pENTRY-vectors can be used 
for a stepwise assembly of artificial operon for recombinant production of enzyme complexes 
(e.g. butyryl-CoA dehydrogenases) or synthetic metabolic pathways provided by several 
enzymatic systems. 
While the transfer reaction for insertion of DNAs from pENTRY-vectors into fusion 
vectors was identical to the previously described procedure for expression vectors, the 
assembly of those fragments into pENTRY requires a slightly different protocol as it described 
below, but is also readily accomplished within 1 h at 30°C. 
Standard transfer reaction mixture (final volume of 50 µL)  
pENTRY-IBA51 (25 ng/ µL) 1.0 µL 
pFF.rbs_GOI1  (25 ng/ µL) 1.0 µL 
pFFc_GOI2 (25 ng/ µL) 1.0 µL 
Buffer Tango  10x 5.0 µL 
DTT (10 mM) 5.0 µL 
ATP (10 mM) 2.5 µL 
LguI (5 U/µL) 1.0 µL 
T4ligase (5 U/µL) 1.0 µL 
Sterilized distilled water 33.5 µL 
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3.2. Biochemical Methods 
 
3.2.1. Gene expression and biomass production  
Gene expression was performed in E. coli Rosetta™-pLysE-cells harboring the 
expression plasmid of the individual genes. Freshly transformed cells were plated in LB-agar 
plates supplemented with carbenicillin (50 µg/ mL) and chloramphenicol (34 µg/ mL). After 
incubation overnight at 37 °C, three different colonies were picked to inoculate 2 mL LB-
medium supplemented with the previously mentioned antibiotics. Over day cultures were 
used to inoculate 100 mL overnight cultures with the same antibiotics. Overnight cultures 
were used to inoculate 500 mL of the same medium and the cells were induced with 
anhydrotetracycline (AHT) when the optical densities reached OD578nm of about 0.5. The 
biomass was harvested 2 h post-induction by centrifugation for 10 min at 5,000 x g. 
Subsequently, the pellet was washed with Tris-buffered saline (TBS), centrifuged again and 
stored at -80°C until used.  
Composition of TBS buffer (one liter) pH= 7.2- 7.5  
 Stock solution Volume End Conc. 
Tris 1 M 10 mL 10 mM 
HCl 1 M 9.2 mL 9.2 mM 
NaCl 5 M 30 mL 150 mM 
 
3.2.2. Cell free extract preparation  
About one gram of frozen cells were re-suspended in 15 mL resuspension buffer 
(essential buffer as indicated for individual enzymes, Table 3.1) supplemented with 
Lysozyme (50 µg/ mL), avidin (25 µg/ mL), RNAse and DNAse (2.5 µg/ mL each). The 
suspension was incubated for 15 min at 37°C with gently shaking. Afterwards, it was 
subjected to sonication using a Branson Sonifier with a duty cycle of 50% at 60% power for 
10 min in an ice-water bath. Cell debris were removed by centrifugation at 6,000 x g for 1 h at 
4 °C and subsequently passed via Sephadex G25 to remove large particular matters.  
 
Table.3.1: Essential buffer composition for individual enzymes 
THIA1  Tris-Cl (pH 8.0, 20 mM), DTT (1 mM), EDTA (1 mM)  
BHBD Phosphate buffer (pH 7.0, 20 mM), DTT (1 mM), EDTA (1 mM) 
CRT2 Phosphate buffer (pH 7.0, 20 mM), DTT (1 mM), EDTA (1 mM) 
BCD2 Phosphate buffer (pH 7.5, 20 mM), 5 mM MgCl2, DTT (1 mM) 
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PBT Phosphate buffer (pH 7.5, 20 mM), DTT (1 mM), EDTA (1 mM) 
BUK Phosphate buffer (pH 7.5, 20 mM), DTT (1 mM), 5 mM MgCl2 
 
3.2.3. Protein purification 
Recombinant proteins were purified using StrepTactin™-Macroprep columns (5mL, 
IBA GmbH, Göttingen, Germany). Prior purification, these columns were equilibrated with at 
least 100 mL of the washing buffer (350 mM NaCl in essential buffer). Then, the cell-free 
extracts were loaded onto the column using a peristaltic pump at flow rates of about 1mL/ 
min. Loading of the column was followed by washing steps with 5-column volumes of 
washing buffer. Then, the target enzyme was eluted with elution buffer (2.5 mM desthiobiotin 
in washing buffer). After purification, StrepTactin-columns were regenerated with 100 mL 
regeneration buffer (5 mM HABA in washing buffer). 
 
3.2.4. Determination of protein concentration  
Protein concentration was determined according to the binding of Coomassie Brilliant 
Blue G-250 to proteins [98] using a Roti-Nanoquant protein assay kit (Carl Roth, GmbH, 
Germany). Bovine serum albumin (BSA) was used as standard. Absolute protein 
concentrations were determined at 280 nm and calculated based on the molar extinction 
coefficients of the proteins [99]. 
 
3.2.5. Determination of molecular mass  
The molecular mass was determined with sodium dodecylsulfate-polyacrylamide gel 
electrophoresis (SDS-PAGE) [100]. The polyacrylamide gel was casted as a separating gel 
topped with a stacking gel (Table 3.2). PageRuler unstained broad range protein ladder 
(Fermentas, Germany) was used as marker, which contains 11 bands corresponding to 
molecular mass of 5, 10, 15, 20, 30, 40, 50, 70, 100, 150 and 250 kDa. Cell free extract, flow 
through, washing and elution fractions were mixed with protein loading buffer and cooked at 
95 °C for 10 min prior loading on the gel. The gel was fixed in a BioRad electrophoresis 
apparatus, PowerPac HCTM (USA), and the separation was performed at a constant voltage 
(200 V) for one hour (until the tracking dye drain off the gel). Afterwards, the proteins were 
stained for 30 min with hot staining solution (heating in a microwave at 380 W for 5 min). 
The binding dye with protein was established by drowning the gel for additional 30 min in 
heated fixing solution, and then the excess of the dye was taken out by de-staining the gel 
overnight in de-staining solution. 
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Table.3.2: Casting SDS-PAGE gels (all values are in µL) 
Component 
Final 
Conc. 
Stacking gel Separating gel 
6 % 8% 10 % 12 % 15 % 
Tris-HCl (pH 8.8, 1M) 375 mM ------- ------- 2,250 2,250 2,250 
Tris-HCl (pH 6.8, 0.95 M) 375 mM 790 790 ------- ------- ------- 
Distilled water variable 850 750 2,070 1,770 1,320 
Acrlyamide/ Bis-acrylamide 
40% (37/1) 
variable 300 400 1,500 1,800 2,250 
SDS (10% w/v) 0.1% 20 20 60 60 60 
TEMED (10%) 0.05% 10 10 30 30 30 
APS (10%) 0.15% 30 30 90 90 90 
Final volume in µL  2,000 2,000 6,000 6,000 6,000 
 
SDS-PAGE Solutions 
• Tris-HCl buffer (pH 8.8, 1M) 
60.5g Tris + 152 mL HCL (1 M), then complete the volume with distilled water to 500 
mL. 
• Tris-HCl buffer (pH 6.8, 0.95 M) 
60.5g Tris + 525 mL HCL (1 M) 
• SDS (10% w/v) 
Dissolve 20 g of SDS in distilled water and adjust the final volume to 200 mL. Then, 
the solution was filtered with 0.45 µm filters. 
• APS (10% w/v) 
Dissolve 1 g of APS in 10 mL distilled water 
• TEMED (10% v/v) 
1 mL TEMED + 9 mL distilled water  
• Electrophoresis Running Buffer (10x, dilute 1:10 with distilled water prior use) 
 Weight/ Volume End Conc. 
Tris   30 g                        3.0 % 
Glycine 144 g 14.4 % 
SDS (10%) 100 mL  1.0 % 
Distilled water Complete the volume to one liter 
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• Protein loading Buffer (2x, 50 mL) 
 Volume End Conc. 
Distilled water 11.5  mL   
Tris-HCl (pH 6.8, 0.95 M) 6.5  mL 125  mM 
SDS (10% w/v) 20  mL 4  % (w/v ) 
Glycerol 10  mL 20  % (v/v ) 
Bromphenol blue (5%) 2 mL 0.2 % (w/v ) 
DTT (1M)   Add before use 20  mM 
 
• Staining, Fixing and De-staining solutions 
Staining solution  Fixing solution De-staining solution 
Acetic acid solution (20%) 
Serva Blue R (0.2% in 95% ethanol)  
Then mix 1:1 from the above solutions 
Acetic acid (10%) 
Ethanol (40%) 
Acetic acid (10%) 
Ethanol (20%) 
 
3.2.6. Enzyme Activity measurements 
Unless otherwise mentioned, all enzyme measurements were carried out at room 
temperature (23- 25 °C) in a final volume of 1 mL and started by the addition of enzyme. 
 
3.2.6.1.Thiolase (THIA1) 
Acetyl-CoA C-acetyltransferase (thiolase, EC 2.3.1.9) activity was determined in the 
thiolysis direction [21] using CoA-SH and acetoacetyl-CoA. The decrease in the absorbance 
was detected at 303 nm (ε303nm of 14 mM−1cm−1) [22]. The enzyme was added to start the 
enzymatic reaction. A base line to account spontaneous hydrolysis of acetoacetyl-CoA in the 
presence of alkaline pH and magnesium ions was obtained by omitting CoA-SH. One unit of 
enzyme activity is defined as the amount of enzyme catalyzing the thiolytic cleavage of 1.0 
µmol of acetoacetyl-CoA per min under the given conditions. 
Final assay mixture for THIA1 activity 
Tris-HCl (pH 8) 100 mM 
MgCl2 10 mM 
DTT 1 mM 
Acetoacetyl-CoA 50 µM 
CoA-SH 50 µM 
 
 Unit/ mg enzyme =  
14 (Enzyme volume) (mg protein/ ml Enzyme )
 (    A303nm/ min Test-    A303nm/min Blank) (Dilution factor)∆∆
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3.2.6.2. β-Hydroxybutyryl-CoA dehydrogenase (BHBD) 
 β-Hydroxybutyryl-CoA dehydrogenase (EC 1.1.1.157) activity was determined at 340 
nm (ε340nm of 6.22 mM−1cm−1) [57] by monitoring the oxidation of NADH resulting from the 
reduction of acetoacetyl-CoA to 3-hydroxybutyryl-CoA [27]. The reaction was initiated by 
enzyme, and the activity was calculated against a control, in which acetoacetyl-CoA was 
omitted. One unit of enzyme activity is defined as the amount of enzyme oxidizing 1.0 µmol 
of NADH per min under certain conditions. 
Final assay mixture for BHBD activity 
Phosphate buffer (pH 6) 50 mM 
DTT 1 mM 
NADH 200 µM 
Acetoacetyl-CoA 50 µM 
 
 
 
 
3.2.6.3.Crotonase (CRT2) 
3-Hydroxybutyryl-CoA dehydratase (crotonase, EC 4.2.1.55) activity was determined 
by monitoring the hydration of the conjugated double bond of crotonyl-CoA photometrically 
at 263 nm (∆ε263nm of 6.7 mM−1cm−1) [18, 27]. The strong dilution of the enzyme which was 
needed measure activity reliably was performed in TBS supplemented with BSA (1 mg/ mL).  
One unit of enzyme activity is defined as the amount of enzyme hydrating 1.0 µmol of 
crotonoyl-CoA to 3-hydroxybutyryl-CoA per min under certain conditions. 
Final assay mixture for CRT2 activity 
Tris-HCl (pH 7.5) 100 mM 
MgCl2 5 mM 
DTT 1 mM 
EDTA 1 mM 
BSA 50 µg 
Crotonyl-CoA 50 µM 
 
 
 
 
Unit/ mg enzyme =  
6.22 (Enzyme volume) (mg protein/ ml Enzyme )
 (    A 340nm/ m in  Test-    A 340nm/m in  Blank) (Dilution factor)∆∆
Unit/ mg enzyme =  
 (    A263nm/ min Test-    A263nm/min Blank) (Dilution factor)∆∆
6.7 (Enzyme volume) (mg protein/ ml Enzyme )
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3.2.6.4. Butyryl-CoA dehydrogenase (BCD) 
Butyryl-CoA: NAD+ oxidoreductase (EC 1.3.99.2) activity was measured under 
various conditions.  
 
3.2.6.4.1. Ferricenium hexafluorophosphate assay 
Butyryl-CoA dehydrogenase activity was measured with butyryl-CoA and ferricenium 
hexafluorophosphate (Fc+FP6-) as an artificial electron acceptor. The reaction of ferricenium 
was followed at 300 nm (ε300nm= 4.3 mM−1cm−1) [101]. The redox indicator ferricenium 
hexafluorophosphate was prepared in HCl (10 mM) solution to a final concentration of 2 mM 
set at 617 nm (ε617nm = 0.41 mM-1cm-1) [101]. One unit of enzyme activity is defined as the 
amount of enzyme reducing 2.0 µmol of ferricenium per min under certain conditions. 
Final assay mixture 
Potassium phosphate buffer (pH 7.5) 50 mM 
Ferricenium 100 µM 
Butyryl-CoA 
FAD 
50 
5 
µM 
µM 
 
 
 
 
 
3.2.6.4.2. NADH oxidation under oxic condition  
The rate of NADH oxidation in oxic atmosphere was determined in the absent and 
present of crotonyl-CoA. Transferring the electrons from NADH to O2 (diaphorase activity) 
or to crotonyl-CoA (physiological activity) was followed at 340 nm (ε340nm of 6.22 
mM−1cm−1) [57]. One unit of enzyme activity is defined as the amount of enzyme oxidizing 
1.0 µmol of NADH per min under certain conditions. 
 
Final assay mixture 
Tris-HCl buffer (pH 7.5) 50 mM 
MgCl2 10 mM 
NaCl 50 mM 
NADH 150 µM 
Crotonyl-CoA 
FAD 
50 
5 
µM 
µM 
Unit/ mg enzyme =  
4.3 X 2 (Enzyme volume) (mg protein/ ml Enzyme )
 (    A 300nm/ min  Test-     A 300nm/min  Blank) (Dilution factor)∆ ∆
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3.2.6.4.3. NADH/ crotonyl-CoA reduction under anoxic condition  
The enzyme activity in the physiological direction was measured with crotonyl-CoA 
and NADH under anoxic atmosphere in the previously mentioned assay mixture 
supplemented with ferredoxin obtained from C. pasteurianum. The necessary reoxidation of 
ferredoxin was achieved with recombinant ferredoxin: NADP oxidoreductase (0.3 U/ mL) in 
presence of NADP+ (100 µM). Enzyme activity was calculated based on monitoring the 
oxidation of NADH at 340 nm.  
 
3.2.6.5. Butyrate kinase (BUK) 
ATP: butyrate phosphotransferase (butyrate kinase, EC 2.7.2.7) was assayed in the 
butyrate-forming direction, in a coupled assay with glucokinase from C. difficile (EC 2.7.1.2) 
and glucose-6-phosphate dehydrogenase from Bacteroides fragilis (EC 1.1.1.49), by 
monitoring the increase in absorbance at 340 nm due to the reduction of NADP+ (ε340nm= 6.22 
mM−1cm−1) [102]. Rate-limiting amounts of butyrate kinase were added to the assay mixture 
to initiate the reaction and the activity was calculated against a control, in which butyryl-
phosphate was omitted. One unit of enzyme activity is defined as the amount of enzyme 
yielding reduction 1.0 µmol of NADP+ per min under certain conditions. 
Final assay mixture 
Phosphate buffer (pH 7.5) 50 mM 
MgCl2 5 mM 
NADP 200 µM 
ADP 100 µM 
Butyryl-phosphate 1 mM 
Glucose 4 mM 
Glucokinase 1 U 
G-6-P dehydrogenase 1 U 
Unit/ mg enzyme =  
6.22 (Enzyme volume) (mg protein/ ml Enzyme )
∆∆ (    A340nm/ min Test-    A340nm/min Blank) (Dilution factor)
 
 
3.2.6.6.Phosphate butyryltransferase (PBT) 
Phosphate butyryltransferase (EC 2.3.1.19) activity was assayed as described above 
for BUK, replacing butyryl-phosphate by butyryl-CoA (50 µM) and providing BUK (1 U/ 
mL) in excess. The reaction was initiated by the addition of rate-limiting amounts of the 
enzyme and a control was done by omitting butyryl-CoA. 
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3.3. Butyrate production 
For butyrate production under aerobic conditions, 2 mL M9 liquid medium 
supplemented with carbenicillin (50 µg/ mL) and chloramphenicol (34 µg/ mL) was 
inoculated with one colony of E. coli strains harboring butyrate plasmids following incubation 
at 37°C with shaking at 200 rpm over day. This culture was used to inoculate 100 mL from 
the same medium in a 250 mL conical flask following incubation overnight. The overnight 
culture was used to inoculate 500 mL M9 medium in a liter conical flask. The foreign genes 
were induced with AHT (200 ng/ mL) when the OD578 was reached of 0.5.  Culture samples 
(1.5 mL) were taken at various time points during growth. The samples were centrifuged 
(13,000 rpm, 5 min), and cells and the supernatants were used in individual analyses. 
  
3.3.1. Cell growth 
Resuspended cells were used for OD578 determinations and subsequently recovered for 
enzyme tests. 
  
3.3.2. Determination of glucose concentration 
Glucose concentration was measured enzymatically based on a coupled enzyme 
reaction with recombinant glucokinase and glucose 6-phosphate dehydrogenase [102] by 
observing the increase of the absorbance at 365 nm due to reduction of NADP (ε365nm= 3.5 
mM−1cm−1) [103]. The standard curve was done with glucose standards and the trend-line 
slope was used to calculate the glucose concentration in culture dilutions.  
 
Reaction mixture 
Tris-HCl, pH 7.5 50 mM 
MgCl2 5 mM 
DTT 2 mM 
ATP 1 mM 
NADP 0.2 mM 
G-6-P dehydrogenase 0.2 U 
Glucokinase 0.1 U 
Concentration (mM)  =  
3.5 X 1000 (d) (sample volume) 
∆∆ (    A365nm / Test -  A    365nm / Blank) (Dilution factor)  (V) X 180
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Where:  - 180 is glucose molecular weight (g/ mol) 
- 3.5 is the molar extinction coefficient at 365 nm 
- (d) is the thickness (cm)  
- (V) is the test volume (mL) 
 
3.3.3. Analysis of fermentation products.  
Short-chain fatty acids were analyzed by high performance liquid chromatography 
(HPLC) according to Schiffels et al.[104]. 
 
3.3.3.1.Sample preparation. 
Samples (300 µL) were transferred into 1.5 mL polypropylene test tubes. Two 
spatula of NaCl (≈ 0.2 g) and 100 µL of concentrated HCl were added and vigorously mixed 
with 800 µL of diethyl ether (containing 5 mM cyclohexylcarboxylic acid as an internal 
standard) for 1 min. The mixture was briefly centrifuged to remove residual water droplets 
from the ether phase. Part of the ether phase (200 µL) was transferred to 1.5 mL screw capped 
glass vials and mixed with a solution of oxalyl chloride (250 mM) in 200 µL of N,N-dimethyl 
formamide: acetonitrile (1:100 v/v) and briefly mixed. Then, 800 µL of derivatization reagent 
(30 mM 4-nitophenol in 500 mM pyridine/ acetonitrile) was added and mixed. The samples 
were directly inserted into the auto-sampler rack for measurement. 
 
3.3.3.2.Measurement of standards and samples 
 20 µL from each sample was injected via auto-sampler. Binary gradients with 
triethylamine- acetate buffer (20 mM, pH 4.8) 35% (v/v) acetonitrile (solvent A), and the 
same buffer with 80% (v/v) acetonitrile (solvent B) were used for separation on a Synergi 
polar-RP (80 Å, 4 µm, 250 x 4.6 mm) column at 45 °C. All measurements were detected at 
295 nm with a flow rate of 1 mL/ min. 
 
3.3.4. Fermentation models 
In a fermentation process, there are certain rates for compound consumption or production. 
These rates are usually expressed as mol/ time, e.g., glucose consumption rate in mol glucose 
per hour, biomass growth rate in C-mol biomass per hour, acetate and butyrate production rate 
in mole per hour etc. It is important to obtain the values of these rates as they occur in 
fermentation processes, for that the following models were used for these calculations [105].  
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RateX
dMX
dt =
MX2- MX1
t2 - t1
µ  RateX
MX
=
=
=
=
hour
hour-1 In MX / MX0
t
= =µ max 
RateB  
dMB
dt =
MB2- MB1
t2 - t1
= =
mmol Butyrate
hour qB 
RateB
MX
==
mmol Butyrate/ hour
Doubling time (τd) In2µmax ==
0.693
µmax
hour-1
C-mol biomass
C-mmol biomass
 
 
Where: X 
dMX 
MX0/ MX/ MX1/ MX2 
µ 
µmax 
τd 
Biomass 
Change in total amount of biomass 
C-mmol of biomass at time zero/ t/ t1/ t2 
Specific growth rate 
Maximum specific growth rate 
Doubling time 
 
B 
dMB 
MB1 
MB2 
qB 
Butyrate 
Change in total amount of butyrate 
Total amount of butyrate at time t1 
Total amount of butyrate at time t2 
Specific butyrate production rate 
 
G 
dMG 
MG0 
MG1 
MG2 
qG 
qGmax 
Glucose 
Change in total amount of glucose 
mmol of glucose at zero time 
mmol of glucose at time t1 
mmol of glucose at time t2 
Specific glucose consumption rate 
Maximum Specific glucose consumption rate 
RateG
dMG
dt =
MG2- MG1
t2 - t1
= =
mmol Glucose
hour
qG
RateG
MX
==
mmol Glucose/ hour
C-mmol biomass
qG
max
  
MG(t)- MG0
MX(t)- MX0
==
mmol Glucose* h -1
C- mmol biomass 
µmax
  
Yield(X/G)
RateX
RateG
==
C-mmol biomass 
mmol glucose 
Yield(B/G)
RateB
RateG
==
mmol butyrate
mmol glucose
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4. Results 
4.1. Molecular biology results 
4.1.1. Background: 
Butyrate formation in Clostridia is required in order to balance the intracellular redox 
potential upon growth with glucose. Utilization of glucose in the glycolytic pathway yields 
redox equivalents in form of 2 NADH per molecule of glucose. Its reoxidation is essentially 
required to enable further glucose consumption. In Clostridia, pyruvate as oxidation product is 
further oxidized to yield acetyl-CoA, carbon dioxide and reduced ferredoxin by the 
pyruvate: ferredoxin oxidoreductase (EC 1.2.7.1). In the NADH reoxidizing pathway, several 
individual enzymes are involved: The condensation of two molecules of acetyl-CoA is 
mediated by an acetyl-CoA C-acetyltransferase (thiolase, EC 2.3.1.9). Acetoacetyl-CoA is 
then reduced to 3-hydroxybutyryl-CoA by 3-hydroxybutyryl-CoA dehydrogenase (EC 
1.1.1.157). From this compound, water is eliminated by the action of crotonase (EC 4.2.1.55) 
and the crotonyl-CoA thus formed serves as the oxidant in the butyryl-CoA dehydrogenase-
(EC 1.3.99.2)-mediated oxidation of a second NADH. The latter enzyme is a complex of three 
subunits, the butyryl-CoA dehydrogenase and two subunits of an electro-transferring 
flavoprotein (ETF). The butyryl-CoA finally formed can now serve to conserve energy in 
form of ATP. There exist two different possibilities to achieve ATP-synthesis: The butyryl-
CoA is either directly converted to butyryl-phosphate by phosphate butyryltransferase (EC 
2.3.1.19), which is the substrate for ATP-regeneration by butyrate kinase (EC 2.7.2.7). In an 
alternative pathway, butyryl-CoA and acetate are converted to acetyl-CoA and butyrate by the 
butyrate CoA-transferase (EC 2.8.3.9) and acetyl-CoA is further converted via acetyl-
phosphate to ATP by consecutive action of phosphate acetyltransferase (EC 2.3.1.8) and 
acetate kinase (EC 2.7.2.1). In a first step, the available genome of Clostridium difficile strain 
630 was, therefore, analyzed by bioinformatics in order to establish the butyrate synthetic 
pathway active in this organism.  
 
4.1.2. Identification of butyrate forming genes in C. difficile: 
The identification of enzymes in genome-sequenced microbes is strongly facilitated by 
the DBGet-database (http://www.genome.jp/dbget/). Using a single EC number, this database 
enables the rapid screen of whole genome information for the occurrence of the necessary 
genes. As shown in figure (4.1), Clostridium difficile (and also C. acetobutylicum, not shown) 
possesses the necessary genes encoding for both pathways. From this diagram (Fig.4.1), direct 
links are available to the necessary data: By simple mouse-click on the EC numbers of 
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enzymes given in green, the amino acid sequence of the protein but also the gene sequence 
encoding this protein can be yielded (Fig.4.2). 
 
 
Fig.4.1: Butyrate pathway in C. difficile strain 630  
 
 
Fig.4.2: Online available data of crotonase from C. difficile 630   
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These data were first used to summarize data of the encoded proteins including amino 
acid content, molecular masses and isoelectric points (Table 4.1). Likewise, the corresponding 
genes from C. acetobutylicum were identified. Please note that the analysis of the butyrate 
CoA-transferase is actually subject of a bachelor thesis in our group and was, therefore, not 
considered in this thesis.  
 
Table.4.1: Analysis of butyrate pathway biosynthetic enzymes 
Name 
Gene 
name 
EC 
Content 
(AA) 
Mw 
(kDa) pI ε280 
Thiolase thiA1 2.3.1.9 391 40.92 5.02 0.360 
3-hydroxybutyryl-CoA 
dehydrogenase 
hbd 1.1.1.157 281 30.68 5.74 0.254 
Crotonase crt2 4.2.1.55 265 28.43 4.77 0.229 
Butyryl-CoA dehydrogenase bcd2 
1.3.99.2 
378 41.31 5.57 0.666 
Electron transfer flavoprotein 
beta-subunit 
etfB2 265 28.91 4.61 0.663 
Electron transfer flavoprotein 
alpha-subunit 
etfA2 336 36.07 4.92 0.444 
Butyryl-CoA dehydrogenase bcd 
1.3.99.2 
379 41.48 5.92 0.601 
Electron transfer flavoprotein 
beta-subunit 
etfB 259 28.11 5.02 0.724 
Electron transfer flavoprotein 
alpha-subunit 
etfA 336 28.02 5.43 0.461 
Phosphate butyryltransferase pbt 2.3.1.19 300 32.464 5.48 0.162 
Butyrate kinase buk 2.7.2.7 359 38.697 5.17 0.397 
E.C, enzyme commission number 
ε280, extinction coefficient at 280 nm (Abs 0.1% (=1 g/L) 
Highlighted rows refer to genes cloned from C. acetobutylicum. 
Mw, molecular weight 
AA, amino acid 
pI, Isoelectric point 
 
4.1.3. Analysis of the protein-encoding genes: 
Some features crucial for cloning of the enzyme-encoding genes and the recombinant 
enzyme production in E. coli might by beneficially discussed already here. In C. difficile, the 
genes encoding enzymes converting acetyl-CoA to butyryl-CoA are grouped in an operon. 
The average GC content of these genes is about 33.7%. The Codon Adaptation Index (CAI) 
of these genes as compared to the E. coli codon is about 0.58. The lower this number the 
higher is the chance that these genes will be expressed poorly [106]. The most problematic 15 
codons are shown in figure (4.3).  
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Fig.4.3: Relative adaptiveness of codons. Black bars indicate the codons usage in E. coli. The colored bars 
give the clostridial codons usage. bcd/etfAB are the only three genes cloned from 
C. acetobutylicum, however, the rest are cloned from C. difficile. 
 
The data obtained from this analysis revealed that the clostridial codon usage differs 
significantly from the codon usage of E. coli. It should be noted, however, that the 
recombinant enzyme production of such proteins is frequently possible in genetically 
engineered strains, which provide additional copies of rare tRNA genes, and, therefore, 
strongly facilitate clostridial enzyme production in this host. 
Features relevant for molecular cloning of individual genes like size, GC content, 
codon adaptation index (CAI) and the differences in codon usage between E. coli and 
clostridia are presented in table (4.2). In addition, the accession numbers are given to 
document the origin of genomic sequences used for planning of cloning experiments.  
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Table.4.2: Analysis of butyrate pathway biosynthetic genes 
Gene name Accession 
number 
Size 
(bp) 
GC% 
content CAI 
Difference in  
Codon Usage % 
thiA1 CD1059 1176 36.2 0.56 47.3 
hbd CD1058 846 29.3 0.58 48.3 
crt2 CD1057 798 33.0 0.59 49.6 
bcd2 CD1054 1137 35.1 0.59 44.9 
etfB2 CD1055 798 32.7 0.59 45.7 
etfA2 CD1056 1011 34.1 0.59 45.5 
bcd CA_C2711 1140 34.6 0.60 45.5 
etfB CA_C2710 780 35.0 0.59 45.0 
etfA CA_C2709 1011 34.7 0.57 44.9 
pbt CD0112 903 33.0 0.61 45.1 
buk CD0113 1080 32.8 0.60 46.9 
 
The gray-highlighted rows shown bcd, etfB and etfA genes which were cloned from C. acetobutylicum.  
 
4.1.4. Gene cloning and expression 
In order to clone individual genes, two primers were designed (Fig.4.4) for gene 
amplification by PCR. The forward primer starts with the natural start codon ATG of the 
protein encoding genes. The sequences were chosen to provide a 100% identity with the 
genes and of a length ranging from 18 to 38 bp. Primer ends were usually GC-clamps of at 
least 2 bp. The calculated melting points of the pairing regions were chosen between 55 and 
60 °C. Each sense primer then was fused with a 5’-AAGCTCTTCA-extension. This sequence 
contains a LguI-recognition site (GCTCTTC), which directs formation of a 5’-ATG-overhang 
in the PCR-products upon digest with this enzyme. The reverse primers for gene amplification 
were deduced following similar rules, including the fact that sense and antisense primers 
exhibited a ∆Tmelt < 2 °C. All antisense primers ended with the codon directly upstream of the 
natural stop codon. The antisense primer sequences were inverted and obtained a 5’-extention 
of the sequence AAGCTCTTCTCCC. This sequence also contains a LguI-recognition site, 
which is placed in a position to create a 5’-CCC-overhang at the PCR-product upon digest. 
All primers used in the current study are listed in detail in appendix (App.1).  
 
 
Results  
-34- 
 
T4ligase 
pE_GOI
2877 bp
1   - 1
<== Primer N.361  - 51 - Tm=61,6°C
==> Primer N.360  - 1661 - Tm=60,5°C
Esp3I - 1692
Esp3I - 2830
G
OI
kan
ori
Forward primer 
AAGCTCTTCAATGGATTTTAATTTAACAAGAGAACAAGAATTAGTAAG 
          ...................................... 
       5´-ATGGATTTTAATTTAACAAGAGAACAAGAATTAGTAAGNNNNNNNNNNNN 
 
          NNNNNNNNNNNNNNGTTCAGAAATTAGTTATTTCAGGAAAAATTTTTAGA-3´ 
                        |||||||||||||||||||||||||||||||||||| 
                        CAAGTCTTTAATCAATAAAGTCCTTTTTAAAAATCTCCCTCTTCTCGAA 
                                                           Reverse primer 
 
Fig.4.4: Design of forward and reverse primers. The grey highlighted sequences refer to the LguI-recognition 
site, bold letters show the overhang dedicated for recombination into the vector. Coding sequence is 
otherwise given in black, non relevant nucleotides are indicated by “N”. 
 
After analysis of the PCR products for the expected sizes by MultiNA chip 
electrophoresis, these products were purified and inserted into dedicated cloning vectors. The 
primer design allowed direct cloning of the PCR-products in vectors (pENTRY-IBA51), which 
carry a pair of LguI restriction sites in opposite orientation for the accommodation of the 
genes via the ATG- and CCC-overhang (Fig.4.5). The insertion of amplified DNA fragments 
into pENTRY-IBA51 vector was achieved by simultaneously occurring digest with LguI and 
T4-ligase mediated re-ligation. Please note that the resulting recombinant plasmids did no 
longer contain LguI-recognition sites and are therefore, resistant to LguI-digest (Fig.4.5).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.4.5: Cloning the PCR product into pENTRY(IBA51). Both PCR product and pENTRY(IBA51) were 
simultaneously cut with LguI and ligated with T4-ligase in one step reaction.  
GGG                             
kan ori
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The highly efficient insertion of PCR products owned by this method enabled a fairly 
restricted choice of clones for downstream analysis. In general, 2-3 individual colonies were 
picked from plates obtained after transformation of E. coli DH5α with the transfer reaction. In 
average, more than 90% of the resulting clones were in perfect agreement with the fragment 
patters predicted for the recombinant plasmids, when digested with suitable endonucleases 
and chip-electrophoretic analysis of the fragment sizes (Fig.4.6, more details about individual 
vectors analysis are presented in the supplemented appendix). 
 
Output fragments (bp) LM 76 131 151 408 801 1355 UM 
Expected fragments (bp) ----- 69 129 150 413 804 1309 ----- 
 
Fig.4.6: Chip electrophoretic analysis of pE_bcd2 (CD1054) fragments after suitable digest with Csp61. On 
the left hand, a pDRAW file is shown which indicatites the restriction of Csp61. On the right hand, an 
electropherogram of the digst vector is shown. LM, lower marker; UM, upper marker.  
 
The high efficiency obtained for insertion of individual PCR-products also holds when 
more than one PCR-products are simultanously inserted. This feature of the cloning strategy 
was employed in order to create silent point mutations genes, which contained naturally 
occurring LguI- or Esp3I-recognition sites. Since these sequences interfere with the sub-
cloning strategies further used to create multiple gene expression plasmids (see below), this 
silent mutation strategy at the early stage of the cloning scheme was reasonable. In order to 
achieve this, the naturally occurring triplet encoding an amino acid within the recognition site 
was replaced by an alternative codon encoding the same amino acid (e.g. a GAG glutamate 
codon exchanged by a GAA or vice versa). Then, this triplet was placed at the end of 
additional antisense and sense primers, which then allowed to use these triplets as extensions 
activitaed by LguI-recognition sites. The mutagenic triplet created an additional, unique pair 
of overhangs, which allowed fusion of the partially amplified genes upon insertion into the 
entry vector. 
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After thus primary testing of insertion by RFLP, the nucleotide sequences were 
confirmed by DNA sequencing. The sequence analysis was performed by Eurofins MWG 
Operon-Biotech (Ebersberg, Germany) using vector derived primers No. 360 and No.361. 
The positions of these primers in the plasmid sequence are indicated in figure (4.6). The 
sequences were then compared to the original sequences used for planning of the experiments. 
Since the template DNA used for cloning of the genes was derived from the wild type strain 
Clostridium difficile DSM 1296T while the strain genome sequenced was strain 630 [11], 
some minor strain-related changes were observed (Table 4.3). 
 
Table 4.3: The observed substitutions in nucleotide and amino acid sequences.  
The shaded silent mutation in the pbt gene was introduced to remove the natural LguI recognition site. The 
two observed substitutions in amino acids were conserved to strong groups. 
 
 Thereafter, the cloned genes were transferred into expression vectors. While the 
initially generated entry clones lacked LguI-cleavage sites, the inserted genes were flanked by 
a unique pair of Esp3I-recognition sites. When this enzyme is used to cut the plasmids, the 
inserted genes are released with 5’-AATG overhangs at the coding strand and 5’-CCCT-
overhangs at the non-coding strand. These overhangs are suitable for the insertion of the 
insert into dedicated Stargate®-pASG-Expression vectors. These vectors provide the required 
regulon for expression of foreign genes and a variety of vectors for the recombinant enzyme 
production of protein variants are available. In order to produce a wild type enzyme, the 
vector pASG-IBAwt1 was used. Since the genes were originally cloned lacking the natural 
stop codon, this vector provides a short 3’ coding extension, which fuses two amino acids 
Gene name Accession number Nucleotide Amino Acid 
bcd2 CD1054 non non 
etfB2 CD1055 non non 
etfA2 CD1056 T315  G A414  C 
non 
non 
crt2 CD1057 
A459  G 
A550  G 
non 
I184  V 
hbd CD1058 T696  C non 
thiA1 CD1059 
C766  T 
T1140  C 
non 
non 
pbt CD0112 A633  G A706  C 
non 
non 
buk CD0113 T555  C T748  C 
non 
non 
bcd CA_C2711 G856  A A286 T286 
etfB CA_C2710 non non 
etfA CA_C2709 C51   T non 
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Acceptor vector
3850 bp
1 - 1
tetP - 2939
Esp3I - 3060
Esp3I - 3754
lac
z
tetR
Am
p
te
t P
ori
pE_GOI
2877 bp
1   - 1
Esp3I - 1692
Esp3I - 2830
GO
I
kan
ori
pASG.wt_GOI
4294 bp
1   - 1
tetP - 2939
GO
I
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A
m
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te tP
ori
pASG.5_GOI
4336 bp
1  - 1
tetP - 2939
StrepII - 3062
GO
I
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A
m
p
te tP
ori
pASG.3_GOI
4321 bp
1   - 1
tetP - 2939
StrepII   - 4199
GO
I
tetR
A
m
p
tetP
ori
(GS) to the resulting recombinant protein and provides, thereafter, a stop codon. In order to 
create enzyme variants with a C-terminal StrepII-tag for affinity chromatography purification, 
the vector pASG-IBA3 was used, which adds the StrepII-tag sequence GSAWSHPQFEK to 
the recombinant protein (Fig.4.7). The vector pASG-IBA5 was used to create expression 
plasmids for production of recombinant proteins, which carry N-terminal StrepII-tags 
(MASAWSHPQFEKSG). This vector also provides the C-terminal extension which fuses the 
short GS-sequence to the C-terminus of the protein.   
Since Stargate® expression vectors generally provide a unique pair of divergently 
oriented Esp3I-sites for target gene accommodation via TTAC- and GGGA-overhangs, the 
ATTG- and CCCT-overhangs of the released genes from the entry vector perfectly match the 
requirements for accommodation. Moreover, the resulting recombinant plasmid lacks Esp3I-
recognition sites and is, therefore, resistant to further digest. Hence, transfer of the insert from 
the entry vector into the expression vector is easily achieved in a one-tube-reaction when 
Esp3I and T4-ligase are present simultaneously.  
 
 
Fig.4.7: Generation of expression plasmids (pASG_GOI). GOI, gene of interest; Amp, ampicillin resistance 
gene; tetR, tetracycline repressor; tetP, tetracycline promoter; ori, ColE1 origin.   
 
 The very high sub-cloning efficiency (generally more than 90% of recombinant vector 
are formed within 1 h) and the oriented transfer of a pre-defined insert, allowed for the 
omission of additional sequencing of the resulting expression plasmids. Rather, correct clones 
were solely identified by RFLP-analysis of the prepared vector stocks and subsequent analysis 
by DNA chip electrophoresis.  
Esp3I +T4ligase 
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While this strategy directly derived the expression clones for enzymes composed of 
identical polypeptides (e.g. acetyl-CoA C-acetyltransferase, 3-hydroxybutyryl-CoA 
dehydrogenase, crotonase, phosphate butyryltransferase and butyrate kinase), the butyryl-
CoA dehydrogenase is a complex protein, which is composed of the dehydrogenase and two 
electron-transferring flavoprotein subunits. Hence, it was necessary to provide expression 
vectors, which allowed a balanced production of individual proteins. Moreover, it was desired 
to create N- and C-terminally tagged enzymes for facilitated purification. The latter was 
hampered by the fact that a prediction of structural interference of these tags attached to 
individual subunits was difficult. Thus, we decided to create 7 expression plasmids, which 
were either used for wild type enzyme production (note that also these proteins carried the 
GS-extension at their C-terminus) and variants providing N- or C-terminally StrepII-tags at 
either subunit.  
In order to create these vectors, we took advantage of the available Stargate® fusion 
vectors. One of these vectors (pNFuse-IBA11) provides Esp3I-accommodation sites 
compatible with the donor sites of entry vectors and fuses the inserted gene with the GS-
extension, a stop codon and – downstream – with an optimized ribosomal binding site for 
expression in E. coli. The second vector (pCFuse-IBA11) does not alter the transferred gene 
but creates a shift in the LguI-mediated overhang of the released insert (ATG to AAT). A 
compatible overhang (TTA) is created at the 3’-end of the assembly created within the 
pNFuse-vector by LguI. Taking into account that the original ATG- overhang at the 5’ of the 
first gene and the CCC-overhang at the 3’ of the second gene are retained when both fragment 
are released simultaneously from the fusion vectors, both inserts can be assembled and 
inserted into the entry vector via the TAC/GGG-accommodation sites. Obviously, a second 
cycle of fusion cloning starting with a bicistronic vector and the missing gene within the 
pCFuse-vector enabled the synthesis of vectors, which carried all three subunit encoding 
genes, in which the second and the third genes are preceded by a ribosomal binding site for 
efficient translation in E. coli  (Fig.4.8). Given that three different orders of genes (ABC, 
BCA and CAB) were readily generated in a parallel approach, it is rather obvious that simple 
sub-cloning of these assemblies into dedicated expression vectors will directly yield the 
desired vectors for expression of various recombinant proteins, each of which is uniquely 
equipped with StrepII-tags at the first (pASG-IBA5) or the last (pASG-IBA3) encoded protein 
in the vector, while transfer into the pASG-IBAwt1 vector yielded expression of a non-tagged 
enzyme variant. 
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It should be noted, that the assembly cloning of C. difficile butyryl-CoA 
dehydrogenase genes was performed by R. Fischer at Philipps-University, who kindly 
provided some vectors and expression clones used in this study. The assembly cloning of the 
orthologous genes from C. acetobutylicum are part of this work and, therefore, chosen to 
exemplify the cloning scheme as depicted in figure (4.8 & 4.9). 
 
Fig.4.8: Construction of butyryl-CoA dehydrogenase and its two electron transfer subunits (etfB and etfA) 
from C. acetobutylicum as example for the fusion strategy employed in the current work. 
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pASG.5_bcdABC 
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pASG.5_bcdCAB 
 
Fig.4.9: The six variants of bcd/etf complex from C. acetobutylicum constructed in the current study. 
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Cloning of individual genes 
pE_bcd pE_etfA pE_etfB 
pNFUSE_bcd pCFUSE_etfB 
pE_bcd.rbs_etfB 
pNFUSE_bcd.rbs_etfB 
pE_bcd.rbs_etfB.rbs_etfA 
pASG.3_bcdABC 
pCFUSE_etfA 
pASG.5_bcdABC 
 4.2. Protein purification and enzyme characterization
The genes of butyrate synthetic enzymes from 
expressed in E. coli Rosetta™
expressed from dedicated expression p
Specific activities, molecular masses, kinetic constants (
determined for each of these enzymes.
4.2.1. Thiolase 
Acetyl-CoA C-acetyltransferase (Thiolase, EC 2.3.1.9) is the first enzyme in the 
butyrogenic pathway and catalyzes the condensation of two molecules of acetyl
acetoacetyl-CoA. Thiolase from 
while the enzyme has been intensively studied from other sources. The 
enzyme was shown here as example for thiolase production and purification (Fig.4.10) 
because it was purer than N-
purified close to apparent homogeneity as judge by 12% SDS
(Fig.4.10) showing a single band corresponding to a molecular mass of 45.1 kDa which is in 
agreement with the calculated molecular mass (about 42 kDa) using 
(version 3.2). Thiolase behaves
180±5 kDa (4*45 kDa) in native gel electrophoresis (Fig.4.10).
CFE PTC W1 W2 
55 µg  35 µg     40 µg     3 µg                    15 µg      25 µg     14 µg      4 µg
 
Fig.4.10:Purification of C-terminally tagged Thiolase. 
The left gel is 12% SDS-PAGE Stained with Coomassie.
the column; W, wash fraction
The right gel is 7% Native
following protein markers:
dehydrogenase, 140 kDa; Bovine serum albumin, 66 kDa. 
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The enzyme activity was measured in the thiolytic direction (Eq. 4.1; bold blue arrow) 
by monitoring the decrease in absorbance at 303 nm at room temperature using a molar 
extinction coefficient of 14 mM−1cm−1  [22]. The assay contained Tris-HCl (pH 8, 100 mM), 
MgCl2 (10 mM), DTT (1 mM), acetoacetyl-CoA and CoA-SH (50 µM each). The specific 
activity was about 29 U/mg in cell free extract (CFE) and increased to 532 U/mg for the pure 
enzyme with 18 fold-purified proteins. 
Kinetic Constants: The kinetic constants were determined in the thiolytic direction (Eq. 4.1), 
under conditions previously described, with varying acetoacetyl-CoA concentrations (5- 100 
µM) in the presence of fixed concentrations of CoA-SH (1.5- 100 µM) and the pure enzyme 
(21 ng) per test. Lineweaver-Burk plots were obtained by plotting reciprocal initial thiolysis 
velocity versus reciprocal CoA-SH concentration in the presence of fixed concentrations of 
acetoacetyl-CoA (Fig.4.11). The parallel straight lines indicate that the kinetic mechanism for 
thiolase is a Ping Pong pattern involving an acetyl-enzyme covalent intermediate. In order to 
calculate the apparent KM and Vmax values graphically, two different secondary graphs were 
plotted using the data from the primary graph (Fig.4.11). In the first graph (Fig.4.12.A), the 
linear reciprocal plot of varied acetoacetyl-CoA concentrations was plotted against ordinate 
intercepts which were obtained from figure (4.11). The apparent KM value for acetoacetyl-
CoA was about 33 µM with an estimated Vmax of 625 U/mg. A second graph (Fig.4.12.B) was 
employed to calculate the apparent KM for CoA-SH, in which the linear reciprocal plot of 
varied acetoacetyl-CoA concentrations was plotted versus abscissa intercepts which were 
derived from figure (4.11). As a result, thiolase had an apparent KM about 27 µM for CoA-SH. 
The inhibitor effect of CoA-SH was observed at low concentration of acetoacetyl-CoA and 
high concentration of CoA-SH (Fig.4.11).  The kcat value in the thiolytic direction was 470 s-1 
and kcat/ KM was 14 µM-1s-1. 
 
Fig.4.11: Double reciprocal plots of 
thiolase activity at varied 
CoA-SH concentrations in 
the presence of fixed 
concentrations of 
acetoacetyl-CoA as 
indicated in legend.  
THIA12 CH3
O
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Fig.4.12: Secondary plots of reciprocal acetoacetyl-CoA concentration against ordinate intercepts (A) and 
abscissa intercepts (B) which were obtained from figure (4.11).  
 
4.2.2. β-Hydroxybutyryl-CoA dehydrogenase 
β-Hydroxybutyryl-CoA dehydrogenase (BHBD, EC 1.1.1.157) catalyzes the reduction 
of acetoacetyl-CoA with NADH to form 3-hydroxybutyryl-CoA. This subprocess is the initial 
and necessary step towards the ultimate production of butyrate and butanol. The hbd gene, 
encoding BHBD from C. acetobutylicum ATCC 824 and C. difficile, has already been cloned 
in E. coli and sequenced [25, 26], but it had not yet been purified or characterized from C. 
difficile. This work describes the purification to homogeneity of BHBD from C. difficile as it 
is shown in 15% SDS-PAGE for the C-terminally tagged BHBD with a monomeric molecular 
mass of 33.5 kDa, correlating with the predicted molecular mass (32 kDa). The enzyme was 
determined to be a tetramer with a native molecular mass of 144±3 kDa (4*33.5) (Fig.4.13).  
The enzyme activity was measured in the physiological direction (reduction of 
acetoacetyl-CoA, Eq. 4.2) by monitoring the decrease in absorbance at 340 nm at room 
temperature using a molar extinction coefficient of 6.22 mM−1cm−1 [57]. The assay contained 
Kpp (pH 6, 50 mM), DTT (1 mM), acetoacetyl-CoA (50 µM) and NADH (200 µM). The 
specific activity in the CFE was 1.3 and 1.1 U/mg for the C- and N-terminal tagged enzyme, 
respectively.  The purification proceeded 20 and 18 fold with specific activities of 26 and 20 
U/mg, respectively.  The BHBD from C. difficile showed a relative activity about 3% with 
NADPH compared to NADH indicating that BHBD is NADH-depended. 
 
0
0,15
0,3
-0,12 0 0,12 0,24
1/ CoA-SH  
1/ AcetoAcetyl-CoA (µM-1) 
B
KM = 27 µM
 CFE PTC M W1 W
  70 µg   45 µg            50 µg   7 µg     2.5 µg   19 µg   16 µg   4 µg 1.5µg
 
Fig.4.13: Purification of C-terminally tagged
The left gel is 15% SDS-PAGE Stained with Coomassie.
the column; W, wash fraction; E, elution fractions; M, PageRuler™ Unstained Protein 
The right gel is 7% Native
following protein markers:
dehydrogenase, 140 kDa; Bovine serum albumin, 66 kDa. 
 
 
Kinetic Constants. Kinetics properties for BHBD were analyzed in the acetoacetyl
reduction direction (Eq. 4.2) by variation of acetoacetyl
the presence of fixed concentrations of NADH (25
tagged enzyme under the previously described conditions. Figure (4.14) 
enzyme exhibits substrate inhibition and the pattern of inhibition is related to the saturation 
with NADH. In order to calculate 
were employed. In the primary plot (Fig.4.15), the initial velocity at various NADH 
concentrations is plotted reciprocally versus acetoacetyl
enzyme is inhibited by acetoacetyl
acetoacetyl-CoA concentration was
was determined to be 17 µM for acetoacetyl
against the ordinate intercepts that were
for NADH, calculated as 210 µM with an apparent 
kcat value for ΒΗΒD in the redaction direction of acetoacetyl
1.8 µM-1s-1. 
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Fig.4.14: Michaelis-Menten plots 
of BHBD activity.  
 
 
 
 
 
 
 
 
 
 
 
 
Fig.4.15: Double reciprocal plots 
of BHBD activity. 
 
 
 
 
 
 
 
 
 
 
 
  
Fig.4.16: Secondary plots of 
NADH concentrations 
versus ordinate intercepts 
that were obtained from 
figure (4.15). 
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  The ki value for acetoacetyl-CoA was obtained from Dixon plots, in which 
acetoacetyl-CoA concentration was plotted against reciprocal velocity in two different graphs, 
either in the presence of un-saturated fixed concentrations of NADH (25- 100 µM) 
(Fig.4.17.A), or in the presence of fixed saturating concentrations of NADH (200 and 400 
µM) (Fig.4.17.B). The data show that acetoacetyl-CoA was a non-competitive inhibitor for 
ΒΗΒD with an apparent ki of 43 µM.  
 
 
 
 
 
 
 
 
 
 
 
Fig.4.17. Dixon plots for BHBD at different concentrations of acetoacetyl-CoA in the presence of non-
saturated (A) or saturated (B) fixed NADH concentrations.  
 
Mechanistically, the data shown indicate a non-competitive inhibition in the presence 
of un-saturated concentrations of acetoacetyl-CoA (Fig.4.18.A). On the contrary, competitive 
inhibition was observed in the presence of saturated concentrations of acetoacetyl-CoA (25- 
100 µM) (Fig.4.18.B). These findings are compatible with a steady-state ordered bi-bi 
sequential bi-reactant kinetic mechanism with NADH binding first to the free enzyme.  
 
 
 
 
 
 
 
 
 
 
 
Fig.4.18. Double reciprocal plots for BHBD activity in the presence of un-saturated (A) or saturated (B) 
fixed acetoacetyl-CoA concentrations.  
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pH optimum: Activity for BHBD was measured at different pH values using acetate buffer 
(pH 5.5 and 6.0), phosphate buffer (pH 6.0- 7.5) and Tris-HCl buffer (pH 7.5- 9.0). 
Noteworthy, the enzyme precipitated under acidic conditions (acetate buffer pH less than 5.5). 
The enzyme showed high relative activities from pH 5.5 to 6.5 (Fig.4.19) with an optimum 
pH of about 6. When the enzyme works in neutural or light alkaline conditions, the relative 
activity sharply decreases to 67 and 27% in pH 7.0 and 7.5, respectively.   
 
Fig.4.19: Optimum pH for BHBD.  
 
 
 
 
 
 
 
 
 
 
 
 
4.2.3. Crotonase 
3-Hydroxybutyryl-CoA dehydratase (Crotonase, EC 4.2.1.55) capable of catalyzing 
the reversible hydration of crotonyl-CoA to hydroxybutyryl-CoA from C. difficile has been 
purified to apparent homogeneity. The purity of C-terminally tagged crotonase was confirmed 
via 15% SDS-PAGE (Fig.4.20) showing a single band corresponding to a molecular mass of 
29.7 kDa, close to the calculated molecular mass. The native molecular mass was 125±3 kDa 
(Fig.4.20), suggesting that it is a tetramer (4*29.7). The enzyme activity was measured by 
monitoring the decrease of crotonyl-CoA due to hydration of the conjugated double bond at 
263 nm (the reverse direction of Eq. 4.3) [27] at room temperature using a molar extinction 
coefficient of 6.7 mM−1cm−1 [18, 27]. The assay contained Tris-HCl (pH 7.5, 100 mM), 
MgCl2 (5 mM), DTT (1 mM), EDTA (1 mM), Bovine serum albumin (50 µg) and crotonyl-
CoA (50 µM). The enzyme was significantly more stable when diluted in a BSA containg 
buffer (1 mg/mL) as compared to dilution in buffer without BSA. The specific activity in cell 
extracts was 705 U/mg for C-terminally tagged enzyme. The enzyme could be purified 26 fold 
with specific activity of 18,600 U/mg.  
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Fig.4.20: Purification of C-terminally tagged
The left gel is 15% SDS-PAGE Stained with Coomassie.
the column; W, wash fraction; E, elution fractions; M, PageRuler™ Unstained Protein 
The right gel is 7% Native
following protein markers:
dehydrogenase, 140 kDa; Bovine serum albumin, 66 kDa. 
 
Kinetic Constants. C-terminally tagged crotonase was employed to calculate apparent 
and KM values because the purity and yield were better than the 
Values for Vmax and KM were calculated from Lineweaver
from non-linear regression of Michaels
(reverse direction of Eq. 4.3) employing previously described conditions with 
and varying concentrations of crotonyl
was about 52 µM with a Vmax
crotonase was about 11.12*10
 
Fig.4.21: Double reciprocal plots of 
crotonase. 
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Fig.4.22: Michaelis-Menten curve 
for Crotonase. 
 
 
 
 
 
 
 
 
 
4.2.4. Butyryl-CoA dehydrogenase/ ETF complex 
As stated initially, one of the most important aims of this study was to figure out the 
nature of butyryl-CoA dehydrogenase from Clostridium difficile. The finding that the genome 
of C. difficile harbors rnf-genes, which could allow energy conservation aided by reduced 
ferredoxin produced by a bi-forking enoyl-CoA reductase, let us to expect such an enzyme in 
this organism. In contrast, the genome of C. acetobutylicum lacks rnf-genes, suggesting that a 
common butyryl-CoA dehydrogenase is present in the latter organism. Thus, the enzyme from 
C. acetobutylicum was introduced in this study for control purposes. 
The previous work on butyryl-CoA dehydrogenase/ETF complex (EC 1.3.99.2) 
constructed from C. difficile showed that the six enzyme variants using the different 
constructed plasmids (Fig.4.9) expressed in E. coli have a different activity behavior in cell 
free extract than the pure proteins [107]. These investigations have shown that only an 
enzyme variant which carries a C-terminal StrepII-tag at the etfA-subunit exhibits high 
specific activity and retained complex stability, while other variants were either significantly 
less active (< 30% of wild type) and/ or incomplete regarding their subunit composition. 
These findings were basically confirmed with the enzymes from C. acetobutylicum and the 
plasmid pASG.3´_bcdABC was used for recombinant production of Butyryl-CoA 
dehydrogenase from C. difficile and C. acetobutylicum in E. coli. The purification was 
performed under both aerobic and anaerobic conditions. As shown by SDS-PAGE (Fig.4.23 
& 4.24), three bands between 28 and 43 kDa corresponding to purified butyryl-CoA 
dehydrogenase/ETF complex were observed and it is almost equal to the mass calculated 
from amino acid sequence. Staining intensities suggest a stoichiometry (αβγ) of 1:1:1 and 
1:2:1 for butyryl-CoA dehydrogenase/ ETF complex from C. difficile and C. acetobutylicum 
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The enzyme activity was measured 
to facilitate understanding of the reaction mechanism.
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Fig.4.23: SDS-PAGE 15% showing purity and molecular mass for butyryl
ETF complex from C. difficile
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Fig.4.24: SDS-PAGE 12% showing purity and molecular mass for butyryl
ETF complex from C. acetobutylicum
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4.2.4.1. Ferricenium hexafluorophosphate assay 
Butyryl-CoA dehydrogenase/ ETF complex from C. difficile is active under aerobic 
conditions and it is not sensitive to oxygen. In contrast, the one from C. acetobutylicum is 
slightly oxygen sensitive [56-59]. The activity was measured under aerobic conditions using 
ferricenium hexafluorophosphate (Fc+PF6-) as artificial electron acceptor (Eq. 4.4), in an assay 
which it is well established for measuring activity of acyl-CoA dehydrogenases in the 
oxidative direction. Enzyme activity was calculated based on monitoring the reduction of 
ferricenium at 300 nm using a molar extinction coefficient of 8.6 (2*4.3) mM−1cm−1 [101]. 
The assay contained Kpp (pH 7.5, 50 mM), FAD (5.0 µM), ferricenium (100 µM) and 
butyryl-CoA (50 µM). The specific activities for the BCD/ ETF complexes obtained from C. 
difficile and C. acetobutylicum in CFE were 0.41 and 0.72 U/mg, respectively, for the 
complexes with C-terminal tagged ETFA-subunits. After purification, specific activities 
raised to 10.2 and 8.4 U/mg achieving 25 and 12-time fold purification, respectively.  
 
Kinetic Constants: The apparent KM and Vmax values for butyryl-CoA were calculated from 
non-linear regression of the Michaels-Menten equation (Fig. 4.25). Butyryl-CoA 
dehydrogenase from C. difficile has an apparent KM of 10 µM for butyryl-CoA at an apparent 
Vmax of 15.3 U/mg. It was a result of testing varied butyryl-CoA concentrations (2.5- 35 µM) 
in the presence of fixed concentration of ferricenium (100 µM) and 180 ng pure enzyme 
complex. The turnover number (kcat) for butyryl-CoA dehydrogenase from C. difficile 
calculated from a sub-complex molecular mass of 110.3 kDa was 28 s-1 per active site and the 
kcat/ KM was 2.8 µM-1s-1. 
 
Fig.4.25: Michaels-Menten plots of BCD/ 
ETF complex from C. difficile 
produced in E. coli.  
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C. difficile BCD/ ETF complex under oxic 
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Fig.4.27: Establishment the optimum measurement for BCD
 
Table.4.4: Establishment the 
Reaction Nr. FAD 
1 0 µM 
2 5 µM 
3 10 µM 
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6 10 µM 
7 10 µM 
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Table.4.5: Kinetic constants of BCD/ ETF complex 
Substrate 
KM 
(µM) 
Vmax (U/mg) 
Sub-complex 
mass (kD) 
kcat 
 
(s-1) 
kcat/ KM 
(µM-1s-1 ) 
NADH 145 19.4 110.3 36 0.25 
Ferredoxin 2.0 20.2 110.3 37 18.5 
Crotonyl-CoA 2.5 10.2 110.3 19 7.6 
 
 
 
Fig.4.28: Michaels-Menten plots for BCD/ ETF complex from C. difficile produced in E. coli.  The assay 
contained Tris-HCl (pH=7.5, 50 mM), MgCl2 (10 mM), NaCl (50 mM), FAD (10 µM), NADP (100 
µM), FPR (0.3U), 120 ng pure BCD/ETF, Fd (10 µM) and Crotonyl-CoA (50 µM).  
 
 
Fig.4.29: Michaels-Menten plots for BCD/ ETF complex from C. difficile produced in E. coli.  The assay 
contained Tris-HCl (pH=7.5, 50 mM), MgCl2 (10 mM), NaCl (50 mM), FAD (10 µM), NADP (100 
µM), FPR (0.3U), 120 ng pure BCD/ETF, NADH (200 µM) and Crotonyl-CoA (50 µM).  
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 Fig.4.30: Michaels-Menten plots for B
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The re-generation system employed in the current study wa
reductase (FPR, EC 1.18.1.2) which couple
ferredoxin (Fdred) to form NAD(P)H and oxidized ferredoxin (Fd
from E. coli (accession Nr. b3924
purified and characterized in the current work (Fig.4.31). The molecular mass for the 
C−terminally tagged protein was 29 kDa. The specific activity for the pure enzyme was 38 
U/mg in the assay containing 
NADPH (200 µM) and Ferricyanide (
compared to NADPH and this activity decreased in the 
56 U/mg and KM of 18 and 11 µM for NADPH and Ferricyanide were obtained, respectively 
(Fig.4.32).  
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Fig.4.31: SDS-PAGE 15% showing purity and 
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Fig.4.32: Michaels-Menten plots for FPR.
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 4.2.5. Butyrate kinase 
Butyrate kinase (EC 2.7.2.7), 
from butyryl phosphate with concomitant phosphorylation of ADP, has been de
different clostridia [27, 43, 45
subunit band corresponding to a molecular mass of 42.6 kDa (Fig.4.3
agreement with its calculated molecular mass (40 kDa). The native molecular mass was 
determined by Native-PAGE and it was about 89± 3 kDa (Fig.4.35). This suggests that the 
native enzyme is apparently a homodimer
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which catalyzes the reversible formation of butyrate 
-47]. The purified C-terminally tagged enzyme showed a single 
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enzyme was monitored using a molar extinction coefficient of 6.22 mM−1cm−1 [102]. The 
assay contained Kpp (pH 7.5, 50 mM), MgCl2 (5 mM), glucose (4 mM), (1 mM) DTT, 
NADP+ (200 µM), ADP (100 µM), butyryl-phosphate (1 mM), glucokinase and glucose 6-
phosphate dehydrogenase (one unit each). The specific activity in cell free extract was 21 U/ 
mg and after purification, it had sharply increased to achieve 322 U/mg with about 15-time 
fold.  
 
Kinetic Constants.  Kinetic properties of BUK were analyzed in the butyrate-forming 
direction by varied butyryl-phosphate concentrations (0.09- 5.75 mM) in the presence of 
different fixed concentrations of ADP (25- 250 µM) and 43 ng pure enzyme (Fig.4. 34). In 
order to calculate KM and Vmax values graphically, Lineweaver-Burk plots were employed 
(Fig.4.35). The straight lines were intersecting in x-axis showing an apparent KM value of 470 
µM for butyryl-phosphate (Fig.4.35). Moreover, a secondary graph (Fig.4.36) was plotted 
with the reciprocal of the ADP concentration against the ordinate intercepts, which were 
obtained from figure (4.35). The enzyme had an apparent KM for ADP of about 70 µM with 
an apparent Vmax of 345 U/mg. The calculated turnover number (kcat) was 245 s-1 and kcat/ KM 
was 0.52 µM-1s-1. The Lineweaver-Burk plots (Fig.4.35) indicate that the butyrate kinase 
reaction follows a formation of a ternary complex of enzyme-butyrylphosphate-ADP by 
random bi-bi pattern.  
 
 
 
Fig.4.34: Michaels-Menten kinetics of BUK. 
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Fig.4.35: Lineweaver-Burk plots of B
varied butyryl-phosphate. The legend 
shows the ADP concentrations.
 
4.2.6. Phosphate butyryltransferase (PBT
Phosphate butyryltransferase (EC 2.3.1.19), an enzyme capable of catalyzing the 
reversible transfer of the butyryl group from butyryl
CoA and an inorganic phosphate, has been found in all clostridia. The purified 
tagged PBT showed a single subunit band corresponding to a molecular mass of 34.2 kDa 
(Fig.4.37) and is in agreement with the predicted molecular mass (33.7 kDa). 
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6-phosphate dehydrogenase. This method was more effective than the commonly used DTNB 
assay, because the latter is strongly affected by DTT, which was used as an anti-oxidant to 
protect enzyme activity. The assay contained Kpp (pH 7.5, 50 mM), MgCl2 (5 mM), glucose 
(4 mM), NADP+ (200 µM), ADP (100 µM), butyryl-CoA (50 µM), DTT (1 mM) and one unit 
of each glucokinase, glucose 6-phosphate dehydrogenase and butyrate kinase. The specific 
activity was 8 U/mg in the cell free extract and 180 U/mg for the pure protein (22 fold). The 
enzyme activity with alternative substrates was 5% with acetyl-CoA, 26% with acetoacetyl-
CoA, and 33% with propionyl-CoA.  
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Kinetic Constants.  Apparent KM and Vmax values for PBT from C. difficile produced in E. 
coli were calculated mathematically with non-linear regression of Michaels- Menten equation 
and graphically from Lineweaver-Burk plot (Fig.4.38) in the previously described buffer, 
different butyryl-CoA concentrations (1.5- 200) and 50 ng pure enzyme. The enzyme had 
apparent KM of 72 µM for butyryl-CoA with apparent Vmax 257 U/mg. At optimal substrate 
concentration the turnover number (kcat) was 151 s-1 and the kcat/ KM was 2.1 µM-1s-1. 
 
Fig.4.38: Michaels-Menten and Lineweaver-Burk plots of phosphate butyryltransferase activity.  
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Cloning of individual genes 
pE_bcd pE_hbd pE_crt2 pE_pbt pE_buk pE_thiA1 
 
pE_etfA pE_etfB 
pFF.rbs_bcd pFFc_etfB pFF.rbs_thiA1 pFF.c_hbd pFF.c_crt2 pFF.rbs_pbt pFF.c_buk 
pE_bcd.rbs_etfB pE_ThiA1.rbs_Hbd pE_Pbt.rbs_buk 
pFF.rbs_bcd.rbs_etfB 
 
pE_bcd.rbs_etfB.rbs_etfA 
pFF.rbs_thiA1.rbs_hbd 
 
pE_thiA1.rbs_hbd.rbs_crt2 
 
pFF.rbs_bcd.rbs_etfB.rbs_etfA pFF.c_pbt.rbs_buk 
pE_bcd.rbs_etfB.rbs_etfA.rbs_thiA1.rbs_hbd.rbs_crt2.rbs 
pFF.rbs_bcd.rbs_etfB.rbs_etfA.rbs_thiA1.rbs_hbd.rbs_crt2.rbs 
 
pE_bcd.rbs_etfB.rbs_etfA.rbs_thiA1.rbs_hbd.rbs_crt2.rbs_pbt.rbs_buk 
 
pASG_bcd.rbs_etfB.rbs_etfA.rbs_thiA1.rbs_hbd.rbs_crt2.rbs_pbt.rbs_buk 
pFF.c_thiA1.rbs_hbd.rbs_crt2 
pFF.c_etfA 
4.3. Establishment of the butyrate synthetic pathway in Escherichia coli 
4.3.1. Construction of co-expression plasmids 
Since it has been previously shown that the individual enzymes required for butyrate 
production were produced in E. coli in an active state, two different butyrate metabolic 
pathway modules, pASG.wt_BUTD and pASG.wt_BUTAC, are constructed (the construction 
scheme is given in figure 4.39). The underlying fusion process was previously exemplified 
with butyryl-CoA dehydrogenase/ ETF complex (Fig.4.8 & 4.9).  
Fig.4.39: Construction scheme of butyrate metabolic pathway module. 
 
Please note that both expression plasmids contained most butyrate fermentation genes 
(thiA1, hbd, crt2, pbt and buk) from Clostridium difficile. Only the butyryl-CoA 
dehydrogenase/ETF complex genes originated from either C. difficile (pASG.wt_BUTD) or 
C. acetobutylicum (pASG.wt_BUTAC) (Fig.4.40) 
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Fig.4.40: The constructed butyrate biosynthetic expression plasmids used in the current work.  
 
The plasmids were then transformed into E. coli Rosetta and the expression of the 
foreign genes was accomplished by induction of the tetR-regulated artificial operon by 
anhydrotetracycline (AHT, 200 ng/ mL).  
As summarized in tables (4.6 and 4.7), the recombinant proteins were readily detected 
in cell-free extracts of the recombinant strains (further referred to as BUTD and BUTAC), 
while their activities were either totally absent or very low in control cells. In fact, it turned 
out that the expression levels of individual enzymes was strongly reduced as compared with 
the single enzyme expression for purification of particular targets, but the enzyme production 
still remained clearly visible on Coomassie-stained SDS-PAGE (Fig.4.41.b). Thus, it can be 
stated that also under the conditions of co-expression some enzymes required for the transfer 
of acetyl-CoA to butyrate were produced in similar amounts and clearly detectable via the 
enzyme activities. 
Table 4.6: Enzymes specific activities in E. coli Rosetta, BUTD and BUTAC
 
strains 
strains 
Specific activity (U/mg) 
THIA1 BHBD CRT2 BCD PBT BUK 
Rosetta 0.4 >>0.01 0.2 ND ND 0.1 
BUTD  13.8 0.38 64.3 0.043 1.95 13.2 
BUTAC  18.7 0.65 89.1 0.098 2.09 25.2 
 
Table 4.7: The expression levels of individual genes in recombinant
 
E. coli strains 
strains THIA1 BHBD CRT2 BCD PBT BUK 
BUTD  12 3 1 4 3 19 
BUTAC  11 3 1 Nd 3 37 
    ND, not detected; Nd, not determined 
pASG.wt_ButD
11029 bp
1   - 1
tetP - 2939
rbs3a - 4205
rbs3a   - 5021rbs3a   - 6050
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 Fig.4.41.a: Coomassie-stained gels with individually purified 
C-terminally StrepII-tagged 
3), BUK (43 kDa, lane 5) and 
12% SDS-PAGE. The 
ETF-subunits A (39 kDa) and B (29 kDa) with a C
separated on 15% SDS-
mass standards (M) are indicated for comparison
Fig.4.41.b: Coomassie-stained gels
(pASG.wt-BUTD). The induction time
the new bands corresponding to 1, T
ETFB. The sizes of relevant molecular mass standards (M) are indicated for comparison
 
4.3.2. Production of butyrate by the recombinant strains 
The recombinant production 
to investigate the formation of its product
known, E. coli does neither produce butyric acid as a fermentation end product nor is 
capable of utilizing butyrate as carbon
foreign genes was predicted to induce both capabilities in the rec
Rosetta and the recombinant strains were checked for butyrate production upon growth on 
liquid medium with 20 mM glucose as a sole carbon source under aerobic conditions 
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-61- 
recombinant enzymes
THIA1 (45 kDa, lane 1), BHBD (34 kDa, lane 2), 
N-terminally StrepII-tagged PBT (35 kDa, lane 4) were separated on 
BCD/ETF complex (15 µg) composed of the reductase (42 kDa) and the 
-terminal StreppII-tag attached to ETFA was 
PAGE. The sizes of relevant proteins of PageRuler™ (Fermentas) molecular 
. 
 show the expression of butyrate pathway biosynthetic module 
s (per hours) indicate above each lane. The 
HIA1 plus BUK; 2, BCD; 3, ETFA; 4
 
of the butyrate forming enzymes in E. coli
ion by the recombinant strains. As previously 
/energy source [90, 108]. The introduction of the 
ombinant strains. 
 
. 5-10 µg of                  
CRT2 (30 kDa, line 
 
right arrows show 
, BHBD; 5, CRT2 plus 
. 
 encouraged us 
it 
E. coli 
M9 
Results  
-62- 
 
(Fig.4.42.b, c & d).  From these cultures, samples were taken at various time-points and 
analyzed in order to collect data sets including growth, substrate consumption and product 
formation. 
The biomass (dry mass) of E. coli was calculated from the optical density of the 
culture with a correlation factor of 0.35 mg dry mass per unit OD578nm. The glucose 
concentration in the medium was followed by a coupled optic enzymatic test using 
glucokinase from C. difficile and glucose-6-phosphate dehydrogenase from Bacteroides 
fragilis (both recombinantly produced in E. coli). The fatty acid analysis was performed using 
a HPLC-method recently developed in our laboratory [109]. Therefore, fatty acids were 
extracted from the medium with diethyl ether and converted to the corresponding acid 
chlorides with oxalylchloride. The acid chlorides were then esterified with p-nitrophenol and 
the nitrophenyl esters were separated by RP-HPLC using a Synergi Polar-RP (18Å, 4µm, 
250*4.6 mm) column as stationary phase. As shown in figure (4.42.a), fatty acids from C2 to 
C5 were readily separated by the method employed and allowed simultaneous quantification 
of acetic, propionic, butyric and valeric acid using an internal standardization calibration with 
cyclohexyl carboxylic acid as internal standard.  
 
 
b) E. coli Rosetta 
a)  Standard 
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Fig.4.42: Chromatograms show the analysis of short-chain fatty acids: a) Standard of 20 mM of Ac, 
acetate; Pro, propionate; But, butyrate; Val, valerate; ISTD, cyclohexyl carboxylic acid was 
used as internal standard.  b) E. coli Rosetta obtained as control; c) E. coli BUTD; d) E. coli 
BUTAC. 
 
 As expected, the host strain as well as the recombinant ones readily consumed glucose 
and grew reasonably. The fatty acid analysis revealed a growth-associated increase of the 
acetate concentration during exponential growth, which reached a maximum of 16.6 mM in 
the host or 9.3 and 6.6 mM in the BUTD- or BUTAC-strains, respectively. As expected, only 
the recombinant strains were capable to form butyrate and maximum values of 3.1 and 3.7 
mM were obtained, respectively. 
As shown in figure (4.43.a), the host strain consumed the offered glucose rapidly and 
grew within 5.7 h to an optical density of 2.0 (CDM = 0.7 g/L). The growth of the cells was 
slightly bi-phasic. During rapid glucose consumption and exponential growth, a rapid and 
significant formation of acetate was observed. After glucose consumption, the intermediately 
formed acetate was re-utilized with a rate equal to its production rate. The butyrate 
concentration in the media never exceeded background levels. 
d)  E. coli BUTAC 
c) E. coli BUTD 
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Fig.4.43.a: Growth curve, glucose consumption, butyrate and acetate concentrations in E. coli Rosetta 
culture. Note, all the curves were simulated using exponential equation and the value represented by 
an open symbol was taken from the simulation.   
 
The recombinant strains grew significantly slower than the host did while the biomass 
production in these cultures was slightly reduced (0.46 and 0.5 g CDM/L at time point 5.7 h). 
In sharp contrast, the recombinant strains readily started to produce butyrate after induction of 
the foreign genes by anhydrotetracycline (Fig.4.43.b). It is rather obvious from the data 
depicted that the butyrate formation occurred on the expense of acetate. Its maximum 
concentration was significantly reduced in the cultures of recombinant strains. 
 It should be noted, that the introduction of butyrate fermentation pathway genes into 
E. coli was originally expected to promote not only butyrate formation from acetyl-CoA, but 
also to enable butyrate oxidation in the opposite direction. Thus, it must be considered 
remarkable that no butyrate oxidation was observed after glucose consumption by the 
recombinant strains at all, while acetate was oxidized to an extent, which is similar to the host 
(Fig.4.43.b). 
While butyrate formation is shared by both strains and the final concentration of 
butyrate is even slightly higher in BUTAC harboring the butyryl-CoA dehydrogenase from 
C. acetobutylicum, the kinetics of product formation differs significantly between both strains. 
It can be clearly seen in figure (4.43.b) that butyrate formation is readily induced by the 
addition of anhydrotetracycline in BUTD while its formation occurs strongly delayed in 
BUTAC. 
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Fig.4.43.b: Growth curve, glucose consumption, butyrate and acetate concentrations in recombinant 
E. coli strains (BUTD & BUTAC) cultures. All the curves were simulated using exponential 
equation and values represented by open symbols were taken from the simulation. The induction-
point is reflected by brown dotted arrow. 
 
4.3.3. Models of butyrate fermentation  
The kinetic model of batch fermentation provides information to understand cell mass 
and product generation, when the basic parameters of a fermentation process are known. 
Therefore, kinetic growth parameters, substrate utilization, product- and by-product formation 
must be known. In the following section, these parameters are calculated in order to provide 
information necessary to discuss the experimental findings in detail. 
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4.3.3.1.Biomass production 
The growth of microorganisms in batch cultures occurs in a characteristic, multi-
phasic manner: In the so-called lag phase the organisms must adapt to medium conditions. 
Subsequently, the microbes grow with maximum rate during exponential phase until the 
nutrient supply becomes limiting in the stationary phase. The maximum specific growth rate 
(µmax) is a very characteristic kinetic parameter of growing organisms and it has a constant 
value for cultures growing under identical conditions. The µmax is obtained in the exponential 
phase by plotting ln (MX/MX0) against time, where MX is the C-mmol biomass at a given time 
point and MX0 the C-mmol biomass at the beginning of the experiment. The C-mmol biomass 
calculated from the equation (C-mmol= 1/25 mg CDM, where 25 is the molecular weight in 
grams for the biomass formula C1 H1.8 O0.5 N0.2). Applied on a non-disturbed growth situation, 
as can be assumed for the host cells, a straight line is observed with a slope that equals µmax 
throughout substrate consumption (Fig.4.44). In contrast, any disturbances introduced (e.g. by 
induction of foreign genes) must definitely alter the appearance of this graph in a way that a 
stair-like plot is observed. As shown in figure (4.44), this is indeed the case, when the host 
cell behaviour is compared to the recombinant strains. While E. coli Rosetta grew upon 
glucose consumption with a rather constant µmax of 0.54 h-1, BUTD, and BUTAC strains 
exhibited  only slightly reduced  µmax  of 0.46 and 0.44 h-1 pre-induction (a fact that might be 
attributed to the need to sustain plasmid proliferation) the picture is significantly changed 
upon induction of the genes by anhydrotetracycline. Now, the energy demanding protein 
synthesis takes place and, moreover, significant part of the intracellular carbon flux is 
redirected into butyrate formation. In consequence, an almost complete intermediate arrest of 
cell growth is observed (Table 4.8). Noteworthy, this arrest is of transient nature, which 
suggests that the induction of the foreign genes by the light-sensitive inducer is not stable 
over time and might be decreased in later stages of the fermentation process. Indeed, it was 
observed that the specific activities for butyrate forming enzymes decreased at the end of the 
exponential growth phase 
but remained detectable 
even in stationary phase at 
reduced rates.    
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Fig.4.44: Maximum specific growth rate (µmax) for E. coli Rosetta, BUTD, & BUTAC Strains, where MX, the 
C-mmol biomass at a given time point; MX0, the C-mmol biomass at zero time.  
 
Table 4.8: Changes of specific growth rate (µ) over time.  
interval time 
Specific growth rate (µ) per hour 
Rosetta BUTD BUTAC 
0.00- 1.50 0.299 0.311 0.277 
1.50- 2.75 0.469 0.505 0.380 
2.75- 3.75 0.769 0.589 0.659 
3.75- 4.75 0.568 0.427 0.453 
4.75- 5.75 0.478 0.360 0.352 
5.75- 7.00 0.000 0.039 0.000 
7.00- 8.50 0.007 0.000 0.055 
8.50- 10.0 0.014 0.018 0.060 
10.0- 12.0 0.025 0.102 0.084 
12.0- 13.0 0.029 0.169 0.227 
13.0- 21.5 0.029 0.023 0.024 
The Gray-shading cells shows the induction time. 
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4.3.3.2.Glucose utilization 
The carbon source provided in a growth medium in batch cultures is generally used to 
generate metabolic energy for cell growth. It should be noted, however, that in particular 
under aerobic conditions, the majority of the carbon ends up in biomass. In fact, the total 
glucose consumption (YG) is actually linked to the amounts individually used for energy 
metabolism (catabolism, YC) and biomass production (anabolism, YA) and it holds that 
YG = YC + YA 
When the values entering the different pathways are known, it is possible to calculate 
the amount of ATP, which is formed in the energy metabolism. For E. coli, this value is close 
to 20 ATP per mole of glucose, and it is readily calculated that upon growth on glucose only 
about 20% of the glucose are used in the energy metabolism while about 80% end up in 
biomass. 
The introduction of foreign genes, however, strongly alters this balance. Carbon which 
is irreversibly converted to butyrate significantly decreases the amount of ATP, which can be 
formed in average per mole of glucose (e.g. the reduction of 2 mole of acetyl-CoA to butyrate 
yields 1 mole of ATP, while the oxidation of two molecules of acetyl-CoA via the Krebs 
cycle yields 14 ATP in E. coli). Thus, it is very important to determine the fractional amounts 
of glucose utilized for different purposes in the recombinant and host strains. It should be 
noted, however, that only the value for total glucose consumption and biomass formation are 
readily assessable by measurements, while the values for product and by-product formations 
must be dissected by some theoretical considerations. 
The conversion of glucose to biomass, Yield(G/X), is obtained in the exponential phase 
by plotting (MGt-MG0) versus (MXt-MX0) where MGt is the mmol glucose at time t; MG0, the 
mmol glucose at the beginning of the experiments; MX, the C-mmol biomass at a given time 
point; MX0, the C-mmol biomass at the beginning of the experiments. A trendline is observed 
with a slope of Y(G/X) equal to qGmax/µmax (Fig.4.45), where qGmax is the maximum specific 
glucose utilization (mmol glucose consumed/ h/ C-mmol biomass produced). The conversion 
of glucose to biomass for E. coli Rosetta, BUTD, and BUTAC strains were 0.53, 0.34, and 0.37 
mmol glucose per producible C-mmol biomass, respectively. Additionally, (qGmax) was of 
0.29, 0.16 and 0.16 mmol glucose per hour per C-mmol biomass. It seems that the two 
butyrate strains have equal qGmax with a significant decrease of about 45% compared to the 
control.  This reflects a positive effect of the induction of foreign genes on glucose uptake and 
utilization, under conditions, where the flow of the metabolic flux through glycolysis is 
limiting for the utilization of glucose. In addition, the overflow of acetyl-CoA normally 
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observed is used to produce butyrate beside biomass rather than acetate, probably because it is 
more beneficial in terms of redox balance under condiditions where plenty of intermediates 
from TCA-cycle are shuttled into biosynthetic pathways.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.4.45: Maximum specific substrate utilization rate (qGmax), where MGt is the mmol glucose at time t; MG0, 
the mmol glucose at the beginning of the experiments; MX, the C-mmol biomass at a given time 
point; MX0, the C-mmol biomass at the beginning of the experiments. 
 
In the control, the maximum consumption of glucose was observed at the end of the 
exponential growth phase (Fig.4.43.a). In contrast, a decrease in glucose consumption was 
monitored in butyrate producing strains (Fig.4.43.b) with conversion of glucose to biomass, 
acetate and butyrate. Thus, glucose uptake was related to biomass and butyrate production 
instead of biomass and acetate in control. The maximum productivity of biomass and butyrate 
was linked to a decline in glucose concentration in the culture. It is, therefore, likely that 
butyrate strains needed longer time to consume glucose as evident by its total consumption 
within 13 h in the recombinant strains as compared to 7 h in the control.  
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4.3.3.3.Butyric acid production. 
As mentioned above, the host strain E. coli Rosetta produced only trace levels of 
butyrate (less than 0.03 mM). It was evident from the enzyme activities in cell free extracts 
(Table. 4.6) that E. coli Rosetta is not capable of producing significant amounts of butyric 
acid.  In contrast, the modified strains harboring plasmids with the genes encoding butyrate-
forming clostridial genes produce significant amounts of butyrate (Fig.4.43.b).  
The maximum rate for butyrate production (RBmax) in modified strains was determined 
by plotting the changes on butyrate production over time (Fig.4.46). No butyric acid was 
observed before the addition of the inducer anhydrotetracycline. E. coli BUTD strain started to 
produce butyrate readily post-induction. The exponential production of butyrate was achieved 
for short period, from inducing point 3.75 to point 7.0 h, with butyrate concentration rising 
from 0.08 to 2.43 mM, respectively. Then, the production decreased due to the limitation of 
glucose in the culture. The maximum production of butyrate was about 3.04 mM (268 mg/l) 
after 13 h post- inoculation, when glucose-limitation in the culture occurred (Fig.4.43.b). It is 
worth noting that the butyrate production in this strain stopped fairly prior total glucose 
consumption and that a limitation of the cells in terms of enzyme activities can be excluded 
by the activity measurements shown in table (4.6). 
  
Fig.4.46: Butyric acid production over time in butyrate strains. The dashed blue line with a square mark                                        
(          ) refers to butyrate production rate in E. coli BUTD strain, while the dotted black line with 
black cycle mark (           ) refers to E. coli BUTAC, while strain arrow showed the induction point. 
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On the other hand, the E. coli BUTAc strain started to produce butyrate only about two 
hours post-induction and exponential butyrate production started even later. The delayed 
butyrate production was accompanied by a sharp increase of acetate production (Fig.4.43.b). 
The data in figure (4.46) show that the maximum rates of butyrate production, obtained 
during exponential butyrate production phase, were 0.74 and 0.81 mmol butyrate per hour for 
E. coli BUTD and BUTAc strains, respectively.  
 
4.3.3.4.Acetic acid production 
Acetic acid is a by-product during metabolic growth of E. coli. During the growth 
under aerobic conditions, the overflow of acetyl-CoA leads to acetate production to gain 
another ATP molecule instead of going into the citrate cycle, thereby increasing the redox 
potential in the cells.  For that, the acetate production curve is very similar to the growth 
curve and increased with increasing cell growth and vice versa. In the control cells, 
exponential acetate production starts after about 2.75 h post-inoculation and a maximum of 16 
mM acetate was observed after about 8.5 h (Fig.4.47). It is worth noting that after glucose 
consumption, the cells utilized acetate as an alternative carbon source with rates similar to its 
production rate and a smaller but significant growth was observed (Table 4.8). 
In the modified strain E. coli BUTD, the productivity of acetate was lower than in the 
control. Additionally, the maximum acetate production was reduced significantly to reach 9.3 
mM acetate after 10 h post-inoculation (Fig.4.47). This reflects the redirection of parts of the 
metabolic fluxes towards butyrate, which can be attributed to the expression of butyrogenic 
genes. Notably, also the recombinant strains reutilized acetate readily after glucose 
consumption.  
In contrast, the acetate production in E. coli BUTAC resembled the control prior 
induction, where the maximum acetate concentration was 6.63 mM at time point 3.75 h 
(Fig.4.47). Suddenly after induction of foreign genes, here the acetate concentration decreased 
sharply. Notably, this decrease is not directly linked with butyrate formation, which occurred 
delayed. A significant increase in acetate concentrations was found to combine the first period 
of butyrate production (time between 5.75 to 7.0 h) to reach 4.68 mM, followed by a decrease 
in acetate production, which was linked with the exponential production of butyrate. 
Afterwards, the cells began to produce additional acetate, which was also readily consumed in 
the “stationary” phase.  
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Fig.4.47: Acetate production over time in E. coli Rosetta, BUTD and BUTAC strains.  
 
4.3.3.5.Operational yields 
The data evaluation described so far enables the generation of time dependent plots of 
the operational yields of butyrate (YB/X) and (YB/G), from which the biomass-specific product 
formation (µ) can be obtained. Therein, YB/X reflects the yield of mmol butyrate per C-mmol 
biomass produced while (YB/G) gives the yield of mmol butyrate per mmol of glucose 
consumed. When these data were plotted versus the incubation time (Fig.4.48), the 
differences between the two recombinant strains became much clearer. Rather obviously, in 
both strains the induction of foreign genes was accompanied by a significant but transient 
drop in the values for µ . More remarkably, butyrate formation was clearly linked with the 
exponential growth in cells harbouring the butyryl-CoA dehydrogenase from C. difficile, 
while its formation occurred predominantly in the stationary phase in cells harboring the 
corresponding genes from C. acetobutylicum. This fact becomes even more apparent, when 
the rate of butyrate formation was based on the glucose consumption as indicated by the 
YieldB/G values. 
In the strain harboring C. difficile butyryl-CoA dehydrogenase, the maximum 
Yield(B/X) was 1.36 mmol butyrate per C-mmol biomass per L with a YB/G of 0.503 mmol 
butyrate produced per 1 mmol glucose consumed. The theoretical conversion ratio of glucose 
to butyrate is 1:1. Thus, the stoichiometry of glucose consumption to butyrate formation by E. 
coli BUTD was above half of the theoretical maximum during exponential growth.   
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On the other hand, in E. coli BUTAC the butyrate Yield(B/X) was 1.43 mmol butyrate 
per C-mmol biomass, showing a glucose conversion rate of 0.535 mmol butyrate 
produced per mmol glucose consumed (Fig.4.49.b). Thus, also this strain produced 
butyrate with similar maximum efficiency, although kinetically delayed. Since the 
butyryl-CoA dehydrogenases encoded in the information carrying plasmids were the 
only difference between the recombinant strains, these observations might reflect 
different kinetic properties of butyryl-CoA dehydrogenase and its two electrons 
transfer subunits between C. difficile and C. acetobutylicum in vivo. 
 
 
Fig.4.48: Changes of operational Yields and specific biomass production over incubation time for butyrate 
strains. Abbreviation in legend; Yield(B/X), yield of mmol butyrate per C-mmol biomass produced; 
Yield(B/G), yield of mmol butyric acid per mmol glucose consumed; µ , specific biomass production. 
Please note that, the (-) sign for Yield(B/G) which refer to the consumption of glucose is removed. 
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5. Discussion 
 
The aim of this study was to elucidate a novel cloning and expression system for 
systematic applications in synthetic biology. Trial and error approaches in this context are 
rather costly in terms of time and money, and the development of structured routine protocols 
was supposed to be a reasonable approach.  
As a model system, we have chosen the butyrate fermentation of C. difficile, which 
has not been studied in detail before. Here, the major question to address was whether or not 
the butyrate forming pathway in this organism involves a novel member of the recently 
discovered bi-forking butyryl-CoA dehydrogenases or not. 
In order to succeed, individual enzymes were initially produced in E. coli in order to 
demonstrate their functional production followed by an initial characterization in vitro.  
Successively, the enzyme encoding genes were assembled in synthetic operon 
structures to create artificial metabolic pathway modules, which could be expressed from a 
single plasmid and enabled the formation of the predicted product, butyrate. Thus, it has been 
demonstrated that crucial intermediates shared by different metabolic pathways (e.g. butyryl-
CoA as an intermediate of butan-1-ol production or polyketide synthesis) can be formed using 
the information provided by a single plasmid. Given that E. coli can harbor multiple plasmids, 
a modular testing of various afferent (substrate delivering) and divergent (product forming) 
pathways is readily possible and might provide rapid access to the development of novel 
(synthetic) metabolic pathways in combinatorial approaches. 
 
5.1. Protein purification and in vitro characterization 
Using the Stargate™ cloning system, the seven enzymes in question from C. difficile 
as well as the control butyryl-CoA dehydrogenase from C. acetobutylicum were successfully 
produced in a functional state in E. coli. The initial characterization of individual enzymes 
was very much facilitated by the easiness to create enzyme variants with StrepII-tags for 
affinity purification: Thiolase, β-hydroxybutyryl-CoA dehydrogenase, crotonase, butyryl-
CoA dehydrogenase/ETF complex, phosphate butyryltransferase and butyrate kinase were 
readily produced in an active state in the host and could be used in order to obtain reliable 
kinetic data for the enzymes in question in reasonable time. The results of these in vitro 
studies will be discussed for the individual enzymes in the following sections. 
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5.1.1. Thiolase 
The first step in the metabolic pathway for butyrate formation in clostridial species is 
the condensation of two molecules of acetyl-CoA to yield acetoacetyl-CoA. This reaction is 
catalyzed by the enzyme acetyl-CoA-C-acetyl transferase (EC 2.3.9.1, further referred to as 
thiolase). Recombinant thiolase from C. difficile consists of 402 amino acid (the wild type has 
391 amino acids) with a calculated molecular mass of 42.2 kDa.  This is in agreement with 
the molecular weight of thiolase from different organisms such as C. acetobutylicum which 
was about 42 kDa [19, 20] and 44 kDa [21], 41 kDa in C. kluyveri [22] and 41.5 kDa in E. 
coli [110]. Thiolase from C. difficile is a tetramer with a native molecular mass of 180±5 kDa 
(4*45 kDa) and it is closely related to thiolase from different bacteria, for which a  tetrameric 
structure with native masses between 150-190 kDa have been reported[21, 22, 111, 112].  
The values observed for the Vmax and Kcat of the recombinant enzyme from C. difficile 
were significantly higher than those previously reported for enzymes derived from other 
bacterial sources, while the KM-values for the substrates fell well into the ranges previously 
described (Table 5.1). 
 
Table (5.1): Comparison of the kinetic parameters of thiolase 
Organism 
KM (µM) Vmax 
(U/mg) 
Kcat (s-1) Reference 
Acetoacetyl-CoA CoA-SH 
C. difficile 33 27 625 470 This work 
C. acetobutylicum 32 4.8 216 160 [21] 
Bacillus subtilis 50 70 114 80 [113] 
 
 
According to the mechanism, parallel straight lines were observed in reciprocal plots 
of initial velocity versus CoA-SH in the presence of fixed acetoacetyl-CoA concentrations. 
The parallel lines indicate that the kinetic mechanism for thiolase follows a Ping Pong pattern 
(Fig. 5.1), a behavior, which has been reported before in different thiolases from various 
sources [21, 23, 114-116]. 
 
Fig.5.1: Simplified schematic view of the Ping Pong mechanism of thiolase. 
 
E
A cetyl-C oA
E-A cetyl-C oA
C oA -S H
F- A cetyl
A cetyl-C oA
F- A cetoacetyl-C oA
A cetoacetyl-C oA
E
Discussion  
-76- 
 
5.1.2. β-Hydroxybutyryl-CoA dehydrogenase 
Acetoacetyl-CoA formed by thiolase is then reduced with NADH to yield 
hydroxybutyryl-CoA. This reaction is catalyzed by β-hydroxybutyryl-CoA dehydrogenase 
(EC 1.1.1.157, further referred to as BHBD). The subunit mass for the recombinant BHBD 
was calculated to be 32 kDa and in agreement with the one from C. acetobutylicum (30.5 kDa 
[25]). It should be noted that C. kluyveri has two hbd genes with accession numbers CKL-
0458 and CKL-2795. The encoded proteins consist of 282 and 319 amino acids with predicted 
molecular mass of 30.3 and 35.4 kDa, respectively. The native molecular mass for C. difficile 
BHBD is 144±3 kDa and suggests a tetrameric structure (4*33.5 kDa), which is in 
disagreement with BHBD from C. kluyveri that has been reported to form an octamer (8*26 
kDa [24]).   
 The BHBD from C. difficile differs from the previously studied one in C. kluyveri 
(Table 5.2) in that the former is NADH-dependent in contrast to the latter, which has been 
shown to be NADPH-dependent [24]. The authors observed a second enzyme in the cell 
lysates, which was, however, NADH-dependent. These results suggest that C. difficile BHBD 
is similar to enzymes in the butyrate forming pathways of other clostridia. It indicates that 
NADH is naturally involved in fermentative butyrate synthesis as reported by Hartmanis and 
Gatenbeck for ΒΗΒD from C. acetobutylicum [27] and that the NADPH-dependent enzyme 
in C. kluyveri might be involved in hitherto unknown biosynthetic pathways.  
 
Table (5.2): Comparison of the kinetic parameters of BHBD 
Organism 
KM (µM) Vmax 
(U/mg) 
Kcat 
(s-1) 
Reference 
Acetoacetyl-CoA NADH NADPH 
C. difficile 17 210 -- 54 30 This work 
C. kluyveri 50 --- 70 290- 450 195 [22, 24] 
 
BHBD from C. difficile was substrate inhibited by acetoacetyl-CoA. It has been 
previously suggested that the enolate–form of the substrate is a potent competitive inhibitor, 
which resembles both crotonyl-CoA and β-hydroxybutyryl-CoA [30].  
The pH-dependent activity profile of BHBD from C. difficile resembles  the one 
previously described for the C. kluyveri enzyme, which has an optimum at pH 6.5 with an 
activity pH range covered from 5.5 to 7.0 with about 90% relative activity [24]. BHBD from 
C. saccharobutylicum is known to exhibit higher activity during solvent production at pH 5.5 
[117]. 
Discussion  
-77- 
 
The kinetic mechanism of the reaction catalyzed by the bi-reactant enzyme BHBD has 
been studied extensively. The enzyme can be largely classified into two classes, following 
either a sequential or a Ping Pong mechanism. Intersecting straight lines observed in the 
double reciprocal plots of the kinetic data of BHBD from C. difficile suggest that the enzyme 
follows a sequential, but not a Ping Pong mode. Since converting initial velocity patterns are 
characteristically for the ordered bi-bi and the random bi-bi mechanism, the reaction of 
BHBD follows one of these rapid bi-reactant mechanisms. The ordered addition of substrates 
is well established for many dehydrogenases: D-hydroxyisovalerate dehydrogenase from 
Fusarium sambucinum [118],  (S)-lactate dehydrogenase from Plasmodium falciparum  [119] 
and 3-oxoacyl-ACP reductase from Plasmodium falciparum [120]are known to bind first the 
nicotinamide cofactor, followed by the binding of the substrate. In contrast, other 
dehydrogenases bind the substrate first. This binding mode has been shown for UDP-glucose 
dehydrogenase (EC 1.1.1.22) from beef liver [121], yeast aldehyde dehydrogenase [122], and 
histidinol dehydrogenase (EC 1.1.1.23) from Salmonella typhimurium [123]. BHBD also 
shows substrate inhibition by acetoacetyl-CoA and its inhibition was not observed with the 
coenzyme (NADH). This may reflect that NADH indeed binds first to the enzyme without 
affecting the binding of acetoacetyl-CoA. In turn, binding of acetoacetyl-CoA to the free 
enzyme inhibits the enzyme activity, probably decreasing the affinity of the enzyme-substrate 
complex for the Co-enzyme. This property suggests that only one substrate (NADH) binds to 
the free enzyme, while the second substrate is bound by the binary complex, and binding of 
acetoacetyl-CoA forms an inhibitory complex not capable of proceeding the catalytic cycle. 
Therefore, the reaction mechanism of BHBD likely follows an ordered bi-bi mechanisms with 
NADH as leader substrate (Fig. 5.2).  
 
Fig.5.2: Schematic representation of the ordered bi-bi mechanism of ΒΗΒD.  
 
5.1.3. Crotonase 
The present study describes the purification and partial characterization of crotonase 
from C. difficile, an enzyme catalyzing the reversible syn-hydration of crotonyl-CoA. The 
subunit molecular mass was about 29.7 kDa as judged by SDS-PAGE and calculated from the 
amino acid sequence (276 amino acids). Molecular masses  of 40 kDa has been described for 
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crotonase from C. acetobutylicum [32], but the molecular mass from amino acid sequence 
derived calculations (261 amino acid) is only 28.2 kDa [25]. Crotonase from C. difficile was a 
tetramer (4*29.7 kDa) with a native molecular mass of 125±3 kDa. This structure is in 
agreement with previous findings[32]. The oligomeric structure of C. difficile crotonase is 
also reflected by the observation, that the StrepII-tag fused to the recombinant variants 
strongly affected enzyme activities (table 5.3). 
 
Table (5.3): Comparison of the kinetic parameters of crotonase 
Organism 
KM (µM) Vmax 
(U/mg) 
Kcat 
(s-1) 
Reference 
Crotonyl-CoA 
C. difficile 52 22,470 11,120 This work 
C. acetobutylicum 30 6,500 4,330 [32] 
 
5.1.4. Butyryl-CoA dehydrogenase 
The central question to be answered in this work was whether or not Clostridium 
difficile possesses a butyryl-CoA dehydrogenase, which belongs to the recently discovered 
sub-class of enzymes that couple NADH oxidation with the thermodynamically unfavourable 
reduction of ferredoxin [33]. Since validation of such an enzyme in the organism enables 
electron transport phosphorylation using the RNF-complex [49], its detection is of general 
importance to understand the remarkable metabolic versatility previously considered for this 
emerging human pathogen [10, 11]. 
The data presented here demonstrate that the butyryl-CoA dehydrogenase from 
C. difficile belongs to the recently described novel sub-family of bi-forking enzymes capable 
to couple the crotonyl-CoA reduction with the endergonic NADH-driven reduction of 
ferredoxin. 
Butyryl-CoA dehydrogenases form a functional complex with electron transferring 
flavoproteins (ETF).  In the crystal structure of human ETF, FAD and AMP are found as 
prosthetic groups [124]. The Megasphaera elsdenii enzyme is the only well-studied and 
structurally characterized bacterial BCD/ETF complex [17]. Here, the ETF contains 2 mol of 
FAD per heterodimer but no AMP; one FAD is covalently bound to the protein, whereas the 
other appears to readily dissociate from the enzyme and has unusual spectral properties [125].  
It has been previously shown that function of butyryl-CoA/ETF complexes 
recombinantly produced in E. coli is strongly affected by the position of affinity tags attached 
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to the nature polypeptides by the means of genetic manipulations for facile purification [107]. 
These data were previously obtained by Regina Fischer and the results are crucial for this 
work, too [107]. While all the recombinant enzyme complexes transferred butyryl-CoA 
dehydrogenase activity into the host, which was readily measurable in cell lysates, most of the 
recombinant enzymes were either inactive or significantly impaired in their catalytic activities 
after purification. Only the enzyme variant in which the StrepII-tag for affinity purification 
was fused to the C-terminus of the EtfA-subunit was fully active, while in other variants the 
activity was strongly reduced or virtually absent, due to complex decay upon purification. 
Thus, all data presented herein refer to this particular enzyme variant. 
The recombinant BCD from C. difficile was purified under oxic conditions and the 
activity was initially measured following the oxidation of butyryl-CoA with ferricenium 
hexaflourophosphate, which serve as an artificial, strong oxidizing electron acceptor [101]. 
Like other clostridial acyl-dehydrogenases, the enzyme consists of three subunits: α-subunit 
(butyryl-CoA dehydrogenase, 42.3 kDa), a large ETF β-subunit (38.7 kDa) and a small ETF 
γ-subunit (29 kDa) encoded by bcd, etfA and etfB, respectively. A stoichiometry of 1:1:1 and 
1:2:1 was found for the three subunits (αβγ) from C. difficile and C. acetobutylicum produced 
in E. coli, respectively. For propionyl-CoA dehydrogenase isolated from C. propionicum a 
stoichiometry of 2:1:1 has been reported [126], as well as butyryl-CoA dehydrogenase 
purified from C. kluyveri [33]. This suggests that the enzymes from various sources differ in 
their composition. 
The butyryl-CoA dehydrogenase from C. difficile is the first clostridial enzyme, which 
has been produced in E. coli and was purified to homogeneity prior to enzyme measurements. 
Previously, Inui and co-workers cloned the crt-bcd-etfB-etfA-hbd operon (4.8 kb) from 
C. acetobutylicum ATCC 824, expressed it in E. coli, measured the activity in the cell free 
extract and demonstrated that the ETF-subunits are essential for activity [57]. In line with its 
essential requirement, ETF is tightly bound in some dehydrogenase enzymes [33, 126, 127]. 
This holds also true for the enzyme from C. difficile.  
Li and co-workers first purified the enzyme from C. kluyveri under anoxic conditions, 
which is the prototype of a bi-forking butyryl-CoA dehydrogenase, and found that this 
enzyme is absolutely ferredoxin-dependent [33]. They unquestionably demonstrated that 
reduced ferredoxin is a second product of the enzyme catalyzed reaction, which was 
quantified by means of hydrogenase-mediated H2-release. On the other hand, Herrmann 
reported that FAD can at least partially substitute for ferredoxin in the enzyme from C. 
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tetanomorphum [127]. In line with the latter observation, we found that C. difficile BCD can 
also use free FAD as alternative electron acceptor. In this work, we developed a novel assay 
for BCD, in which oxidized ferredoxin is regenerated under anoxic conditions by soluble 
Ferredoxin:NADP oxidoreductase from E. coli on the expense of provided NADP+ (Eq. 4.6). 
Under anoxic conditions and with limited FAD concentrations, NADH-driven crotonyl-CoA 
reduction was strictly dependent on the co-reduction of ferredoxin.  
It should be noted, however, that the recombinant enzyme from C. difficile was rather 
oxygen stable and showed significant activity under oxic conditions, too. This is in particular 
true for the physiological direction of the catalyzed reaction, the reduction of crotonyl-CoA 
with NADH. The enzyme complex from C. acetobutylicum, which was analyzed as a control, 
was oxygen-sensitive and lost activity when stored under air. The C. difficile enzyme retained 
activity for several days. Freshly prepared enzymes from both organisms yielded readily 
measurable activity for the ferricenium hexafluorophosphate-dependent oxidation of butyryl-
CoA. Both enzymes exhibited diaphorase activities with NADH, but only the enzyme from 
C. difficile was able to reduce crotonyl-CoA with NADH under air. In sharp contrast to the 
enzyme from C. acetobutylicum, which was entirely inactive with crotonyl-CoA and NADH 
under air when the release of butyryl-CoA is concerned, the enzyme from C. difficile carried 
out the reduction of crotonyl-CoA. For the latter enzyme, a crotonyl-CoA-dependent 
oxidation of NADH was readily detected by increased consumption of NADH, and the 
predicted product, butyryl-CoA, was unquestionably detected by MALDI-TOF-MS. It should 
be noted that the oxygen sensitivity and the failure to measure the enzyme in the crotonyl-
CoA reducing direction have been previously noted for the C. acetobutylicum enzyme [27, 57, 
59, 66]. Thus, the enzyme from C. difficile is rather unique in that this enzyme can utilize O2 
as an alternative oxidant, which replaces the natural substrate (oxidized ferredoxin) under oxic 
conditions. 
 In a meaningful manner, the catalytic properties of the butyryl-CoA dehydrogenase 
from C. difficile can be compared only to the bi-forking enzymes previously described in 
C. kluyveri and C. tetanomorphum, although its ability to oxidize butyryl-CoA with 
ferricenium is shared with other enzymes. Regarding to the kinetics constants, butyryl-CoA 
dehydrogenase from C. difficile fell well in the range of values previously observed for 
enzymes from other sources (Table 5.4). The only significant difference is the KM-value for 
NADH, which is almost 10-times higher for the C. difficile enzyme than previously reported 
for BCD from C. kluyveri. 
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Table (5.4): Range of kinetic constants for Bcd/ETF complexes from different sources.  
Substrates KM (µM) Vmax (U/mg) Kcat (s-1) References 
Butyryl-CoA 
6-16 
10 
1.3- 331 
15 
2-237 
28 
[127-129] 
This work 
Crotonyl-CoA  
4 
2.5 
18 
10 
31 
19 
[127]  
This work 
Ferredoxin 
10 
2 
5-14 
20 
---- 
37 
[33] 
This work 
NADH  
18 
145 
12 
19 
21 
36 
[127] 
This work 
The values given were taken from the indicated references and the values for C. difficile 
BCD are show in bold numbers. 
 
5.1.5. Butyrate kinase 
Butyrate kinase (BUK) phosphorylates ADP on the expense of various acyl-
phosphates. BUK from C. difficile has a molecular mass of 42.6 kDa, which is similar to the 
values reported for enzymes from C. acetobutylicum (39 kDa, [45] and  43 kDa for its 
isozyme, [43]). The enzyme from C. difficile is a dimer of two identical subunits with a native 
mass of 89±3 kDa like previously reported for the BUKs of C. acetobutylicum, were native 
masses of 80 kDa (2*39 kDa) for BUK [45] and 85 kDa (2*43 kDa) for BUK-isozyme have 
been reported [43].  
It is worth noting that in this study the activity of butyrate kinase was measured for the 
first time in its physiological, butyrate-forming direction using glucokinase and glucose-6- 
phosphate dehydrogenase to detect ATP synthesis. This method is more sensitive and 
accurate than the method of Rose, which measures activity in the reverse direction using a 
very small extinction co-efficient of ε540nm= 0.169 mM-1cm-1 [130]. A reducing agent such as 
1 mM DTT was found to be necessary for optimum activity during purification and storage of 
the enzyme. Hartmanis investigated the effect of treatment with sulfhydryl-modifying 
reagents and suggested that there is no involvement of sulfhydryl groups at the catalytic site 
[45]. A possible explanation for the requirement of a reducing agent for enzyme stability 
might be that the 4 cysteines per enzyme molecule upon oxidation form intra- or inter-chain 
disulfides and, thereby, alter the conformation of the enzyme leading to a sub-optimum 
activity [45].  
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The Lineweaver-Burk plots of butyryl-phosphate concentrations in the presence of fixed 
ADP concentrations versus initially velocity presented straight lines which intersect on the   
x-axis. This indicates formation of a ternary complex of enzyme-butyrylphosphate-ADP in 
either a random or an ordered bi-bi mechanism.  
 
Table (5.5): Comparison of the kinetic parameters of BUK 
Organisms 
KM (µM) Vmax 
(U/mg) 
Kcat 
(s-1) 
References 
Butyryl-P ADP Butyrate ATP 
C. difficile 470 70 ---- ----  345 245 This work 
C. acetobutylicum BUKI 
                          BUKII 
----- ---- 
14*103 
620 
1.4*103 
---- 
420 
165 
273 
118 
[45] 
[43] 
C. tetanomorphum ----- ---- 10.8*103 5.06*103 65 ----- [46] 
C. butyricum ---- ---- 20*103 1.4*103 163 ----- [47] 
 
5.1.6. Phosphate butyryl-transferase 
The release of butyrate from butyryl-CoA is coupled with energy conservation by 
substrate level phosphorylation. In the metabolism of anaerobes, the coupling of ATP 
regeneration is either achieved directly, employing phosphate butyryl-transferase and butyrate 
kinase, or indirectly, using a butyrate CoA-transferase for acetyl-CoA synthesis followed by 
ATP-synthesis aided by phosphate acetyl-transferase and acetate kinase. The investigation 
presented here focused on the first way, employing phosphate butyryl-transferase and butyrate 
kinase.  
Phosphate butyryl-transferase (PBT) catalyzes the transfer of a butyryl-residue from 
coenzyme A to phosphate. PBT and related enzymes are widespread in microbes and capable 
of producing acyl-phosphates including acetyl- [131], propionyl- [132], butyryl- [42], 
carbamayl- and aspartyl-phosphates, which are either employed in energy conservation or 
provide essential metabolic building blocks. PBT has been partially purified from 
C. butyricum and was also detected in several other clostridial species [42]. It has been 
isolated form C. acetobutylicum ATCC 824 in order to establish its physical and kinetic 
properties [40].  
The molecular mass of the N-terminally-tagged PBT (34.2 kDa) from C. difficile falls 
well in the range of clostridial PBTs, which exhibit molecular masses of 33 kDa in 
C. butyricum [39] and 31 kDa in C. acetobutylicum [40, 41].  
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Comparison of the kinetic parameters of PBT is hampered by the fact, that previously 
studied enzymes were measured with DTNB[133] in order to detect the release of free CoA 
(table 5.6).  The enzyme from C. difficile was measured using a novel coupled assay, in which 
the butyrate kinase-mediated ATP-formation was detected with glucokinase and glucose-6-
phosphate dehydrogenase. Although this hampers the comparison of the enzyme with its 
counterparts in other organisms, it is closer to the in situ metabolic context, and might, 
therefore, provide data more relevant in the assessment of the enzymes function in vivo. 
 
Table (5.6): Comparison of the kinetic parameters of PBT 
Organisms 
KM (µM) Vmax 
(U/mg) 
Kcat 
(s-1) 
References 
Butyryl-CoA 
C. difficile 72 257 151 This work 
C. acetobutylicum 110 1,380 713 [40] 
C. beijerinckii 40 1,560 858 [39] 
 
The kinetics of PBT followed a classic random bi- bi mechanism (Fig. 5.3). Enzymes 
from other sources exhibited broad substrate specificity and utilized various substrates 
including propionyl-CoA, valeryl-CoA, isovaleryl-CoA, and isobutyryl-CoA as described for 
PBT from C. acetobutylicum [40], while acetyl-CoA (relative specific activity  against 
butyryl-CoA 35%) and acetoacetyl-CoA (relative specific activity 83%) were additional 
substrates for PBT from C. butyricum [39]. Likewise, PBT from C. difficile exhibited relative 
specific activities of 5, 26 and 33% for acetyl-CoA, acetoacetyl-CoA and propionyl-CoA, 
respectively, when assayed with Ellman’s reagent[133]. Likewise, the relative activities with 
alternative substrates were 4, 18 and 23% in the coupled assay, suggesting that also butyrate 
kinase from C. difficile exhibits rather broad substrate specificity. 
  
Fig.5.3: Simplified schematic of the random bi-bi mechanism of phosphate butyryl-transferase.  
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5.2. Butyrate production by the recombinant strains 
The data presented thus far clearly demonstrated that the C. difficile-derived genes 
encoding enzymes of the butyrate forming pathway are readily expressed in E. coli and 
yielded functional recombinant enzymes. In the next step, individual genes were combined in 
single expression vectors, which harbored all the genes required for butyrate formation. In 
order to elucidate the different properties of the “conventional” butyryl-CoA dehydrogenase 
from C. acetobutylicum and the bi-forking one from C. difficile in a physiological context, 
two plasmids (pASG-BUTAC and pASG-BUTD) were created, which exclusively differed in the 
origin of the genes encoding the BCD complex. All other genes were from C. difficile. 
Transfer of these genes into E. coli-Rosetta pLysE created two recombinant strains, E. coli 
BUTAC and E. coli BUTD, respectively. Both strains and the host strain were then grown in 
minimal medium with glucose as sole source of energy and carbon in order to establish 
growth related fermentation parameters including specific growth rates, substrate 
consumption and product formation rates. 
As expected, only the recombinant strains, E. coli BUTAC and BUTD, were capable of 
forming butyrate and maximum values of 3.1 and 3.7 mM were obtained with a maximum 
yield 0.54 and 0.51 mmol butyrate per mmol glucose consumed. Likewise, the maximum 
production rates were 0.81 and 0.74 mmol butyrate per hour per C-mmol biomass and 
appeared rather similar. These data reflect that there is no significant difference between both 
strains in the maximum yield or the production rate. Likewise, the effects of the foreign gene 
expression on growth rate, glucose consumption and acetate formation were rather similar in 
the recombinant strains. 
While the net results between both strains did not differ significantly, the kinetics of 
butyrate formation were rather different. While E. coli BUTD readily started to produce 
butyrate upon induction of the foreign genes, E. coli BUTAC butyrate formation was 
significantly delayed and occurred at high rates only at comparable high cell densities. This 
observation is in line with the oxygen sensitivity of the latter enzyme and has been previously 
reported by Inui et al. [57], who found that butan-1-ol production in recombinant E. coli 
harboring the C. acetobutylicum solventogenic genes was not observed in actively growing 
cells but in harvested cells incubated under anoxic conditions. Notably, this behavior was 
attributed to the oxygen sensitivity of BCD also by these authors. 
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5.2.1. Effects of the foreign genes and their regulatory properties in E. coli  
In order to address in vivo effects of foreign genes in E. coli, their influences in the 
normal carbon flux and their impact in the regulation of metabolic pathways of the host must 
be known. Acetyl-CoA is a common and central intermediate of glucose oxidation in E. coli 
under oxic and anoxic conditions [77, 134-137]. Under oxic conditions, mainly two major 
reactions compete for acetyl-CoA in the energy metabolism of the organism: The available 
pool of acetyl-CoA is predominantly shuttled via citrate into the Krebs cycle and finally 
oxidized to CO2 and H2O in the respiratory chain [74, 138-142]. It is, however, long known 
that significant portions of acetyl-CoA in aerobically, exponentially grown E. coli are 
redirected to substrate level phosphorylation as readily evident by the large concentration of 
acetate, which accumulates in cultures growing with glucose [143-146]. Likewise, it is well 
established that the intermediately formed acetate is readily end oxidized when glucose is no 
longer available as energy source [78, 89, 90, 147]. The host strain E. coli Rosetta pLysE 
nicely showed this behavior. In sharp contrast, butyrate once formed was not at all reutilized 
by the recombinant strains. 
 E. coli produces acetic acid as an extracellular by-product of aerobic fermentation and 
this exists in the ionic form at the neutral pH. The rate of acetate formation is directly related 
to the cell’s growth rate, oxygen consumption rate, and the rate of glucose uptake [139, 143, 
148, 149].  In the common operational mode of a fed-batch process, the growth rate of the 
culture is determined by the feeding rate of the limiting nutrient: specifically, E. coli generates 
acetate when glucose is the limiting nutrient and the cells grow above a threshold growth rate 
[78, 148, 150]. Despite the fully aerobic conditions, acetate formation is not related to the 
availability of oxygen, but rather relates to the rate of oxygen consumption. Regardless of the 
oxygen supply to the bioreactor, E. coli can only consume oxygen up to a maximum rate 
[151]. This plateau in oxygen consumption corresponds with the threshold growth rate at 
which acetate formation begins [148]. The value of the threshold growth rate depends on the 
strain but has been reported in defined media to be in the range of 0.14– 0.17 h-1 for fed-batch 
processes [152] and 0.35–0.48 h-1 for chemostats or accelerostats [153, 154]. The specific 
growth rate for the E. coli Rosetta strain, which was used in this work as control was 0.54 h-1 
in M9 medium. There are two explanations for the relationship between acetate accumulation 
in the culture and oxygen limitation. Firstly, the respiratory system, where NADH is 
reoxidized, has a limited capacity. As flux to the TCA cycle results in NADH production and 
flux to acetate does not, redirection of acetyl-CoA flux to acetate would be necessary to avoid 
accumulation of NADH when the respiration saturates [8, 11]. A second explanation is that 
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the TCA cycle has a limited capacity and that its limitation is reached before that of the 
respiration. When the TCA cycle saturates, increasing glucose uptake will redirect acetyl-CoA 
to form acetate. In this case, NADH production and respiration can increase further until the 
maximum respiration capacity or the maximum glucose uptake is reached [155].   
 In the recombinant strains, the cells reach the maximum specific growth rate before 
the cells were induced for recombinant protein production. Indeed, initial acetate 
accumulation was likewise observed in these cultures. Foreign gene expression, however, 
caused a shift in the metabolic behavior of the cells and rather than acetate, butyrate was 
produced. At the same time, cells consumed more energy to produce recombinant protein as 
reflected by a growth arrest. Furthermore, recombinant proteins redirected the overflow of 
acetyl-CoA into the butyrate cycle as readily evident by product formation. Delisa et al. 
reported that the expression of a recombinant protein can significantly change fermentation 
process behavior, even when no intermediates are directly redirected [82]. Koh et al. reported 
that acetate becomes more inhibitory to recombinant protein producing cells than in the wild-
type  [156] and the threshold growth rate for the onset of acetate formation is lower for cells 
that are induced to generate a recombinant protein [157]. All these effects might be beneficial 
in terms of butyrate formation by the recombinant strains. Thus, the observation that E. coli 
BUTAC showed a delayed butyrate production as compared with E. coli BUTD might be best 
explained by the oxygen sensitivity of the C. acetobutylicum BCD [57].  
Introduction of expression plasmids harboring the genes of butyrate forming enzymes 
from clostridia introduce another competing metabolic pathway. Here, acetyl-CoA is partially 
captured by thiolase and shuttled into a reductive pathway, which finally yields butyrate. 
While this novel pathway increases the ability of the cell to reoxidize NADH formed in 
glycolysis and pyruvate dehydrogenase reaction, it decreases the ATP yield, which can be 
obtained by substrate level phosphorylation employing phosphate transacetylase and acetate 
kinase. Compared to butyric acid formation, formation of acetic acid yields twice as much 
ATP per mole of acetyl-CoA by substrate phosphorylation. Assuming that about 2 mole of 
ATP are generated by reoxidation of NADH within the truncated respiratory chain of E. coli, 
the ATP yield is further reduced to below half of that in the normal situation, when 2 out of 4 
NADH formed in glycolysis and pyruvate oxidation are oxidized by butyrogenesis. A similar 
situation is given in fermentative growing clostridia, where the necessity to balance redox 
equilibrium by butyrate formation enforces the reduction of ATP yield, which could be 
obtained from acetyl-CoA. Therefore, the organism’s capacity to regulate butyrogenesis and 
thus the ratio of acetate and butyrate is also vital to control the yield of ATP in anaerobes. In 
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this respect, it is worth noting that both citrate synthases and thiolases are known to be 
regulated by ATP as well as by the shared product CoA-SH and it has been suggested that 
both regulators compete with acetyl-CoA for the active site [21, 158, 159].  
In the thiolytic direction, CoA-SH has been demonstrated here to cause substrate 
inhibition of thiolase from C. difficile competing with acetoacetyl-CoA and this feature is 
shared by thiolases from different organisms [21, 114, 115]. Indeed, it is obvious that thiolase 
was more sensitive towards the CoA-SH concentration than towards acetoacetyl-CoA. This 
indicates that thiolase activity depends on the presence of acetyl-CoA and the consumption of 
CoA-SH (the ratio of CoA-SH to acetyl-CoA). Thiolase from C. acetobutylicum is sensitive 
even at low ratios of CoA-SH to acetyl-CoA as well as to the accumulation of butyryl-CoA or 
ATP in high internal concentrations, suggesting that all these molecules may act as feedback 
inhibitors [21]. Additionally, the ratio of CoA-SH to acetyl-CoA has been shown to be an 
important regulator for NADH oxidation in C. butyricum and this is also thought to be an 
important mechanism of regulating the ratio of acetic to butyric acid [158].  
Other groups suggested that changes in the intracellular pH might be another 
important factor in regulating thiolase in C. acetobutylicum, since the activity of thiolase in 
C. pasteurianum falls with decreasing pH from an optimum of pH 8.0 [23]. Wiesenborn and 
co-workers confirmed that the pH profile in the condensation direction for C. acetobutylicum 
thiolase is very different from the one from C. pasteurianum, in that thiolase from 
C. acetobutylicum has high activity over a broad range of pH values from at least pH 5.5 to 
above 7.0 [21]. It has been shown, however,  that in C. acetobutylicum batch fermentation the 
internal pH remains constant within the range of about pH 5.5 to 7.0 in the environment 
[160].  
Acetoacetyl-CoA is the product of the thiolase catalyzed reaction and provides a 
cross-over point in diverse metabolic pathways in microbes. It acts as a substrate for butanol/ 
butyrate and acetone formation, and is also a precursor in β-polyhydroxybutyrate (PHB) 
synthesis [161, 162]. Thus, regulatory properties of BHBD might also be of relevance when 
the flux control of carbon through the cells is the matter of concern. BHBD from C. difficile 
was inhibited by acetoacetyl-CoA and the extent of inhibition was depended on the NADH 
concentration. It has been suggested that BHBD influences the ratio of butyrate to 
acetoacetate in acidogensis and the ratio of butanol to acetone during solventogenesis [163-
166]. In the latter, decreased NADH
 
and high concentration of acetoacetyl-CoA are known to 
redirect metabolic flux to acetoacetate/acetone pathway rather than converting it to β-
hydroxybutyryl-CoA to complete butyrate/butanol pathway [27, 117]. It is known that the 
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enolate form of acetoacetyl-CoA acts as competitive inhibitor not only for BHBD but also for 
bovine liver crotonase [29, 30]. Acetocacetyl-CoA enolate structurally resembles both 
crotonyl-CoA and β-hydroxybutyryl-CoA and it can be considered a transition state structure 
for crotonase [30]. It is evident that acetoacetyl-CoA plays an important role in regulation of 
fatty acid pathways.  
It is worth noting that in contrast to acetate, which is readily utilized at the end of 
aerobic growth [78, 89, 90, 147], butyrate was not reoxidized at the end of the experiments. 
This is surprising, because butyrate can deliver more than twice the energy of acetate and 
both, activation as well as oxidation to acetyl-CoA might readily be achieved by the 
clostridial genes (Figure 5.4). Indeed, residual enzyme activities were detectable even in 
stationary cells. The capability of E. coli to utilize short-chain fatty acids has been extensively 
studied [89, 90, 167] and it turned out that the organisms inability to utilize short-chain fatty 
acids is restricted to C4 and C5. Longer and shorter fatty acids are readily metabolized. Indeed, 
it has been shown that not the metabolism of these compounds is impaired but the organism 
lacks uptake capability for these substrates [111, 167-170]. 
 
Fig.5.4: Proposed short-chain fatty acid uptake and utilization in modified E. coli strains.  The blue enzyme 
symbols indicate the transferred butyrate pathway genes from clostridia, the red enzymes endogenous in 
E. coli.  
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The differences in short-chain fatty acid (acetate and butyrate) production patterns 
observed for the two modified strains as well as the control reflect the power of the novel 
analytic strategy applied in the current work. The cells harboring modular constructed, 
combinatorial plasmids can be readily generated and are valuable tools in order to study 
specific effects dedicated by the introduction of individual genes in a pre-defined metabolic 
pathway.  
 
 
5.2.2. Rate-limiting step in butyrate fermentation 
With the aim to figure out the rate-limiting step for butyrate production in modified 
E. coli strains, harboring butyrate biosynthetic pathway genes, enzyme activities were 
measured in cell free extracts obtained from butyrate fermentation biomass. Based on these 
data two rate-limiting steps in butyrate pathway fermentation can be identified. The first was 
the insufficient conversion of acetoacetyl-CoA to hydroxybutyryl-CoA with the rate-limiting 
enzyme BHBD. This observation agrees with Fischer et al., who found that the intracellular 
metabolic flux in recombinant E. coli expressing clostridial butyrate and butanol biosynthetic 
genes is strongly affected by this enzyme [66].  The authors found that a shorting in 
conversion of acetoacetyl-CoA to hydroxybutyryl-CoA causes a metabolic bottle-neck and 
suggested that swapping NADH-requiring BHBD for NADPH-requiring 3-hydroxybutyryl-
CoA reductase, such as PhaB might improve the situation [66]. The data presented herein for 
BHBD from C. difficile suggest that the problem is not associated with the expression level of 
the gene but caused by the regulatory properties of the enzyme. Although the crotonase gene 
is expressed at comparable low levels, the resulting enzyme is highly active and may cause 
concentrations of crotonyl-CoA to occur, which are inhibitory and must have detrimental 
effects on BHBD.  
 In line with this, the second rate-limiting step in the butyrate/butanol pathway is the 
conversion of crotonyl-CoA to butyryl-CoA that is catalyzed by butyryl-CoA dehydrogenase/ 
ETF complex. Several groups, who produced butanol from recombinant expression of 
clostridia genes, have reported that BCD/ETF complex is the rate-limiting enzyme, which is 
observed in much lower or not detectable levels at all as compared to other enzymes in the 
pathway [56, 57, 66].  These data rely on the individual measured enzyme activities [56, 57]  
as well as on the quantification of  intracellular metabolites [66]. In addition, several groups 
noted oxygen sensitivity of butyryl-CoA dehydrogenases and the expression of BCD/ETF 
complexes from various origins under aerobic conditions led to low activities in E. coli due to 
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the proposed instability of the enzymes [56, 57, 59, 66].  Although the BCD complex of 
C. difficile is remarkable stable as compared to the C. acetobutylicum derived enzyme, its 
activity in cell lysates of recombinant strains was still the lowest of the pathway. It should be 
noted, however, that the failure to measure BCD from C. acetobutylicum in the crotonyl-CoA 
reducing direction enforced the measurement of oxidative reaction for comparison and that 
this values not at all relates to the physiological reaction of interest. 
 Since the availability of NADH increases [171, 172], one might expect higher butyrate 
yields from glucose under anoxic conditions. It should be noted, however, that growth 
experiments using E. coli BUTD aiming anoxic expression of clostridial genes actually caused 
lower concentrations of butyrate to accumulate in the medium than in aerobically grown 
cultures. This observation is detrimental to the proposal that product formation is solely 
driven by the availability of NADH for substrate reduction. In fact it is known that the ratio of 
NADH to NAD+ rises in E coli from 0.05 to above 0.75 upon transfer from an oxic to an 
anoxic environment [173], a fact that might enhance butyrate formation. Thus, it seems 
reasonable to conclude that the unique properties of bi-forking BCD could be responsible for 
this observation. The in vitro assays revealed a strict requirement of BCD for oxidized 
ferredoxin in anoxic tests, while under air also dioxygen was effective as a co-substrate for 
crotonyl-CoA reduction. Under anoxic conditions, the reoxidation of ferredoxin is predicted 
to be severely impaired in pure cultures. While endogenous ferredoxin:NADP oxidoreductase 
can readily provide oxidized ferredoxin or oxygen itself may act as co-oxidant for BCD in 
vivo, under anoxic conditions the intracellular redox potential is much lower and the 
reoxidation of ferredoxin becomes a more difficult task. In fact, reoxidation of ferredoxin 
under anoxic conditions is almost entirely achieved by hydrogenases in E. coli [174-176], 
which can, however, act in pure cultures only within narrow thermodynamic limits.  
 
 
5.3. Implications of the novel findings for understanding of clostridial butyrate 
metabolism 
Five strains of C. difficile were previously found to be capable of growing either 
chemo-lithotrophically with H2 and CO2 or chemo-organotrophoically with glucose, fructose, 
maltose, mannose and cellobiose [177]. Based on these findings, C. difficile was classified as 
an acetogenic bacterium. The intermediate-key between those two metabolisms is the energy 
conservation via reduced ferredoxin. The novel findings in this study combined with the 
genome-derived data, a new hypothesis regarding the energy conservation in acetogenesis by 
C. difficile can be formulated. Under autotrophic growth condit
Discussion  
-91- 
 
generate reduced ferredoxin and this process is provided by hydrogenases utilizing H2 as 
electron donor. Reduced ferredoxin thus formed is then used for two proposals: Firstly, CO2 is 
reduced via Carbon-monoxide dehydrogenase/ acetyl-CoA synthase (EC 1.2.99.2) to provide 
CO in the Wood-Ljungdahl pathway. Secondly, the reduced ferredoxin is shuttled by a 
membrane-bound protein (RNF-complex) to produce NADH that is needed in the Eastern 
branch of acetogenesis [178, 179]. The reoxidation of ferredoxin via RNF-complex can 
conserve additional energy via electron transport phosphorylation to synthesize ATP, in 
which the released electrons are used to create a proton motive force across the cytoplasma 
membrane [17, 179, 180]. 
Under heterotrophic growth conditions, C. difficile is capable of growing in a defined 
medium with glucose as the sole energy and carbon source [181]. Butyrate formation in 
clostridia was accepted for decades to provide an electron sink for glucose oxidation. During 
glucose oxidation, pyruvate is oxidized by pyruvate: ferredoxin oxidoreductase (PFOR, EC 
1.2.7.1) to provide reduced ferredoxin and CO2, which are essential in heterotrophic growth to 
provide an additional molecule of acetyl-CoA [179, 182, 183]. Consequently, up to 3 mole of 
acetyl-CoA are formed per mol glucose [179]. In the reductive branch of butyrate pathway, 
reduction of crotonyl-CoA to butyryl-CoA is mediated by a bi-forking butyryl-CoA 
dehydrogenase/ ETF complex, which couples the exergonic reduction of crotonyl-CoA with 
the endergonic reduction of ferredoxin and provide additional energy conservation by 
reoxidation of reduced ferredoxin via RNF- complex [17, 33, 179].  
The anoxic oxidation of short-chain fatty acids in clostridia may also reflect the central 
role of the RNF-complex. Anoxic butyrate degradation in C. difficile yields two molecules of 
acetyl-CoA that allows substrate level phosphorylation of ADP within acetyl-phosphate 
transferase and acetate kinase.  The limiting step in this pathway is the oxidation of butyryl-
CoA to crotonyl-CoA with NAD+. This step is endergonic, while all other steps might 
proceed smoothly. This endergonic reaction can only be driven by coupling with exergonic 
oxidation of reduced ferredoxin, which is provided by H2 oxidation and RNF-complex.  
Acetogenesis serves as electron sink necessary to balance redox potential and the strict 
metabolic coupling of butyrate oxidation and acetogenesis has been convincingly shown in 
thermophilic mixed cultures when methanogenesis was suppressed [184] 
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5.4. Outlook 
The two butyrate modules, pASG-BUTD and pASG-BUTAC are readily modified 
replacing pbt and buk genes, by adhe (Fig. 5.6). The adhe encoding a bifunctional 
aldehyde/alcohol dehydrogenase is then able to convert butyryl-CoA to butan-1-ol consuming 
two additional NADH (Fig.5.5) and enables conversion of acetyl-CoA into this commercially 
interesting solvent. The gene from C. acetobutylicum (accession number CA_P0035) was 
cloned and sequenced, and its integration into the vector is presently on the way.    
 
Fig.5.5: The enzymatic reaction of the bi-functional enzymes ADHE. 
 
Given that these novel modules confer butan-1-ol production capability to E. coli, the 
solvent producing capability can be coupled to alternative feedstocks in combinatorial 
approaches.  Thereby, in a truly synthetic biological approach, dedicated strains for the 
specific conversion of various constituents of biomass will be generated, which are not found 
naturally in known organisms and might be highly interesting in technical applications aiming 
conversion of these renewable sources in solvents. Among the most interesting targets for 
nutrients, which are available in large quantities and not utilized for alternative use (e.g. 
human or animal nutrition) are lignocelluloses, which are available in rice straw in huge 
quantities all around the world, or raw glycerol, which is a low value by-product of biodiesel 
production from plant oils.  
 
Fig.5.6: Expression plasmids for butan-1-ol pathway modules. 
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App.1: List of primers used in the current work 
thia1-CD1059-s AAGCTCTTCAATGAGAGAAGTAGTAATTGCCAGTG 
thia1-CD1059-as TTGCTCTTCTCCCTCTCTTAACTATTAAAGTAGTTCCCATTC 
hbd-CD1058-s AAGCTCTTCAATGAAATTAGCTGTAATAGGTAGTGGAAC 
hbd-CD1058-as TTGCTCTTCTCCCTTTATTATAATCATAGAATCCTATCTTAGT 
crt2-CD1057-s AAGCTCTTCAATGAGTACAAGTGATGTTAAAGTTTATGAG 
crt2-CD1057-as TTGCTCTTCTCCCCCCTTTTATAAAGTTAGCTTCTCTCTTTTC 
bcd2-CD1054-s AAGCTCTTCAATGGATTTAAATTCTAAAAAATATCAGATGCT 
bcd2-CD1054-as TTGCTCTTCTCCCTTTTAATAGTTTTCCTGAAATAACCATTCT 
etfB2-CD1055-s AAGCTCTTCAATGGAGGAAGGATTTATGAATATAGTCG 
etfB2-CD1055-as TTGCTCTTCTCCCTATGATATACTTCTCTTTTAATTTATCTATG 
etfA2-CD1056-s AAGCTCTTCAATGGGTAACGTTTTAGTAGTAATAGAACAAAG 
etfA2-CD1056-as TTGCTCTTCTCCCGTTAGCTAAAACTTCACCTTTTTCTTTTGC 
buk-CD0113-s AAGCTCTTCAATGAGCAAAATATTTAAAATCTTAACAATAAATCCTGG 
bukCD0113-as AAGCTCTTCTCCCGTTATCATAAACTTGAGCCTCTTCTTCA 
pbt-CD0112-s AAGCTCTTCAATGAGAAGTTTTGAAGAAGTAATTAAGTTTGC 
pbt-CD0112-mut1 AAGCTCTTCTCGTCCTGCTACAGGATGA 
pbt-CD0112-mut2 AAGCTCTTCAACGAGCTGATATATTATTAGCCCC 
pbt-CD0112-as AAGCTCTTCTCCCTGCCTTTGCTGCCATTAAAACA 
bcd_CA_C2711_s AAGCTCTTCAATGGATTTTAATTTAACAAGAGAACAAGAATTAGTAAG 
bcd_CA_C2711_as AAGCTCTTCTCCCTCTAAAAATTTTTCCTGAAATAACTAATTTCTGAAC 
etfB_CA_C2710_s AAGCTCTTCAATGAATATAGTTGTTTGTTTAAAACAAGTTCC 
etfB_CA_C2710_as   AAGCTCTTCTCCCAATATAGTGTTCTTCTTTTAATTTTGAGACAAC 
etfA_CA_C2709_s AAGCTCTTCAAGATGGAGAATTACAAAAGGTATCATTGG 
etfA_CA_C2709_as AAGCTCTTCTCCCATTATTAGCAGCTTTAACTTGAGC 
etfA_ CA_C2709_SO1 ATGAATAAAGCAGATTACAAGGGCGTATGGGTGTTTGCTGAACAAAG 
etfA_ CA_C2709_SO2 TCTCTTTGTTCAGCAAACACCCATACGCCCTTGTAATCTGCTTTATT 
S, refer to sense primer (forward); as, is antisense primer (reverse); mut, primer to insert a silent mutation. 
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App.2: List of cloning, expression and fusion plasmids used in the current study 
Plasmid Special characteristics Source 
Cloning plasmids 
pE_thiA1 Kanr : with PCR fragment for C. difficile  thiA1(CD1059) R. Fischer 
pE_hbd Kanr : with PCR fragment for C. difficile  hbd (CD1058) R. Fischer 
pE_crt2 Kanr : with PCR fragment for C. difficile  crt2 (CD1057) R. Fischer 
pE_bcdABC2 Kanr : with fused fragments for C. difficile  bcd2 (CD1054) and 
the two electron transfer subunits etfB2 (CD1055), and 
etfA2 (CD1056) 
R. Fischer 
pE-bcd Kanr: with PCR fragment for bcd (CA_C2711) from C. 
acetobutylicum   
This study 
pE-etfB Kanr : with PCR fragment for etfB (CA_C2710) from C. 
acetobutylicum   
This study 
pE-etfA Kanr : with PCR fragment for etfA (CA_C2709) from C. 
acetobutylicum   
This study 
pE_bcdABC Kanr: with fused fragments bcd (CA_C2711) and the tow 
electron transfer subunits etfB (CA_C2710), and etfA 
(CA_C2709) from C. acetobutylicum   
This study 
pE_pbt Kanr : with PCR fragment for C. difficile  pbt (CD0112) This study 
pE_buk Kanr : with PCR fragment for C. difficile buk (CD0113) This study 
Expression plasmids 
pASG.wt_thiA1 Ampr : Expression vector for the wild type thiA1 This study 
pASG.3_thiA1 Ampr : Expression vector for thiA1 with Strep-Tag II attached 
with C-terminal 
R. Fischer 
pASG.5_thiA1 Ampr : Expression vector for thiA1 with Strep-Tag II attached 
with N-terminal 
R. Fischer 
pASG.wt_hbd Ampr : Expression vector for the wild type hbd This study 
pASG.3_hbd Ampr : Expression vector for hbd with Strep-Tag attached with 
C-terminal 
R. Fischer 
pASG.5_hbd Ampr : Expression vector for hbd with Strep-Tag II attached 
with N-terminal 
R. Fischer 
pASG.wt_crt2 Ampr : Expression vector for the wild type crt2 This study 
pASG.3_crt2 Ampr : Expression vector for crt2 with Strep-Tag attached with 
C-terminal 
R. Fischer 
pASG.5_crt2 Ampr : Expression vector for crt2 with Strep-Tag II attached 
with N-terminal 
R. Fischer 
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pASG.wt_pbt Ampr : Expression vector for the wild type pbt This study 
pASG.3_pbt Ampr : Expression vector for pbt with Strep-Tag II attached 
with C-terminal 
This study 
pASG.5_pbt Ampr : Expression vector for pbt with Strep-Tag II attached 
with N-terminal 
This study 
pASG.wt_buk Ampr : Expression vector for the wild type buk This study 
pASG.3_buk Ampr : Expression vector for buk with Strep-Tag II attached 
with C-terminal 
This study 
pASG.5_buk Ampr : Expression vector for buk with Strep-Tag II attached 
with N-terminal 
This study 
pASG.3_bcdABC2 Ampr : Expression vector with fused bcd2, etfB2, and etfA2 from 
C. difficile with Strep-Tag II attached with C-terminal 
R. Fischer 
pASG.5_bcdABC2 Ampr : Expression vector with fused bcd2, etfB2, and etfA2 from 
C. difficile with Strep-Tag II attached with N-terminal 
R. Fischer 
pASG.3_bcdABC Ampr : Expression vector with fused bcd, etfB, and etfA from C. 
acetobutylicum with Strep-Tag II attached with C-
terminal 
This study 
pASG.5_bcdABC Ampr : Expression vector with fused bcd, etfB, and etfA from C. 
acetobutylicum with Strep-Tag II attached with N-
terminal 
This study 
pASG.3_bcdBCA Ampr : Expression vector with fused bcd, etfB, and etfA from C. 
acetobutylicum with Strep-Tag II attached with C-
terminal 
This study 
pASG.5_bcdBCA Ampr : Expression vector with fused etfB, etfA, and bcd
 
from C. 
acetobutylicum with Strep-Tag II attached with N-
terminal 
This study 
pASG.3_bcdCAB Ampr : Expression vector with fused etfB, etfA, and bcd
 
from C. 
acetobutylicum with Strep-Tag II attached with C-
terminal 
This study 
pASG.5_bcdCAB Ampr : Expression vector with fused etfA, bcd, and etfB from C. 
acetobutylicum with Strep-Tag II attached with N-
terminal 
This study 
pASG.wt_pbt-buk Ampr : Expression vector with fused pbt and buk.  This study 
pASG.wt_thiA1-hbd -
crt2 
Ampr : Expression vector with fused thiA1, hbd, and crt2.  This study 
 
pASG.wt_6 genesD Ampr : Expression vector with fused thiA1, hbd, crt2, and 
bcdABC2  
This study 
 
pASG.wt_6 genesAC Ampr : Expression vector with fused thiA1, hbd, crt2, and 
bcdABC 
This study 
 
pASG.wt_BUTD Ampr : Expression vector with fused butyrate biosynthesis This study 
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pathway genes (thiA1, hbd, crt2, bcdABC2, pbt, and buk)  
pASG.wt_BUTAC Ampr : Expression vector with fused butyrate biosynthesis 
pathway genes (thiA1, hbd, crt2, bcdABC, pbt, and buk) 
This study 
 
Fusion plasmids 
pFF.rbs_bcd2.rbs_etfB2.rbs_etfA2 Cluster I 
bcdABC2 
This study 
pFF.rbs_bcd 
Cluster I´ 
bcdABC 
This study 
pFFc_etfB This study 
pFFc_etfA This study 
pE_bcd.rbs_etfB This study 
pFF.rbs_bcd.rbs_etfB This study 
pE_bcd.rbs_etfB.rbs_etfA This study 
pFF.rbs_bcd.rbs_etfB.rbs_etfA This study 
pFF.rbs_thiA1 
Cluster II 
thiA1-hbd-crt2 
This study 
pFFc_hbd This study 
pFFc_crt2 This study 
pE_thiA1.rbs_hbd This study 
pFF.rbs_thiA1.rbs_hbd This study 
pE_thiA1.rbs_hbd.rbs_crt2 This study 
pFFc_thiA1.rbs_hbd.rbs_crt2 This study 
pFF.rbs_pbt 
Cluster III 
Pbt-buk 
This study 
pFFc_buk This study 
pE_pbt.rbs_buk This study 
pFFc_pbt.rbs_buk This study 
pE_bcd2.rbs_etfB2.rbs_etfA2.rbs_thiA1.rbs_hbd.rbs_crt2 Fused cluster I & II 
together (6 genesD) 
This study 
pFF.rbs_bcd2.rbs_etfB2.rbs_etfA2.rbs_thiA1.rbs_hbd.rbs_crt2 This study 
pE_bcd.rbs_etfB.rbs_etfA.rbs_thiA1.rbs_hbd.rbs_crt2 Fused cluster I´ & II 
together (6 genesAC) 
This study 
pFF.rbs_bcd.rbs_etfB.rbs_etfA.rbs_thiA1.rbs_hbd.rbs_crt2 This study 
pE_bcd2.rbs_etfB2.rbs_etfA2.rbs_thiA1.rbs_hbd.rbs_crt2.rbs_ 
       pbt.rbs_buk 
Fused cluster I, II & III 
together (pE-BUTD) 
This study 
pE_bcd.rbs_etfB.rbs_etfA.rbs_thiA1.rbs_hbd.rbs_crt2.rbs_ 
      pbt.rbs_buk 
Fused cluster I´, II & III 
together (pE-BUTAC) 
This study 
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>pE-CD1054_insert 
      1 CGTCTCCAAT GGATTTAAAT TCTAAAAAAT ATCAGATGCT TAAAGAGCTA TATGTAAGCT 
     61 TCGCTGAAAA TGAAGTTAAA CCTTTAGCAA CAGAACTTGA TGAAGAAGAA AGATTTCCTT 
    121 ATGAAACAGT GGAAAAAATG GCAAAAGCAG GAATGATGGG TATACCATAT CCAAAAGAAT 
    181 ATGGTGGAGA AGGTGGAGAC ACTGTAGGAT ATATAATGGC AGTTGAAGAA TTGTCTAGAG 
    241 TTTGTGGTAC TACAGGAGTT ATATTATCAG CTCATACATC TCTTGGCTCA TGGCCTATAT 
    301 ATCAATATGG TAATGAAGAA CAAAAACAAA AATTCTTAAG ACCACTAGCA AGTGGAGAAA 
    361 AATTAGGAGC ATTTGGTCTT ACTGAGCCTA ATGCTGGTAC AGATGCGTCT GGCCAACAAA 
    421 CAACTGCTGT TTTAGACGGG GATGAATACA TACTTAATGG CTCAAAAATA TTTATAACAA 
    481 ACGCAATAGC TGGTGACATA TATGTAGTAA TGGCAATGAC TGATAAATCT AAGGGGAACA 
    541 AAGGAATATC AGCATTTATA GTTGAAAAAG GAACTCCTGG GTTTAGCTTT GGAGTTAAAG 
    601 AAAAGAAAAT GGGTATAAGA GGTTCAGCTA CGAGTGAATT AATATTTGAG GATTGCAGAA 
    661 TACCTAAAGA AAATTTACTT GGAAAAGAAG GTCAAGGATT TAAGATAGCA ATGTCTACTC 
    721 TTGATGGTGG TAGAATTGGT ATAGCTGCAC AAGCTTTAGG TTTAGCACAA GGTGCTCTTG 
    781 ATGAAACTGT TAAATATGTA AAAGAAAGAG TACAATTTGG TAGACCATTA TCAAAATTCC 
    841 AAAATACACA ATTCCAATTA GCTGATATGG AAGTTAAGGT ACAAGCGGCT AGACACCTTG 
    901 TATATCAAGC AGCTATAAAT AAAGACTTAG GAAAACCTTA TGGAGTAGAA GCAGCAATGG 
    961 CAAAATTATT TGCAGCTGAA ACAGCTATGG AAGTTACTAC AAAAGCTGTA CAACTTCATG 
   1021 GAGGATATGG ATACACTCGT GACTATCCAG TAGAAAGAAT GATGAGAGAT GCTAAGATAA 
   1081 CTGAAATATA TGAAGGAACT AGTGAAGTTC AAAGAATGGT TATTTCAGGA AAACTATTAA 
   1141 AAGGGAGGAG ACG 
App.3: The nucleotide sequence of bcd2 cloned from C. difficile DSMZ 1296T. The gray highlighted 
sequences refer to the Esp3I restriction site. The stop codon was replaced with GGG. 
 
pE_CD1054-insert  CGTCTCCAAT GGATTTAAAT TCTAAAAAAT ATCAGATGCT TAAAGAGCTA 
     CD1054-bcd2  --------AT GGATTTAAAT TCTAAAAAAT ATCAGATGCT TAAAGAGCTA 
 
pE_CD1054-insert  TATGTAAGCT TCGCTGAAAA TGAAGTTAAA CCTTTAGCAA CAGAACTTGA 
     CD1054-bcd2  TATGTAAGCT TCGCTGAAAA TGAAGTTAAA CCTTTAGCAA CAGAACTTGA 
 
pE_CD1054-insert  TGAAGAAGAA AGATTTCCTT ATGAAACAGT GGAAAAAATG GCAAAAGCAG 
     CD1054-bcd2  TGAAGAAGAA AGATTTCCTT ATGAAACAGT GGAAAAAATG GCAAAAGCAG 
 
pE_CD1054-insert  GAATGATGGG TATACCATAT CCAAAAGAAT ATGGTGGAGA AGGTGGAGAC 
     CD1054-bcd2  GAATGATGGG TATACCATAT CCAAAAGAAT ATGGTGGAGA AGGTGGAGAC 
 
pE_CD1054-insert  ACTGTAGGAT ATATAATGGC AGTTGAAGAA TTGTCTAGAG TTTGTGGTAC 
     CD1054-bcd2  ACTGTAGGAT ATATAATGGC AGTTGAAGAA TTGTCTAGAG TTTGTGGTAC 
 
pE_CD1054-insert  TACAGGAGTT ATATTATCAG CTCATACATC TCTTGGCTCA TGGCCTATAT 
     CD1054-bcd2  TACAGGAGTT ATATTATCAG CTCATACATC TCTTGGCTCA TGGCCTATAT 
 
pE_CD1054-insert  ATCAATATGG TAATGAAGAA CAAAAACAAA AATTCTTAAG ACCACTAGCA 
     CD1054-bcd2  ATCAATATGG TAATGAAGAA CAAAAACAAA AATTCTTAAG ACCACTAGCA 
 
pE_CD1054-insert  AGTGGAGAAA AATTAGGAGC ATTTGGTCTT ACTGAGCCTA ATGCTGGTAC 
     CD1054-bcd2  AGTGGAGAAA AATTAGGAGC ATTTGGTCTT ACTGAGCCTA ATGCTGGTAC 
 
pE_CD1054-insert  AGATGCGTCT GGCCAACAAA CAACTGCTGT TTTAGACGGG GATGAATACA 
     CD1054-bcd2  AGATGCGTCT GGCCAACAAA CAACTGCTGT TTTAGACGGG GATGAATACA 
 
pE_CD1054-insert  TACTTAATGG CTCAAAAATA TTTATAACAA ACGCAATAGC TGGTGACATA 
     CD1054-bcd2  TACTTAATGG CTCAAAAATA TTTATAACAA ACGCAATAGC TGGTGACATA 
 
pE_CD1054-insert  TATGTAGTAA TGGCAATGAC TGATAAATCT AAGGGGAACA AAGGAATATC 
     CD1054-bcd2  TATGTAGTAA TGGCAATGAC TGATAAATCT AAGGGGAACA AAGGAATATC 
 
pE_CD1054-insert  AGCATTTATA GTTGAAAAAG GAACTCCTGG GTTTAGCTTT GGAGTTAAAG 
     CD1054-bcd2  AGCATTTATA GTTGAAAAAG GAACTCCTGG GTTTAGCTTT GGAGTTAAAG 
 
pE_CD1054-insert  AAAAGAAAAT GGGTATAAGA GGTTCAGCTA CGAGTGAATT AATATTTGAG 
     CD1054-bcd2  AAAAGAAAAT GGGTATAAGA GGTTCAGCTA CGAGTGAATT AATATTTGAG 
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pE_CD1054-insert  GATTGCAGAA TACCTAAAGA AAATTTACTT GGAAAAGAAG GTCAAGGATT 
     CD1054-bcd2  GATTGCAGAA TACCTAAAGA AAATTTACTT GGAAAAGAAG GTCAAGGATT 
 
pE_CD1054-insert  TAAGATAGCA ATGTCTACTC TTGATGGTGG TAGAATTGGT ATAGCTGCAC 
     CD1054-bcd2  TAAGATAGCA ATGTCTACTC TTGATGGTGG TAGAATTGGT ATAGCTGCAC 
 
pE_CD1054-insert  AAGCTTTAGG TTTAGCACAA GGTGCTCTTG ATGAAACTGT TAAATATGTA 
     CD1054-bcd2  AAGCTTTAGG TTTAGCACAA GGTGCTCTTG ATGAAACTGT TAAATATGTA 
 
pE_CD1054-insert  AAAGAAAGAG TACAATTTGG TAGACCATTA TCAAAATTCC AAAATACACA 
     CD1054-bcd2  AAAGAAAGAG TACAATTTGG TAGACCATTA TCAAAATTCC AAAATACACA 
 
pE_CD1054-insert  ATTCCAATTA GCTGATATGG AAGTTAAGGT ACAAGCGGCT AGACACCTTG 
     CD1054-bcd2  ATTCCAATTA GCTGATATGG AAGTTAAGGT ACAAGCGGCT AGACACCTTG 
 
pE_CD1054-insert  TATATCAAGC AGCTATAAAT AAAGACTTAG GAAAACCTTA TGGAGTAGAA 
     CD1054-bcd2  TATATCAAGC AGCTATAAAT AAAGACTTAG GAAAACCTTA TGGAGTAGAA 
 
pE_CD1054-insert  GCAGCAATGG CAAAATTATT TGCAGCTGAA ACAGCTATGG AAGTTACTAC 
     CD1054-bcd2  GCAGCAATGG CAAAATTATT TGCAGCTGAA ACAGCTATGG AAGTTACTAC 
 
pE_CD1054-insert  AAAAGCTGTA CAACTTCATG GAGGATATGG ATACACTCGT GACTATCCAG 
     CD1054-bcd2  AAAAGCTGTA CAACTTCATG GAGGATATGG ATACACTCGT GACTATCCAG 
 
pE_CD1054-insert  TAGAAAGAAT GATGAGAGAT GCTAAGATAA CTGAAATATA TGAAGGAACT 
     CD1054-bcd2  TAGAAAGAAT GATGAGAGAT GCTAAGATAA CTGAAATATA TGAAGGAACT 
 
pE_CD1054-insert  AGTGAAGTTC AAAGAATGGT TATTTCAGGA AAACTATTAA AAGGGAGGAG 
     CD1054-bcd2  AGTGAAGTTC AAAGAATGGT TATTTCAGGA AAACTATTAA AATAG----- 
 
pE_CD1054-insert  ACG 
     CD1054-bcd2  --- 
App.4: Sequence alignment for the cloned bcd2 from C. difficile DSMZ 1296T and the genome derived 
genes from strain 630 [131] (GeneBank accession number CD1054). No mutation was observed. 
  
      pE_CD1054  MDLNSKKYQM LKELYVSFAE NEVKPLATEL DEEERFPYET VEKMAKAGMM 
           Bcd2  MDLNSKKYQM LKELYVSFAE NEVKPLATEL DEEERFPYET VEKMAKAGMM 
 
      pE_CD1054  GIPYPKEYGG EGGDTVGYIM AVEELSRVCG TTGVILSAHT SLGSWPIYQY 
           Bcd2  GIPYPKEYGG EGGDTVGYIM AVEELSRVCG TTGVILSAHT SLGSWPIYQY 
 
      pE_CD1054  GNEEQKQKFL RPLASGEKLG AFGLTEPNAG TDASGQQTTA VLDGDEYILN 
           Bcd2  GNEEQKQKFL RPLASGEKLG AFGLTEPNAG TDASGQQTTA VLDGDEYILN 
 
      pE_CD1054  GSKIFITNAI AGDIYVVMAM TDKSKGNKGI SAFIVEKGTP GFSFGVKEKK 
           Bcd2  GSKIFITNAI AGDIYVVMAM TDKSKGNKGI SAFIVEKGTP GFSFGVKEKK 
 
      pE_CD1054  MGIRGSATSE LIFEDCRIPK ENLLGKEGQG FKIAMSTLDG GRIGIAAQAL 
           Bcd2  MGIRGSATSE LIFEDCRIPK ENLLGKEGQG FKIAMSTLDG GRIGIAAQAL 
 
      pE_CD1054  GLAQGALDET VKYVKERVQF GRPLSKFQNT QFQLADMEVK VQAARHLVYQ 
           Bcd2  GLAQGALDET VKYVKERVQF GRPLSKFQNT QFQLADMEVK VQAARHLVYQ 
 
      pE_CD1054  AAINKDLGKP YGVEAAMAKL FAAETAMEVT TKAVQLHGGY GYTRDYPVER 
           Bcd2  AAINKDLGKP YGVEAAMAKL FAAETAMEVT TKAVQLHGGY GYTRDYPVER 
 
      pE_CD1054  MMRDAKITEI YEGTSEVQRM VISGKLLKG 
           Bcd2  MMRDAKITEI YEGTSEVQRM VISGKLLK. 
App.5: Amino acid alignment for the cloned bcd2 from C. difficile DSMZ 1296T  and the genome derived 
genes from strain 630 [131]. No mutation was observed.  
  
App.6: Analysis of pE_bcd2 (CD1054)
right hand, there is electropherogram for the plasmid. On the left hand, there is pDRAW file shows the 
recognition sites of Csp61 as well as the position of the sequencing primers. 
>pE_CD1055-insert 
      1 CGTCTCCAAT GGAGGAAGGA TTTATGAATA 
     61 CAACAGAAGT TAAACTAGAT CCTAATACAG GTACTTTAAT TAGAGATGGA GTACCAAGTA
    121 TAATAAACCC TGATGATAAA GCAGGTTTAG AAGAAGCTAT AAAATTAAAA GAAGAAATGG
    181 GTGCTCATGT AACTGTTATA ACAATGGGAC CTCCTCAAGC AGATATGGCT TTAAAAGAAG
    241 CTTTAGCAAT GGGTGCAGAT AGAGGTATAT TATTAACAGA TAGAGCATTT GCAGGTGCTG
    301 ATACTTGGGC AACTTCATCA GCATTAGCAG GAGCATTAAA AAATATAGAT TTTGATATTA
    361 TAATAGCTGG AAGACAGGCG ATAGATGGAG ATACTGCACA AGTTGGACCT CAAATAGCTG
    421 AACATTTAAA TCTTCCATCA ATAACATATG CTGAAGAAAT AAAAACTGAA GGTGAATATG
    481 TATTAGTAAA AAGACAATTT GAAGATTGTT GCCATGACTT AAAAGTTAAA ATGCCATGCC
    541 TTATAACAAC TCTTAAAGAT ATGAACACAC CAAGATACAT GAAAGTTGGA AGAATATATG
    601 ATGCTTTCGA AAATGATGTA GTAG
    661 CTAATTTAGG TCTTAAAGGT TCTCCAACTA GTGTATTTAA ATCATTTACA AAATCAGTTA
    721 AACCAGCTGG TACAATATAC AATGAAGATG CGAAAACATC AGCTGGAATT ATCATAGATA
    781 AATTAAAAGA GAAGTATATC ATA
App.7: The nucleotide sequence of 
sequences refer to the Esp3I
pE_CD1055-insert  CGTCTCCA
    CD1055-etfB2  --------
 
pE_CD1055-insert  GTTCCAGATA CAACAGAAGT TAAACTAGAT CCTAATACAG GTACTTTAAT
    CD1055-etfB2  GTTCCAGATA CAACAGAAGT TAAACTAGAT CCTAATACAG GTACTTTAAT
 
pE_CD1055-insert  TAGAGATGGA GTACCA
    CD1055-etfB2  TAGAGATGGA GTACCAAGTA TAATAAACCC TGATGATAAA GCAGGTTTAG
 
pE_CD1055-insert  AAGAAGCTAT AAAATTAAAA GAAGAAATGG GTGCTCATGT AACTGTTATA
    CD1055-etfB2  AAGAAGCTAT AAAATTAAAA GAAGAAATGG GTGCTCATGT AACTGTTAT
 
pE_CD1055-insert  ACAATGGGAC CTCCTCAAGC AGATATGGCT TTAAAAGAAG CTTTAGCAAT
    CD1055-etfB2  ACAATGGGAC CTCCTCAAGC AGATATGGCT TTAAAAGAAG CTTTAGCAAT
 
pE_CD1055-insert  GGGTGCAGAT AGAGGTATAT TATTAACAGA TAGAGCATTT GCAGGTGCTG
    CD1055-etfB2  GGGTGCAGAT AGAG
 
pE_CD1055-insert  ATACTTGGGC AACTTCATCA GCATTAGCAG GAGCATTAAA AAATATAGAT
    CD1055-etfB2  ATACTTGGGC AACTTCATCA GCATTAGCAG GAGCATTAAA AAATATAGAT
 
pE_CD1055-insert  TTTGATATTA TAATAGCTGG AAGACAGGCG ATAGATGGAG 
    CD1055-etfB2  TTTGATATTA TAATAGCTGG AAGACAGGCG ATAGATGGAG ATACTGCACA
 
pE_CD1055-insert  AGTTGGACCT CAAATAGCTG AACATTTAAA TCTTCCATCA ATAACATATG
    CD1055-etfB2  AGTTGGACCT CAAATAGCTG AACATTTAAA TCTTCCATCA ATAACATATG
pE_bcd2(CD 1054)
2874 bp
1   - 1
Csp6I - 1932
Csp6I - 2082
Csp6I - 2495
Csp6I - 2564
Csp6I - 2693
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Expected Fragments  size (bp) 
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 with MultiNA after digestion with Csp61 restriction enzyme.
 
TAGTCGTTTG TATAAAACAA GTTCCAGATA
AAACAT GGACTGTAAA AGATATAGAA GTTGACCCTT
GGGAGGA GACG 
etfB2 cloned from C. difficile DSMZ 1296T. 
 restriction site. The stop codon was replaced with GGG
AT GGAGGAAGGA TTTATGAATA TAGTCGTTTG TATAAAACAA
AT GGAGGAAGGA TTTATGAATA TAGTCGTTTG TATAAAACAA
AGTA TAATAAACCC TGATGATAAA GCAGGTTTAG
GTATAT TATTAACAGA TAGAGCATTT GCAGGTGCTG
Csp6I - 1128
69 129 150 413 
 
 On the 
 
 
 
 
 
 
 
 
 
 
 
 
 
The gray highlighted 
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ATACTGCACA 
 
 
 
804 1309 
 pE_CD1055-insert  CTGAAGAAAT AAAAACTGAA GGTGAATATG TATTAGTAAA AAGACAATTT
    CD1055-etfB2  CTGAAGAAAT AAAAACTGAA GGTGAATATG TATTAGTAAA AAGACAATTT
 
pE_CD1055-insert  GAAGATTGTT GCCATGACTT AAAAGTTAAA ATGCCATGCC TTATAACAAC
    CD1055-etfB2  GAAGATTGTT GCCATGACTT AAAAGTTAAA ATG
 
pE_CD1055-insert  TCTTAAAGAT ATGAACACAC CAAGATACAT GAAAGTTGGA AGAATATATG
    CD1055-etfB2  TCTTAAAGAT ATGAACACAC CAAGATACAT GAAAGTTGGA AGAATATATG
 
pE_CD1055-insert  ATGCTTTCGA AAATGATGTA GTAGAAACAT GGACTGTAAA AGATATAGAA
    CD1055-etfB2  ATGCTTTCGA AAATGATGTA GTAGAAACAT GGACTGTAAA AGATATAGAA
 
pE_CD1055-insert  GTTGACCCTT CTAATTTAGG TCTTAAAGGT TCTCCAACTA GTGTATTTAA
    CD1055-etfB2  GTTGACCCTT CTAATTTAGG TCTTAAAGGT TCTCCAACTA GTGTATTTAA
 
pE_CD1055-insert  ATCATTTACA AAATCAGTTA AACCAGCTGG 
    CD1055-etfB2  ATCATTTACA AAATCAGTTA AACCAGCTGG TACAATATAC AATGAAGATG
 
pE_CD1055-insert  CGAAAACATC AGCTGGAATT ATCATAGATA AATTAAAAGA GAAGTATATC
    CD1055-etfB2  CGAAAACATC AGCTGGAATT ATCATAGATA AATTAAAAGA GAAGTATATC
 
pE_CD1055-insert  ATAGGG
    CD1055-etfB2  ATATAA
App.8: Sequence alignment for the cloned 
genes from strain 630 [131
      pE_CD1055  MEEGFMNIVV CIKQVPDTTE VKLDPNTGTL IRDGVPSIIN PDDKAGLEEA
          etfB2  MEEGFMNIVV CIKQVPDTTE VKLDPNTGTL IRDGVPSIIN PDDKAGLEEA
 
      pE_CD1055  IKLKEEMGAH VTVITMGPPQ ADMALKEALA MGADRGILLT DRAFAGADTW
          etfB2  IKLKEEMGAH VTVITMGPPQ 
 
      pE_CD1055  ATSSALAGAL KNIDFDIIIA GRQAIDGDTA QVGPQIAEHL NLPSITYAEE
          etfB2  ATSSALAGAL KNIDFDIIIA GRQAIDGDTA QVGPQIAEHL NLPSITYAEE
 
      pE_CD1055  IKTEGEYVLV KRQFEDCCHD LKVKMPCLIT TLKDMNTPRY MKVGRIYDAF
          etfB2  IKTEGEYVLV KRQFEDCCHD LKVKMPCLIT TLKDMNTPRY MKVGRIYDAF
 
      pE_CD1055  ENDVVETWTV KDIEVDPSNL GLKGSPTSVF KSFTKSVKPA GTIYNEDAKT
          etfB2  ENDVVETWTV KDIEVDPSNL GLKGSPTSVF KSFTKSVKPA GTIYNEDAKT
 
      pE_CD1055  SAGIIIDKLK EKYII
          etfB2  SAGIIIDKLK EKYII
App.9: Amino acid alignment for the cloned 
genes from strain 630 [131
 
App.10: Analysis of pE_etfB2 (CD1055)
the right hand, there is electropherogram for the plasmid. On the left hand, there is pDRAW file shows 
the recognition sites of NlaIII
pE_etfB2(CD1055)
2535 bp
1  - 1
NlaIII - 20
Nla
Nla
NlaIII - 1034
NlaIII - 1220
NlaIII - 1565
NlaIII - 1607
NlaIII - 1874
NlaIII - 2201
NlaIII - 2223
NlaIII - 2266
NlaIII - 2316
e t
fB
2(C
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Expected Fragments  (bp) 22+26+31
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CCATGCC TTATAACAAC
TACAATATAC AATGAAGATG
AGGA GACG 
---- ---- 
etfB2 from C. difficile DSMZ 1296T and the genome derived 
] (GeneBank accession number CD1055). No mutation was observed. 
ADMALKEALA MGADRGILLT DRAFAGADTW
G 
. 
etfB2 from C. difficile DSMZ 1296T  and the genome derived 
]. No mutation was observed. 
 with MultiNA after digestion with NlaIII restriction enzyme.
 as well as the position of the sequencing primers.  
NlaIII - 740
III - 977
III - 1003
 42+43 50 186 237+239 267 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 On 
327 345 720 
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>pE_CD1056- insert  
      1 CGTCTCCAAT GGGTAACGTT TTAGTAGTAA TAGAACAAAG AGAAAATGTA ATTCAAACTG 
     61 TTTCTTTAGA ATTACTAGGA AAGGCTACAG AAATAGCAAA AGATTATGAT ACAAAAGTTT 
    121 CTGCATTACT TTTAGGTAGT AAGGTAGAAG GTTTAATAGA TACATTAGCA CACTATGGTG 
    181 CAGATGAGGT AATAGTAGTA GATGATGAAG CTTTAGCAGT GTATACAACT GAACCATATA 
    241 CAAAAGCAGC TTATGAAGCA ATAAAAGCAG CTGACCCTAT AGTTGTATTA TTTGGTGCAA 
    301 CTTCAATAGG TAGAGATTTA GCGCCTAGAG TTTCTGCTAG AATACATACA GGTCTTACTG 
    361 CTGACTGTAC AGGTCTTGCA GTAGCTGAAG ATACAAAATT ATTATTAATG ACAAGACCTG 
    421 CCTTTGGTGG AAATATAATG GCAACAATAG TTTGTAAAGA TTTCAGACCT CAAATGTCTA 
    481 CAGTTAGACC AGGGGTTATG AAGAAAAATG AACCTGATGA AACTAAAGAA GCTGTAATTA 
    541 ACCGTTTCAA GGTAGAATTT AATGATGCTG ATAAATTAGT TCAAGTTGTA CAAGTAATAA 
    601 AAGAAGCTAA AAAACAAGTT AAAATAGAAG ATGCTAAGAT ATTAGTTTCT GCTGGACGTG 
    661 GAATGGGTGG AAAAGAAAAC TTAGACATAC TTTATGAATT AGCTGAAATT ATAGGTGGAG 
    721 AAGTTTCTGG TTCTCGTGCC ACTATAGATG CAGGTTGGTT AGATAAAGCA AGACAAGTTG 
    781 GTCAAACTGG TAAAACTGTA AGACCAGACC TTTATATAGC ATGTGGTATA TCTGGAGCAA 
    841 TACAACATAT AGCTGGTATG GAAGATGCTG AGTTTATAGT TGCTATAAAT AAAAATCCAG 
    901 AAGCTCCAAT ATTTAAATAT GCTGATGTTG GTATAGTTGG AGATGTTCAT AAAGTGCTTC 
    961 CAGAACTTAT CAGTCAGTTA AGTGTTGCAA AAGAAAAAGG TGAAGTTTTA GCTAACGGGA 
   1021 GGAGACG 
App.11: The nucleotide sequence of etfA2 cloned from C. difficile DSMZ 1296T. The gray highlighted 
sequences refer to the Esp3I restriction site. The stop codon was replaced with GGG. There are two 
mutation highlighted with red.  
 
pE_CD1056-insert  CGTCTCCAAT GGGTAACGTT TTAGTAGTAA TAGAACAAAG AGAAAATGTA 
    CD1056-etfA2  --------AT GGGTAACGTT TTAGTAGTAA TAGAACAAAG AGAAAATGTA 
 
pE_CD1056-insert  ATTCAAACTG TTTCTTTAGA ATTACTAGGA AAGGCTACAG AAATAGCAAA 
    CD1056-etfA2  ATTCAAACTG TTTCTTTAGA ATTACTAGGA AAGGCTACAG AAATAGCAAA 
 
pE_CD1056-insert  AGATTATGAT ACAAAAGTTT CTGCATTACT TTTAGGTAGT AAGGTAGAAG 
    CD1056-etfA2  AGATTATGAT ACAAAAGTTT CTGCATTACT TTTAGGTAGT AAGGTAGAAG 
 
pE_CD1056-insert  GTTTAATAGA TACATTAGCA CACTATGGTG CAGATGAGGT AATAGTAGTA 
    CD1056-etfA2  GTTTAATAGA TACATTAGCA CACTATGGTG CAGATGAGGT AATAGTAGTA 
 
pE_CD1056-insert  GATGATGAAG CTTTAGCAGT GTATACAACT GAACCATATA CAAAAGCAGC 
    CD1056-etfA2  GATGATGAAG CTTTAGCAGT GTATACAACT GAACCATATA CAAAAGCAGC 
 
pE_CD1056-insert  TTATGAAGCA ATAAAAGCAG CTGACCCTAT AGTTGTATTA TTTGGTGCAA 
    CD1056-etfA2  TTATGAAGCA ATAAAAGCAG CTGACCCTAT AGTTGTATTA TTTGGTGCAA 
 
pE_CD1056-insert  CTTCAATAGG TAGAGATTTA GCGCCTAGAG TTTCTGCTAG AATACATACA 
    CD1056-etfA2  CTTCAATAGG TAGAGATTTA GCTCCTAGAG TTTCTGCTAG AATACATACA 
 
pE_CD1056-insert  GGTCTTACTG CTGACTGTAC AGGTCTTGCA GTAGCTGAAG ATACAAAATT 
    CD1056-etfA2  GGTCTTACTG CTGACTGTAC AGGTCTTGCA GTAGCTGAAG ATACAAAATT 
 
pE_CD1056-insert  ATTATTAATG ACAAGACCTG CCTTTGGTGG AAATATAATG GCAACAATAG 
    CD1056-etfA2  ATTATTAATG ACAAGACCTG CATTTGGTGG AAATATAATG GCAACAATAG 
 
pE_CD1056-insert  TTTGTAAAGA TTTCAGACCT CAAATGTCTA CAGTTAGACC AGGGGTTATG 
    CD1056-etfA2  TTTGTAAAGA TTTCAGACCT CAAATGTCTA CAGTTAGACC AGGGGTTATG 
 
pE_CD1056-insert  AAGAAAAATG AACCTGATGA AACTAAAGAA GCTGTAATTA ACCGTTTCAA 
    CD1056-etfA2  AAGAAAAATG AACCTGATGA AACTAAAGAA GCTGTAATTA ACCGTTTCAA 
 
pE_CD1056-insert  GGTAGAATTT AATGATGCTG ATAAATTAGT TCAAGTTGTA CAAGTAATAA 
    CD1056-etfA2  GGTAGAATTT AATGATGCTG ATAAATTAGT TCAAGTTGTA CAAGTAATAA 
 
pE_CD1056-insert  AAGAAGCTAA AAAACAAGTT AAAATAGAAG ATGCTAAGAT ATTAGTTTCT 
    CD1056-etfA2  AAGAAGCTAA AAAACAAGTT AAAATAGAAG ATGCTAAGAT ATTAGTTTCT 
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pE_CD1056-insert  GCTGGACGTG GAATGGGTGG AAAAGAAAAC TTAGACATAC TTTATGAATT 
    CD1056-etfA2  GCTGGACGTG GAATGGGTGG AAAAGAAAAC TTAGACATAC TTTATGAATT 
 
pE_CD1056-insert  AGCTGAAATT ATAGGTGGAG AAGTTTCTGG TTCTCGTGCC ACTATAGATG 
    CD1056-etfA2  AGCTGAAATT ATAGGTGGAG AAGTTTCTGG TTCTCGTGCC ACTATAGATG 
 
pE_CD1056-insert  CAGGTTGGTT AGATAAAGCA AGACAAGTTG GTCAAACTGG TAAAACTGTA 
    CD1056-etfA2  CAGGTTGGTT AGATAAAGCA AGACAAGTTG GTCAAACTGG TAAAACTGTA 
 
pE_CD1056-insert  AGACCAGACC TTTATATAGC ATGTGGTATA TCTGGAGCAA TACAACATAT 
    CD1056-etfA2  AGACCAGACC TTTATATAGC ATGTGGTATA TCTGGAGCAA TACAACATAT 
 
pE_CD1056-insert  AGCTGGTATG GAAGATGCTG AGTTTATAGT TGCTATAAAT AAAAATCCAG 
    CD1056-etfA2  AGCTGGTATG GAAGATGCTG AGTTTATAGT TGCTATAAAT AAAAATCCAG 
 
pE_CD1056-insert  AAGCTCCAAT ATTTAAATAT GCTGATGTTG GTATAGTTGG AGATGTTCAT 
    CD1056-etfA2  AAGCTCCAAT ATTTAAATAT GCTGATGTTG GTATAGTTGG AGATGTTCAT 
 
pE_CD1056-insert  AAAGTGCTTC CAGAACTTAT CAGTCAGTTA AGTGTTGCAA AAGAAAAAGG 
    CD1056-etfA2  AAAGTGCTTC CAGAACTTAT CAGTCAGTTA AGTGTTGCAA AAGAAAAAGG 
 
pE_CD1056-insert  TGAAGTTTTA GCTAACGGGA GGAGACG 
    CD1056-etfA2  TGAAGTTTTA GCTAACTAA- ------- 
App.12: Sequence alignment for the cloned etfA2 from C. difficile DSMZ 1296T and the genome derived 
genes from strain 630 [131] (GeneBank accession number CD1056). There are two mutations 
highlighted with red.  
       pE_CD1056  MGNVLVVIEQ RENVIQTVSL ELLGKATEIA KDYDTKVSAL LLGSKVEGLI 
           etfA2  MGNVLVVIEQ RENVIQTVSL ELLGKATEIA KDYDTKVSAL LLGSKVEGLI 
 
       pE_CD1056  DTLAHYGADE VIVVDDEALA VYTTEPYTKA AYEAIKAADP IVVLFGATSI 
           etfA2  DTLAHYGADE VIVVDDEALA VYTTEPYTKA AYEAIKAADP IVVLFGATSI 
 
       pE_CD1056  GRDLAPRVSA RIHTGLTADC TGLAVAEDTK LLLMTRPAFG GNIMATIVCK 
           etfA2  GRDLAPRVSA RIHTGLTADC TGLAVAEDTK LLLMTRPAFG GNIMATIVCK 
 
       pE_CD1056  DFRPQMSTVR PGVMKKNEPD ETKEAVINRF KVEFNDADKL VQVVQVIKEA 
           etfA2  DFRPQMSTVR PGVMKKNEPD ETKEAVINRF KVEFNDADKL VQVVQVIKEA 
 
       pE_CD1056  KKQVKIEDAK ILVSAGRGMG GKENLDILYE LAEIIGGEVS GSRATIDAGW 
           etfA2  KKQVKIEDAK ILVSAGRGMG GKENLDILYE LAEIIGGEVS GSRATIDAGW 
 
       pE_CD1056  LDKARQVGQT GKTVRPDLYI ACGISGAIQH IAGMEDAEFI VAINKNPEAP 
           etfA2  LDKARQVGQT GKTVRPDLYI ACGISGAIQH IAGMEDAEFI VAINKNPEAP 
 
       pE_CD1056  IFKYADVGIV GDVHKVLPEL ISQLSVAKEK GEVLANG 
           etfA2  IFKYADVGIV GDVHKVLPEL ISQLSVAKEK GEVLAN. 
  
App.13: Amino acid alignment for the cloned etfA2 from C. difficile DSMZ 1296T  and the genome derived 
genes from strain 630 [131]. No mutation was observed in the amino acid sequence. 
  
App.14: Analysis of pE_etfA2 (CD1056)
the right hand, there is electropherogram for the plasmid. On the left hand, there is pDRAW file shows 
the recognition sites of NlaIII
 
>pE-CD1057-insert 
      1 CGTCTCCAAT GAGTACAAGT GATGTTAAAG TTTATGAGAA TGTAGCTGTT GAAGTAGATG
     61 GAAATATATG TACAGTGAAA ATGAATAGAC CTAAAGCCCT TAATGCAATA AATTCAAAGA
    121 CTTTAGAAGA ACTTTATGAA GTATTTGTAG ATATTAATAA TGATGAAACT ATTGATGTTG
    181 TAATATTGAC AGGGGAAGGA AAGGCATTTG TAGCTGGAGC AGATATTGCA TACATGAAAG
    241 ATTTAGATGC TGTAGCTGCT AAAGATTTTA GTATCTTAGG AGCAAAAGCT TTTGGAGAAA
    301 TAGAAAATAG TAAAAAAGTA GTGA
    361 GTGAACTTGC AATGGCATGT GATATAAGAA TTGCATCTGC TAAAGCTAAA TTTGGTCAGC
    421 CAGAAGTAAC TCTTGGAATA ACTCCAGGAT ATGGAGGAAC TCAAAG
    481 TTGGAATGGC AAAAGCAAAA GAATTAATCT TTACAGGTCA AGTTATAAAA GCTGA
    541 CTGAAAAAAT AGGGCTA
    601 AGAAATTAGC TAAGATAATA GCTAAAAATG CTCAGCTTGC AGTTAGATAC TCTAAAGAAG
    661 CAATACAACT TGGTGCTCAA ACTGATATAA ATACTGGAAT AGATATAGAA TCTAATTTAT
    721 TTGGTCTTTG TTTTTCAACT AAAGACCAAA AAGAAGGAAT GTCAGCTTTC GTTGAAAAGA
    781 GAGAAGCTAA CTTTATAAAA GGG
 
App.15: The nucleotide sequence of 
sequences refer to the Esp3I
mutations highlighted with 
 
pE-CD1057-insert  CGTCTCCA
     CD1057-crt2  --------
 
pE-CD1057-insert  GAAGTAGATG GAAATATATG TACAGTGAAA ATGAATAGAC CTAAAGCCCT
     CD1057-crt2  GAAGTAGATG GAAATATATG TACAGTGAAA ATGAATAGAC CTAAAGCCCT
 
pE-CD1057-insert  TAATGCAATA AATTCAAAGA CTTTAGAAGA ACTTTATGAA GTATTTGTAG
    CD1057-crt2   TAATGCAATA AATTCAA
 
pE-CD1057-insert  ATATTAATAA TGATGAAACT ATTGATGTTG TAATATTGAC AGGGGAAGGA
     CD1057-crt2  ATATTAATAA TGATGAAACT ATTGATGTTG TAATATTGAC AGGGGAAGGA
 
pE-CD1057-insert  AAGGCATTTG TAGCTGGAGC AGATATTGCA TACATGAAAG ATTTAGATG
     CD1057-crt2  AAGGCATTTG TAGCTGGAGC AGATATTGCA TACATGAAAG ATTTAGATGC
 
pE-CD1057-insert  TGTAGCTGCT AAAGATTTTA GTATCTTAGG AGCAAAAGCT TTTGGAGAAA
     CD1057-crt2  TGTAGCTGCT AAAGATTTTA GTATCTTAGG AGCAAAAGCT TTTGGAGAAA
 
pE-CD1057-insert  TAGAAAATAG TAAA
     CD1057-crt2  TAGAAAATAG TAAAAAAGTA GTGATAGCTG CTGTAAACGG ATTTGCTTTA
pE_etfA2(CD1056)
2748 bp
1   - 1
NlaIII - 20
Nla
NlaIII - 977
NlaIII - 1003
NlaIII - 1034
NlaIII - 1220NlaIII - 1565
NlaIII - 1607
NlaIII - 2508
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 with MultiNA after digestion with NlaIII restriction enzyme.
  as well as the position of the sequencing primers.  
TAGCTG CTGTAAACGG ATTTGCTTTA GGTGGAGGAT
GCTT ACAAGATTGG
GTA AATAGAGTCG TTGAGCCAGA CATTTTAATA GAAGAAGTTG
GGGAGGA GACG 
crt2 cloned from C. difficile DSMZ 1296T. 
 restriction site. The stop codon was replaced with 
red.  
AT GAGTACAAGT GATGTTAAAG TTTATGAGAA TGTAGCTGTT
AT GAGTACAAGT GATGTTAAAG TTTATGAGAA TGTAGCTGTT
AGA CTTTAGAAGA ACTTTATGAA GTATTTGTAG
AAAGTA GTGATAGCTG CTGTAAACGG ATTTGCTTTA
III - 740
26+32 42 186 237 260 345 
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pE-CD1057-insert  GGTGGAGGAT GTGAACTTGC AATGGCATGT GATATAAGAA TTGCATCTGC 
     CD1057-crt2  GGTGGAGGAT GTGAACTTGC AATGGCATGT GATATAAGAA TTGCATCTGC 
 
pE-CD1057-insert  TAAAGCTAAA TTTGGTCAGC CAGAAGTAAC TCTTGGAATA ACTCCAGGAT 
     CD1057-crt2  TAAAGCTAAA TTTGGTCAGC CAGAAGTAAC TCTTGGAATA ACTCCAGGAT 
 
pE-CD1057-insert  ATGGAGGAAC TCAAAGGCTT ACAAGATTGG TTGGAATGGC AAAAGCAAAA 
     CD1057-crt2  ATGGAGGAAC TCAAAGACTT ACAAGATTGG TTGGAATGGC AAAAGCAAAA 
 
pE-CD1057-insert  GAATTAATCT TTACAGGTCA AGTTATAAAA GCTGATGAAG CTGAAAAAAT 
     CD1057-crt2  GAATTAATCT TTACAGGTCA AGTTATAAAA GCTGATGAAG CTGAAAAAAT 
 
pE-CD1057-insert  AGGGCTAGTA AATAGAGTCG TTGAGCCAGA CATTTTAATA GAAGAAGTTG 
     CD1057-crt2  AGGGCTAATA AATAGAGTCG TTGAGCCAGA CATTTTAATA GAAGAAGTTG 
 
pE-CD1057-insert  AGAAATTAGC TAAGATAATA GCTAAAAATG CTCAGCTTGC AGTTAGATAC 
     CD1057-crt2  AGAAATTAGC TAAGATAATA GCTAAAAATG CTCAGCTTGC AGTTAGATAC 
 
pE-CD1057-insert  TCTAAAGAAG CAATACAACT TGGTGCTCAA ACTGATATAA ATACTGGAAT 
     CD1057-crt2  TCTAAAGAAG CAATACAACT TGGTGCTCAA ACTGATATAA ATACTGGAAT 
 
pE-CD1057-insert  AGATATAGAA TCTAATTTAT TTGGTCTTTG TTTTTCAACT AAAGACCAAA 
     CD1057-crt2  AGATATAGAA TCTAATTTAT TTGGTCTTTG TTTTTCAACT AAAGACCAAA 
 
pE-CD1057-insert  AAGAAGGAAT GTCAGCTTTC GTTGAAAAGA GAGAAGCTAA CTTTATAAAA 
     CD1057-crt2  AAGAAGGAAT GTCAGCTTTC GTTGAAAAGA GAGAAGCTAA CTTTATAAAA 
 
pE-CD1057-insert  GGGGGGAGGA GACG 
     CD1057-crt2  GGGTAA---- ---- 
 
App.16: Sequence alignment for the cloned crt2 from C. difficile DSMZ 1296T and the genome derived 
genes from strain 630 [131] (GeneBank accession number CD1057). There are two mutations 
highlighted with red.  
 
      pE-CD1057  MSTSDVKVYE NVAVEVDGNI CTVKMNRPKA LNAINSKTLE ELYEVFVDIN 
           Crt2  MSTSDVKVYE NVAVEVDGNI CTVKMNRPKA LNAINSKTLE ELYEVFVDIN 
 
      pE-CD1057  NDETIDVVIL TGEGKAFVAG ADIAYMKDLD AVAAKDFSIL GAKAFGEIEN 
           Crt2  NDETIDVVIL TGEGKAFVAG ADIAYMKDLD AVAAKDFSIL GAKAFGEIEN 
 
      pE-CD1057  SKKVVIAAVN GFALGGGCEL AMACDIRIAS AKAKFGQPEV TLGITPGYGG 
           Crt2  SKKVVIAAVN GFALGGGCEL AMACDIRIAS AKAKFGQPEV TLGITPGYGG 
 
      pE-CD1057  TQRLTRLVGM AKAKELIFTG QVIKADEAEK IGLVNRVVEP DILIEEVEKL 
           Crt2  TQRLTRLVGM AKAKELIFTG QVIKADEAEK IGLINRVVEP DILIEEVEKL 
 
      pE-CD1057  AKIIAKNAQL AVRYSKEAIQ LGAQTDINTG IDIESNLFGL CFSTKDQKEG 
           Crt2  AKIIAKNAQL AVRYSKEAIQ LGAQTDINTG IDIESNLFGL CFSTKDQKEG 
 
      pE-CD1057  MSAFVEKREA NFIKGG 
           Crt2  MSAFVEKREA NFIKG. 
 
App.17: Amino acid alignment for the cloned crt2 from C. difficile DSMZ 1296T  and the genome derived 
genes from strain 630 [131]. There is only one conservative amino acid exchanged, which provides a 
strain-to-strain deviation and is not PCR artefact. The stop codon was replaced with glycin 
.  
  
App.18: Analysis of pE_crt2 (CD1057)
right hand, there is electropherogram for the plasmid. On the left hand, there is pDRAW file shows the 
recognition sites of NlaIII as well as the position of the sequencing primers. 
 
>pE_CD1058-insert  
      1 CGTCTCCAAT GAAATTAGCT GTAATAGGTA 
     61 CTTTTGCAAG TTGTGGACAT GATGTATGTT TAAAGAGTAG AACTCAAGGT GCTATAGATA
    121 AATGTTTAGC TTTATTAGAT AAAAATTTAA CTAAGTTAGT TACTAAGGGA AAAATGGATG
    181 AAGCTACAAA AGCAGAAATA TTAAGTCATG TTAGTTCAAC TACTAATTAT GAAGATTTAA
    241 AAGATATGGA TTTAATAATA GAAGCATCTG TAGAAGACAT GAATATAAAG AAAGATGTTT
    301 TCAAGTTACT AGATGAATTA TGTAAAGAAG ATACTATCTT GGCAACAAAT ACTTCATCAT
    361 TATCTATAAC AGAAATAGCT TCTTCTACTA AGAGACCAGA TAAAGTTATA GGAATGCATT
    421 TCTTTAATCC AGTTCCTATG ATGAA
    481 AAGTTACTTT TGATACAGTA TTTGAATTAT CTAAGAGTAT CAATAAAGTA CCAGTAGATG
    541 TATCTGAATC TCCTGGATTT GTAGTAAATA GAATACTTAT ACCTATGATA AATGAAGCTG
    601 TTGGTATATA TGCAGATGGT GTTGCAAGTA AAGAAGAAAT AGATGAAGCT ATGAAA
    661 GAGCAAACCA TCCAATGGGA CCACTAGCAT TAGGTGATTT AAT
    721 TAGCTATAAT GAACGTTTTA TATACTGAAT TTGGAGATAC TAAATATAGA CCTCATCCAC
    781 TTTTAGCTAA AATGGTTAGA GCTAATCAAT TAGGAAGAAA AACTAAGATA GGATTCTATG
    841 ATTATAATAA AGGGAG
 
App.19: The nucleotide sequence of 
sequences refer to the Esp3I
mutation highlighted with red
 
pE_CD1058-insert  CGTCTCCA
      CD1058-hbd  --------
 
pE_CD1058-insert  ATTGTACAAA CTTTTGCAAG TTGTGGACAT GATGTATGTT TAAAGAGTAG
      CD1058-hbd  ATTGTACAAA CTTTTGCAAG TTGTGGACAT GAT
 
pE_CD1058-insert  AACTCAAGGT GCTATAGATA AATGTTTAGC TTTATTAGAT AAAAATTTAA
      CD1058-hbd  AACTCAAGGT GCTATAGATA AATGTTTAGC TTTATTAGAT AAAAATTTAA
 
pE_CD1058-insert  CTAAGTTAGT TACTAAGGGA AAAATGGATG AAGCTACAAA AGCAGAAATA
      CD1058-hbd  CTAAGTTAGT TACTAAGGGA AAAATGGATG AAGCTACAAA AGCAGAAATA
 
pE_CD1058-insert  TTAAGTCATG TTAGTTCAAC TACTAATTAT GAAGATTTAA AAGATATGGA
      CD1058-hbd  TTAAGTCATG TTAGTTCAAC TACTAATTAT GAAGATTTAA AAGATATGGA
 
pE_CD1058-insert  TTTAATAATA GAAGCA
      CD1058-hbd  TTTAATAATA GAAGCATCTG TAGAAGACAT GAATATAAAG AAAGATGTTT
 
pE_CD1058-insert  TCAAGTTACT AGATGAATTA TGTAAAGAAG ATACTATCTT GGCAACAAAT
      CD1058-hbd  TCAAGTTACT AGATGAATTA TGTAAAGAAG ATACTATCTT 
pE_crt2(CD1057) 
2535 bp
1  - 1
NlaIII - 20
NlaIII - 977
NlaIII - 1003
NlaIII - 1034
NlaIII - 1220
NlaIII - 1565
NlaIII - 1607
NlaIII - 1921
NlaIII - 2064
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 with MultiNA after digestion with NlaIII restriction enzyme.
 
GTGGAACTAT GGGAAGTGGT ATTGTACAAA
ATTAG TTGAAGTTAT AAGTGGTCAG TTAACATCAA
CGGATTA GATGTTGTTT
GAGA CG 
hbd cloned from C. difficile DSMZ 1296T. 
 restriction site. The stop codon was replaced with GGG
. 
AT GAAATTAGCT GTAATAGGTA GTGGAACTAT GGGAAGTGGT
AT GAAATTAGCT GTAATAGGTA GTGGAACTAT GGGAAGTGGT
GTATGTT TAAAGAGTAG
TCTG TAGAAGACAT GAATATAAAG AAAGATGTTT
NlaIII - 740
31 42 143 186 237 314 345
 
 On the 
 
 
 
 
 
 
 
 
 
 
TTAG 
 
 
 
The gray highlighted 
. There is only one 
 
 
 
 
 
 
 
 
 
 
 
 
 
GGCAACAAAT 
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pE_CD1058-insert  ACTTCATCAT TATCTATAAC AGAAATAGCT TCTTCTACTA AGAGACCAGA 
      CD1058-hbd  ACTTCATCAT TATCTATAAC AGAAATAGCT TCTTCTACTA AGAGACCAGA 
 
pE_CD1058-insert  TAAAGTTATA GGAATGCATT TCTTTAATCC AGTTCCTATG ATGAAATTAG 
      CD1058-hbd  TAAAGTTATA GGAATGCATT TCTTTAATCC AGTTCCTATG ATGAAATTAG 
 
pE_CD1058-insert  TTGAAGTTAT AAGTGGTCAG TTAACATCAA AAGTTACTTT TGATACAGTA 
      CD1058-hbd  TTGAAGTTAT AAGTGGTCAG TTAACATCAA AAGTTACTTT TGATACAGTA 
 
pE_CD1058-insert  TTTGAATTAT CTAAGAGTAT CAATAAAGTA CCAGTAGATG TATCTGAATC 
      CD1058-hbd  TTTGAATTAT CTAAGAGTAT CAATAAAGTA CCAGTAGATG TATCTGAATC 
 
pE_CD1058-insert  TCCTGGATTT GTAGTAAATA GAATACTTAT ACCTATGATA AATGAAGCTG 
      CD1058-hbd  TCCTGGATTT GTAGTAAATA GAATACTTAT ACCTATGATA AATGAAGCTG 
 
pE_CD1058-insert  TTGGTATATA TGCAGATGGT GTTGCAAGTA AAGAAGAAAT AGATGAAGCT 
      CD1058-hbd  TTGGTATATA TGCAGATGGT GTTGCAAGTA AAGAAGAAAT AGATGAAGCT 
 
pE_CD1058-insert  ATGAAATTAG GAGCAAACCA TCCAATGGGA CCACTAGCAT TAGGTGATTT 
      CD1058-hbd  ATGAAATTAG GAGCAAACCA TCCAATGGGA CCACTAGCAT TAGGTGATTT 
 
pE_CD1058-insert  AATCGGATTA GATGTTGTTT TAGCTATAAT GAACGTTTTA TATACTGAAT 
      CD1058-hbd  AATTGGATTA GATGTTGTTT TAGCTATAAT GAACGTTTTA TATACTGAAT 
 
pE_CD1058-insert  TTGGAGATAC TAAATATAGA CCTCATCCAC TTTTAGCTAA AATGGTTAGA 
      CD1058-hbd  TTGGAGATAC TAAATATAGA CCTCATCCAC TTTTAGCTAA AATGGTTAGA 
 
pE_CD1058-insert  GCTAATCAAT TAGGAAGAAA AACTAAGATA GGATTCTATG ATTATAATAA 
      CD1058-hbd  GCTAATCAAT TAGGAAGAAA AACTAAGATA GGATTCTATG ATTATAATAA 
  
pE_CD1058-insert  AGGGAGGAGA CG 
      CD1058-hbd  ATAA------ -- 
 
 
App.20: Sequence alignment for the cloned hbd from C. difficile DSMZ 1296T and the genome derived 
genes from strain 630 [131] (GeneBank accession number CD1058). There is only one mutation 
highlighted with red.  
 
 
      pE_CD1058  MKLAVIGSGT MGSGIVQTFA SCGHDVCLKS RTQGAIDKCL ALLDKNLTKL 
           BHBD  MKLAVIGSGT MGSGIVQTFA SCGHDVCLKS RTQGAIDKCL ALLDKNLTKL 
 
      pE_CD1058  VTKGKMDEAT KAEILSHVSS TTNYEDLKDM DLIIEASVED MNIKKDVFKL 
           BHBD  VTKGKMDEAT KAEILSHVSS TTNYEDLKDM DLIIEASVED MNIKKDVFKL 
 
      pE_CD1058  LDELCKEDTI LATNTSSLSI TEIASSTKRP DKVIGMHFFN PVPMMKLVEV 
           BHBD  LDELCKEDTI LATNTSSLSI TEIASSTKRP DKVIGMHFFN PVPMMKLVEV 
 
      pE_CD1058  ISGQLTSKVT FDTVFELSKS INKVPVDVSE SPGFVVNRIL IPMINEAVGI 
           BHBD  ISGQLTSKVT FDTVFELSKS INKVPVDVSE SPGFVVNRIL IPMINEAVGI 
 
      pE_CD1058  YADGVASKEE IDEAMKLGAN HPMGPLALGD LIGLDVVLAI MNVLYTEFGD 
           BHBD  YADGVASKEE IDEAMKLGAN HPMGPLALGD LIGLDVVLAI MNVLYTEFGD 
 
      pE_CD1058  TKYRPHPLLA KMVRANQLGR KTKIGFYDYN KG 
           BHBD  TKYRPHPLLA KMVRANQLGR KTKIGFYDYN K. 
 
App.21: Amino acid alignment for the cloned hbd from C. difficile DSMZ 1296T  and the genome derived 
genes from strain 630 [131]. No mutation was observed in the amino acid sequence. The stop codon 
was replaced with glycin. 
 
  
App.22: Analysis of pE_hbd (CD1058)
right hand, there is electropherogram for the plasmid. On the left hand, there is pDRAW file shows the 
recognition sites of NlaIII as well as the position of the sequencing primers. 
 
>pE_CD1059-insert 
      1 CGTCTCCAAT GAGAGAAGTA GTAATTGCCA 
     61 GAGGAGCATT TAAATCAGTT TCAGCGGTAG AGTTAGGGGT AACAGCAGCT AAAGAAGCTA
    121 TAAAAAGAGC TAACATAACT CCAGATATGA TAGATGAATC TCTTTTAGGG GGAGTACTTA
    181 CAGCAGGTCT TGGACAAAAT ATAGCAAGAC AAATAGCATT AGGAGCAGGA ATACCAGTAG
    241 AAAAACCAGC TATGACTATA AATATAGTTT GTGGTTCTGG ATTAAGATCT GTTTCAATGG
    301 CATCTCAACT TATAGCATTA GGTGATGCTG ATATAATGTT AGTTGGTGGA GCTGAAAACA
    361 TGAGTATGTC TCCTTATTTA GTACCAAGTG CGAGATATGG TGCAAGAATG GGTGATGCTG
    421 CTTTTGTTGA TTCAATGATA AAAGA
    481 GTATTACTGC TGAAAACATA GCAGAGCAAT GGAATATAAC TAGAGAAGAA CAAGATGAAT
    541 TAGCTCTTGC AAGTCAAAAT AAAGCTGAAA AAGCTCAAGC TGAAGGAAAA TTTGATGAAG
    601 AAATAGTTCC TGTTGTTATA AAAGGAAGAA AAGGTGACAC TGTAGTAGAT AAAGAT
    661 ATATTAAGCC TGGCACTACA ATGGAGAAAC TTGCTAAGTT AAGACCTGCA TTTAAAAAAG
    721 ATGGAACAGT TACTGCTGGT AATGCATCAG GAATAAATGA TGGTGCTGCT ATG
    781 TAATGGCTAA AGAAAAAGCT GAAGAACTAG GAATAGAGCC TCTTGCAACT ATAGTTTCTT
    841 ATGGAACAGC TGGTGTTGAC
    901 AAGCTTTAGA AGCTGCTAAT ATGACTATTG AAGATATAGA TTTAGTTGAA GCTAATGAGG
    961 CATTTGCTGC CCAATCTGTA GCTGTAATAA GAGACTTAAA TATAGATATG AATAAAGTTA
   1021 ATGTTAATGG TGGAGCAATA GCTATAGGAC ATCCAATAGG ATGCTCAGGA GCAAGAATAC
   1081 TTACTACACT TTTATATGAA ATGAAGAGAA GAGATGCTAA AACTGGTCTT GCTACACTTT
   1141 GTATAGGCGG TGGAATGGGA ACTACTTTAA TAGTTAAGAG A
 
App.23: The nucleotide sequence of 
sequences refer to the Esp3I
mutations highlighted with 
 
pE_CD1059-insert  CGTCTCCA
    CD1059-thiAI  --------
 
pE_CD1059-insert  GGAAGTTTTG GAGGAGCATT TAAATCAGTT TCAGCGGTAG AGTTAGGGGT
    CD1059-thiAI  GGAAGTTTTG GAGGAGCATT TAAATCAGTT TCAGCGGTAG AGTTAGGGGT
 
pE_CD1059-insert  AACAGCAGCT AAAGAAGCTA TAAAAAGAGC TAACATAACT CCAGATATGA
    CD1059-thiAI  AACAGCAGCT AAAGAAGCTA TAAAAAGAGC TAACATAACT CCAGATATGA
 
pE_CD1059-insert  TAGATGAATC TCTTTTAGGG GGAGTACTTA CAGCAGGTCT TGGACAAAAT
    CD1059-thiAI  TAGATGAATC TCTTTTAGGG GGAGTACTTA 
 
pE_CD1059-insert  ATAGCAAGAC AAATAGCATT AGGAGCAGGA ATACCAGTAG AAAAACCAGC
    CD1059-thiAI  ATAGCAAGAC AAATAGCATT AGGAGCAGGA ATACCAGTAG AAAAACCAGC
pE_hbd (CD1058)
2583 bp
1   - 1
NlaIII - 20
Nla
NlaIII - 1003
NlaIII - 1034
NlaIII - 1220
NlaIII - 1565
NlaIII - 1607
NlaIII - 1766
NlaIII - 1895
NlaIII - 1966 h
bd
 
 
(C
D1
05
8)
kan
ori
Expected fragments (bp) 26+31
Appendix 
- 123 - 
 with MultiNA after digestion with NlaIII restriction enzyme.
 
GTGCAGCTAG AACAGCAGTA GGAAGTTTTG
TGGAT TATCAGACAT ATTTAATAAC TATCACATGG
 CCTAAAATAA TGGGATATGG ACCAGTTCCA GCAACTAAAA
GGGAGGAGA
thiA1 cloned from C. difficile DSMZ 1296T. 
 restriction site. The stop codon was replaced with 
red. 
AT GAGAGAAGTA GTAATTGCCA GTGCAGCTAG 
AT GAGAGAAGTA GTAATTGCCA GTGCAGCTAG AACAGCAGTA
CAGCAGGTCT TGGACAAAAT
NlaIII - 740
III - 977
 42 71 129 159 186 237 345
 
 On the 
 
 
 
 
 
 
 
 
 
 
GAAT 
 
TTAGTAG 
 
 
 
 
 
 
 CG 
The gray highlighted 
GGG. There are two 
AACAGCAGTA 
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pE_CD1059-insert  TATGACTATA AATATAGTTT GTGGTTCTGG ATTAAGATCT GTTTCAATGG 
    CD1059-thiAI  TATGACTATA AATATAGTTT GTGGTTCTGG ATTAAGATCT GTTTCAATGG 
 
pE_CD1059-insert  CATCTCAACT TATAGCATTA GGTGATGCTG ATATAATGTT AGTTGGTGGA 
    CD1059-thiAI  CATCTCAACT TATAGCATTA GGTGATGCTG ATATAATGTT AGTTGGTGGA 
 
pE_CD1059-insert  GCTGAAAACA TGAGTATGTC TCCTTATTTA GTACCAAGTG CGAGATATGG 
    CD1059-thiAI  GCTGAAAACA TGAGTATGTC TCCTTATTTA GTACCAAGTG CGAGATATGG 
 
pE_CD1059-insert  TGCAAGAATG GGTGATGCTG CTTTTGTTGA TTCAATGATA AAAGATGGAT 
    CD1059-thiAI  TGCAAGAATG GGTGATGCTG CTTTTGTTGA TTCAATGATA AAAGATGGAT 
 
pE_CD1059-insert  TATCAGACAT ATTTAATAAC TATCACATGG GTATTACTGC TGAAAACATA 
    CD1059-thiAI  TATCAGACAT ATTTAATAAC TATCACATGG GTATTACTGC TGAAAACATA 
 
pE_CD1059-insert  GCAGAGCAAT GGAATATAAC TAGAGAAGAA CAAGATGAAT TAGCTCTTGC 
    CD1059-thiAI  GCAGAGCAAT GGAATATAAC TAGAGAAGAA CAAGATGAAT TAGCTCTTGC 
 
pE_CD1059-insert  AAGTCAAAAT AAAGCTGAAA AAGCTCAAGC TGAAGGAAAA TTTGATGAAG 
    CD1059-thiAI  AAGTCAAAAT AAAGCTGAAA AAGCTCAAGC TGAAGGAAAA TTTGATGAAG 
 
pE_CD1059-insert  AAATAGTTCC TGTTGTTATA AAAGGAAGAA AAGGTGACAC TGTAGTAGAT 
    CD1059-thiAI  AAATAGTTCC TGTTGTTATA AAAGGAAGAA AAGGTGACAC TGTAGTAGAT 
 
pE_CD1059-insert  AAAGATGAAT ATATTAAGCC TGGCACTACA ATGGAGAAAC TTGCTAAGTT 
    CD1059-thiAI  AAAGATGAAT ATATTAAGCC TGGCACTACA ATGGAGAAAC TTGCTAAGTT 
 
pE_CD1059-insert  AAGACCTGCA TTTAAAAAAG ATGGAACAGT TACTGCTGGT AATGCATCAG 
    CD1059-thiAI  AAGACCTGCA TTTAAAAAAG ATGGAACAGT TACTGCTGGT AATGCATCAG 
 
pE_CD1059-insert  GAATAAATGA TGGTGCTGCT ATGTTAGTAG TAATGGCTAA AGAAAAAGCT 
    CD1059-thiAI  GAATAAATGA TGGTGCTGCT ATGCTAGTAG TAATGGCTAA AGAAAAAGCT 
 
pE_CD1059-insert  GAAGAACTAG GAATAGAGCC TCTTGCAACT ATAGTTTCTT ATGGAACAGC 
    CD1059-thiAI  GAAGAACTAG GAATAGAGCC TCTTGCAACT ATAGTTTCTT ATGGAACAGC 
 
pE_CD1059-insert  TGGTGTTGAC CCTAAAATAA TGGGATATGG ACCAGTTCCA GCAACTAAAA 
    CD1059-thiAI  TGGTGTTGAC CCTAAAATAA TGGGATATGG ACCAGTTCCA GCAACTAAAA 
 
pE_CD1059-insert  AAGCTTTAGA AGCTGCTAAT ATGACTATTG AAGATATAGA TTTAGTTGAA 
    CD1059-thiAI  AAGCTTTAGA AGCTGCTAAT ATGACTATTG AAGATATAGA TTTAGTTGAA 
 
pE_CD1059-insert  GCTAATGAGG CATTTGCTGC CCAATCTGTA GCTGTAATAA GAGACTTAAA 
    CD1059-thiAI  GCTAATGAGG CATTTGCTGC CCAATCTGTA GCTGTAATAA GAGACTTAAA 
 
pE_CD1059-insert  TATAGATATG AATAAAGTTA ATGTTAATGG TGGAGCAATA GCTATAGGAC 
    CD1059-thiAI  TATAGATATG AATAAAGTTA ATGTTAATGG TGGAGCAATA GCTATAGGAC 
 
pE_CD1059-insert  ATCCAATAGG ATGCTCAGGA GCAAGAATAC TTACTACACT TTTATATGAA 
    CD1059-thiAI  ATCCAATAGG ATGCTCAGGA GCAAGAATAC TTACTACACT TTTATATGAA 
 
pE_CD1059-insert  ATGAAGAGAA GAGATGCTAA AACTGGTCTT GCTACACTTT GTATAGGCGG 
    CD1059-thiAI  ATGAAGAGAA GAGATGCTAA AACTGGTCTT GCTACACTTT GTATAGGTGG 
 
pE_CD1059-insert  TGGAATGGGA ACTACTTTAA TAGTTAAGAG AGGGAGGAGA CG 
    CD1059-thiAI  TGGAATGGGA ACTACTTTAA TAGTTAAGAG ATAG------ -- 
 
App.24: Sequence alignment for the cloned thiA1 from C. difficile DSMZ 1296T and the genome derived 
genes from strain 630 [131] (GeneBank accession number CD1059). There are two mutations 
highlighted with red.     
 
 
       pE_CD1059  MREVVIASAA RTAVGSFGGA FKSVSAVELG VTAAKEAIKR ANITPDMIDE
          ThiAI  MREVVIASAA RTAVGSFGGA 
   
      pE_CD1059  SLLGGVLTAG LGQNIARQIA LGAGIPVEKP AMTINIVCGS GLRSVSMASQ
          ThiAI  SLLGGVLTAG LGQNIARQIA LGAGIPVEKP AMTINIVCGS GLRSVSMASQ
      
      pE_CD1059  LIALGDADIM LVGGAENMSM SPYLVPSARY GARMGDAAFV DSMIKDGLS
          ThiAI  LIALGDADIM LVGGAENMSM SPYLVPSARY GARMGDAAFV DSMIKDGLSD
 
      pE_CD1059  IFNNYHMGIT AENIAEQWNI TREEQDELAL ASQNKAEKAQ AEGKFDEEIV
          ThiAI  IFNNYHMGIT AENIAEQWNI TREEQDELAL ASQNKAEKAQ AEGKFDEEIV
 
      pE_CD1059  PVVIKGRKGD TVVDKDEY
          ThiAI  PVVIKGRKGD TVVDKDEYIK PGTTMEKLAK LRPAFKKDGT VTAGNASGIN
 
      pE_CD1059  DGAAMLVVMA KEKAEELGIE PLATIVSYGT AGVDPKIMGY GPVPATKKAL
          ThiAI  DGAAMLVVMA KEKAEELGIE PLATIVSYGT AGVDPKIMGY GPVPATKKAL
 
      pE_CD1059  EAANMTIEDI DLVEANEAFA AQSVAVIRDL NIDMNKVNVN GGAIAIGHPI
          ThiAI  EAANMTIEDI DLVEANEAFA AQSVAVIRDL NIDMNKVNVN GGAIAIGHPI
 
      pE_CD1059  GCSGARILTT LLYEMKRRDA KTGLATLCIG GGMGTTLIVK R
          ThiAI  GCSGARILTT LLYEMKRRDA 
 
App.25: Amino acid alignment for the cloned 
genes from strain 630 [131
was replaced with glycin. 
 
App.26: Analysis of pE_thiA1 (CD1059)
the right hand, there is electropherogram for the plasmid. On the left hand, there is pDRAW file shows 
the recognition sites of NlaIII
>pE-CD0112-insert 
      1 CGTCTCCAAT GAGAAGTTTT GAAGAAGTAA 
     61 CTATATCAGT AGCATGTTGC CAAGATAAAG AAGTTTTAAT GGCAGTTGAA ATGGCTAGAA
    121 AAGAAAAAAT AGCAAATGCC ATTTTAGTAG GAGATATAGA AAAGACTAAA GAAATTGCAA
    181 AAAGCATAGA CATGGATATC GAAAATTATG AACTGATAGA TATAAAAGAT TTAGCAGAAG
    241 CATCTCTAAA ATCTGTTGAA TTAGTTTCAC AAGGAAAAGC CGACATGGTA ATGAAAGGCT
    301 TAGTAGACAC ATCAATAATA CTAAAAGCAG TTTTAAATAA AGAAGTAGGT CTTAGAACTG
    361 GAAATGTATT AAGTCACGTA GCAGTATTTG ATGTAGAGGG ATATGATAGA TTATTTTTCG
    421 TAACTGACGC AGCTATGAAC TTAGC
    481 ATGCTTGCAC AGTAGCACAT TCATTAGATA TAAGTGAACC AAAAGTTGCT GCAATATGCG
    541 CAAAAGAAAA AGTAAATCCA AAAATGAAAG ATACAGTTGA AGCTAAAGAA CTAGAAGAAA
    601 TGTATGAAAG AGGAGAAATC AAAGGTTGTA TGGTTGGTGG 
    661 CAGTATCTTT AGAAGCAGCT AAACATAAAG GTATAAATCA TCCTGTAGCA GGA
    721 ATATATTATT AGCCCCAGAT ATTGAAGGTG GTAACATATT ATATAAAGCT TTGGTATTCT
    781 TCTCAAAATC AAAAAATGCA GGAGTTATAG TTGGGGCTAA AGCACCAATA ATATTAACTT
    841 CTAGAGCAGA CAGTGAAGAA
    901 CAAAGGCAGG GAGGAGACG
 
pE_thiA1 (CD1059)
2913 bp
1  - 1
NlaIII - 20
Nla
NlaIII - 1565
NlaIII - 1607
NlaIII - 2047
NlaIII - 2164 th
lA
1(C
D1
05
9) 
kan
ori
Expected fragments (bp) 26+31
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FKSVSAVELG VTAAKEAIKR ANITPDMIDE
IK PGTTMEKLAK LRPAFKKDGT VTAGNASGIN
KTGLATLCIG GGMGTTLIVK R
thiA1 from C. difficile DSMZ 1296T  and the genome derived 
]. No mutation was observed in the amino acid sequence
 with MultiNA after digestion with NlaIII restriction enzyme.
 as well as the position of the sequencing primers.  
TTAAGTTTGC AAAAGAAAGA GGACCTAAAA
TCCTG ATACAAATAC TAAAAAGCAA ATCATAGAAA
GCCTTTTGCA ATTGAT
 ACTAAACTAA ACTCAATAGC TTTAGGTGTT TTAATGGCAG
 
NlaIII - 740
NlaIII - 977
NlaIII - 1003
NlaIII - 1034
III - 1220
 42 117 186 237 345 
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App.27: The nucleotide sequence of pbt cloned from C. difficile DSMZ 1296T. The gray highlighted 
sequences refer to the Esp3I restriction site. There are two mutations, one of which was introduced on 
purpose to remove a LguI-recognition site and it is green highlighted. The second one observed is a 
strain-to-strain difference and highlighted with red. 
pE-CD0112-insert  CGTCTCCAAT GAGAAGTTTT GAAGAAGTAA TTAAGTTTGC AAAAGAAAGA 
      CD0112-pbt  --------AT GAGAAGTTTT GAAGAAGTAA TTAAGTTTGC AAAAGAAAGA 
 
pE-CD0112-insert  GGACCTAAAA CTATATCAGT AGCATGTTGC CAAGATAAAG AAGTTTTAAT 
      CD0112-pbt  GGACCTAAAA CTATATCAGT AGCATGTTGC CAAGATAAAG AAGTTTTAAT 
 
pE-CD0112-insert  GGCAGTTGAA ATGGCTAGAA AAGAAAAAAT AGCAAATGCC ATTTTAGTAG 
      CD0112-pbt  GGCAGTTGAA ATGGCTAGAA AAGAAAAAAT AGCAAATGCC ATTTTAGTAG 
 
pE-CD0112-insert  GAGATATAGA AAAGACTAAA GAAATTGCAA AAAGCATAGA CATGGATATC 
      CD0112-pbt  GAGATATAGA AAAGACTAAA GAAATTGCAA AAAGCATAGA CATGGATATC 
 
pE-CD0112-insert  GAAAATTATG AACTGATAGA TATAAAAGAT TTAGCAGAAG CATCTCTAAA 
      CD0112-pbt  GAAAATTATG AACTGATAGA TATAAAAGAT TTAGCAGAAG CATCTCTAAA 
 
pE-CD0112-insert  ATCTGTTGAA TTAGTTTCAC AAGGAAAAGC CGACATGGTA ATGAAAGGCT 
      CD0112-pbt  ATCTGTTGAA TTAGTTTCAC AAGGAAAAGC CGACATGGTA ATGAAAGGCT 
 
pE-CD0112-insert  TAGTAGACAC ATCAATAATA CTAAAAGCAG TTTTAAATAA AGAAGTAGGT 
      CD0112-pbt  TAGTAGACAC ATCAATAATA CTAAAAGCAG TTTTAAATAA AGAAGTAGGT 
 
pE-CD0112-insert  CTTAGAACTG GAAATGTATT AAGTCACGTA GCAGTATTTG ATGTAGAGGG 
      CD0112-pbt  CTTAGAACTG GAAATGTATT AAGTCACGTA GCAGTATTTG ATGTAGAGGG 
 
pE-CD0112-insert  ATATGATAGA TTATTTTTCG TAACTGACGC AGCTATGAAC TTAGCTCCTG 
      CD0112-pbt  ATATGATAGA TTATTTTTCG TAACTGACGC AGCTATGAAC TTAGCTCCTG 
 
pE-CD0112-insert  ATACAAATAC TAAAAAGCAA ATCATAGAAA ATGCTTGCAC AGTAGCACAT 
      CD0112-pbt  ATACAAATAC TAAAAAGCAA ATCATAGAAA ATGCTTGCAC AGTAGCACAT 
 
pE-CD0112-insert  TCATTAGATA TAAGTGAACC AAAAGTTGCT GCAATATGCG CAAAAGAAAA 
      CD0112-pbt  TCATTAGATA TAAGTGAACC AAAAGTTGCT GCAATATGCG CAAAAGAAAA 
 
pE-CD0112-insert  AGTAAATCCA AAAATGAAAG ATACAGTTGA AGCTAAAGAA CTAGAAGAAA 
      CD0112-pbt  AGTAAATCCA AAAATGAAAG ATACAGTTGA AGCTAAAGAA CTAGAAGAAA 
 
pE-CD0112-insert  TGTATGAAAG AGGAGAAATC AAAGGTTGTA TGGTTGGTGG GCCTTTTGCA 
      CD0112-pbt  TGTATGAAAG AGGAGAAATC AAAGGTTGTA TGGTTGGTGG ACCTTTTGCA 
 
pE-CD0112-insert  ATTGATAATG CAGTATCTTT AGAAGCAGCT AAACATAAAG GTATAAATCA 
      CD0112-pbt  ATTGATAATG CAGTATCTTT AGAAGCAGCT AAACATAAAG GTATAAATCA 
 
pE-CD0112-insert  TCCTGTAGCA GGACGAGCTG ATATATTATT AGCCCCAGAT ATTGAAGGTG 
      CD0112-pbt  TCCTGTAGCA GGAAGAGCTG ATATATTATT AGCCCCAGAT ATTGAAGGTG 
 
pE-CD0112-insert  GTAACATATT ATATAAAGCT TTGGTATTCT TCTCAAAATC AAAAAATGCA 
      CD0112-pbt  GTAACATATT ATATAAAGCT TTGGTATTCT TCTCAAAATC AAAAAATGCA 
 
pE-CD0112-insert  GGAGTTATAG TTGGGGCTAA AGCACCAATA ATATTAACTT CTAGAGCAGA 
      CD0112-pbt  GGAGTTATAG TTGGGGCTAA AGCACCAATA ATATTAACTT CTAGAGCAGA 
 
pE-CD0112-insert  CAGTGAAGAA ACTAAACTAA ACTCAATAGC TTTAGGTGTT TTAATGGCAG 
      CD0112-pbt  CAGTGAAGAA ACTAAACTAA ACTCAATAGC TTTAGGTGTT TTAATGGCAG 
 
pE-CD0112-insert  CAAAGGCAGG GAGGAGACG 
      CD0112-pbt  CAAAGGCATA A-------- 
App.28: Sequence alignment for the cloned pbt from C. difficile DSMZ 1296T and the genome derived 
genes from strain 630 [131] (GeneBank accession number CD0112).  There are two mutations, 
one of which was introduced on purpose to remove a LguI-recognition site and it is green highlighted. 
The second one observed is a strain-to-strain difference and highlighted with red.    
  
      pE-CD0112  MRSFEEVIKF AKERGPKTIS VACCQDKEVL MAVEMARKEK IANAILVGDI
            Pbt  MRSFEEVIKF AKERGPKTIS VACCQDKEVL MAVEMARKEK IANAILVGDI
 
      pE-CD0112  EKTKEIAKSI DMDIENYELI DIKDLAEASL KSVELVSQGK ADMVMKGLVD
            Pbt  EKTKEIAKSI DMDIENYELI DIKDLAEASL KSVELVSQGK ADMVMKGLVD
 
      pE-CD0112  TSIILKAVLN KEVGLRTGNV LSHVAVFDVE GYDRLFFVTD AAMNLAPDTN
            Pbt  TSIILKAVLN KEVGLRTGNV LSHVAVFDVE
 
      pE-CD0112  TKKQIIENAC TVAHSLDISE PKVAAICAKE KVNPKMKDTV EAKELEEMYE
            Pbt  TKKQIIENAC TVAHSLDISE PKVAAICAKE KVNPKMKDTV EAKELEEMYE
 
      pE-CD0112  RGEIKGCMVG GPFAIDNAVS LEAAKHKGIN HPVAGRADIL LAPDIEGGNI
            Pbt  RGEIKGCMVG GPFAIDNAVS LEAAKHKGIN HPVAGRADIL LAPDIEGGNI
 
      pE-CD0112  LYKALVFFSK SKNAGVIVGA KAPIILTSRA DSEETKLNSI ALGVLMAAKA
            Pbt  LYKALVFFSK SKNAGVIVGA KAPIILTSRA DSEETKLNSI ALGVLMAAKA
 
      pE-CD0112  G 
            Pbt  . 
 
App.29: Amino acid alignment for the cloned 
genes from strain 630 [131
was replaced with glycin. 
 
 
App.30: Analysis of pE_pbt (CD0112)
right hand, there is electropherogram for the plasmid. On the left hand, there is pDRAW file shows the 
recognition sites of NlaIII as well as the sequencing primers positions. 
 
pE_CD0113-insert 
      1 CGTCTCCAAT GAGCAAAATA TTTAAAATCT TAACAATAAA 
     61 AAATAGCTGT ATTTGATAAT GAGGATTTAG TATTTGAAAA AACTTTAAGA CATTCTTCAG
    121 AAGAAATAGG AAAATATGAG AAGGTGTCTG ACCAATTTGA ATTTCGTAAA CAAGTAATAG
    181 AAGAAGCTCT AAAAGAAGGT GGAGTAAAAA CATCTGAATT AGATGCTGTA GTAGGTAGAG
    241 GAGGACTTCT TAAACCTATA AAAGGTGGTA CTTATTCAGT AAGTGCTGCT ATGATTGAAG
    301 ATTTAAAAGT GGGAGTTTTA GGAGAACACG CTTCAAACCT AGGTGGAATA ATAGCAAAAC
    361 AAATAGGTGA AGAAGTAAAT GTTCCTTCAT ACATAGTAGA CCCTGTTGTT GTAGATGAAT
    421 TAGAAGATGT TGCTAGAATT TCTGGTATGC CTGAA
    481 CTTTAAATCA AAAGGCAATA GCAAGAAGAT ATGCTAGAGA AATAAACAAG AAATATGAAG
    541 ATATAAATCT TATAGTTGCA CA
    601 GTAAAATAGT AGATGTTGCA AACGCATTAG ATGGAGAAGG ACCTTTCTCT CCAGAAAGAA
    661 GTGGTGGACT ACCAGTAGGT GCATTAGTAA AAATGTGCTT TAGTGGAAAA TATACTCAAG
    721 ATGAAATTAA AAAGAAAATA AAAGGTAATG GCGGA
    781 ATGCTAGAGA AGTTGAAGAA AGAATTGAAG CTGGTGATGA AAAAGCTAAA TTAGTATATG
pE_pbt CD0112
2640 bp
1   - 1
NlaIII - 20
Nla
NlaIII - 1034
NlaIII - 1220
NlaIII - 1565
NlaIII - 1607
NlaIII - 1761
NlaIII - 1879
NlaIII - 1972
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t (C
D0
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Appendix 
- 127 - 
 GYDRLFFVTD AAMNLAPDTN
pbt from C. difficile DSMZ 1296T  and the genome derived 
]. No mutation was observed in the amino acid sequence
 with MultiNA after digestion with NlaIII restriction enzyme.
 
TCCTGGTTCG ACATCAACTA
ATAAG TAGAGCAAGT GTAGTACATG
CATGGGTG GAGGAGTTTC TGTTGGAGCT CATAAAAATG
CTAGT TGCATACTTA AACACTAATG
NlaIII - 740
NlaIII - 977
III - 1003
31 42 93 118 154 186 237 
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    841 AAGCTATGGC ATATCAAATC TCTAAAGAAA TAGGAGCTAG TGCTGCAGTT CTTAAGGGAG 
    901 ATGTAAAAGC AATATTATTA ACTGGTGGAA TCGCATATTC AAAAATGTTT ACAGAAATGA 
    961 TTGCAGATAG AGTTAAATTT ATAGCAGATG TAAAAGTTTA TCCAGGTGAA GATGAAATGA 
   1021 TTGCATTAGC TCAAGGTGGA CTTAGAGTTT TAACTGGTGA AGAAGAGGCT CAAGTTTATG 
   1081 ATAACGGGAG GAGACG 
 
App.31: The nucleotide sequence of buk cloned from C. difficile DSMZ 1296T. The gray highlighted 
sequences refer to the Esp3I restriction site. There are two mutations highlighted with red. 
 
pE_CD0113-insert  CGTCTCCAAT GAGCAAAATA TTTAAAATCT TAACAATAAA TCCTGGTTCG 
      CD0113-buk  --------AT GAGCAAAATA TTTAAAATCT TAACAATAAA TCCTGGTTCG 
 
pE_CD0113-insert  ACATCAACTA AAATAGCTGT ATTTGATAAT GAGGATTTAG TATTTGAAAA 
      CD0113-buk  ACATCAACTA AAATAGCTGT ATTTGATAAT GAGGATTTAG TATTTGAAAA 
 
pE_CD0113-insert  AACTTTAAGA CATTCTTCAG AAGAAATAGG AAAATATGAG AAGGTGTCTG 
      CD0113-buk  AACTTTAAGA CATTCTTCAG AAGAAATAGG AAAATATGAG AAGGTGTCTG 
 
pE_CD0113-insert  ACCAATTTGA ATTTCGTAAA CAAGTAATAG AAGAAGCTCT AAAAGAAGGT 
      CD0113-buk  ACCAATTTGA ATTTCGTAAA CAAGTAATAG AAGAAGCTCT AAAAGAAGGT 
 
pE_CD0113-insert  GGAGTAAAAA CATCTGAATT AGATGCTGTA GTAGGTAGAG GAGGACTTCT 
      CD0113-buk  GGAGTAAAAA CATCTGAATT AGATGCTGTA GTAGGTAGAG GAGGACTTCT 
 
pE_CD0113-insert  TAAACCTATA AAAGGTGGTA CTTATTCAGT AAGTGCTGCT ATGATTGAAG 
      CD0113-buk  TAAACCTATA AAAGGTGGTA CTTATTCAGT AAGTGCTGCT ATGATTGAAG 
 
pE_CD0113-insert  ATTTAAAAGT GGGAGTTTTA GGAGAACACG CTTCAAACCT AGGTGGAATA 
      CD0113-buk  ATTTAAAAGT GGGAGTTTTA GGAGAACACG CTTCAAACCT AGGTGGAATA 
 
pE_CD0113-insert  ATAGCAAAAC AAATAGGTGA AGAAGTAAAT GTTCCTTCAT ACATAGTAGA 
      CD0113-buk  ATAGCAAAAC AAATAGGTGA AGAAGTAAAT GTTCCTTCAT ACATAGTAGA 
 
pE_CD0113-insert  CCCTGTTGTT GTAGATGAAT TAGAAGATGT TGCTAGAATT TCTGGTATGC 
      CD0113-buk  CCCTGTTGTT GTAGATGAAT TAGAAGATGT TGCTAGAATT TCTGGTATGC 
 
pE_CD0113-insert  CTGAAATAAG TAGAGCAAGT GTAGTACATG CTTTAAATCA AAAGGCAATA 
      CD0113-buk  CTGAAATAAG TAGAGCAAGT GTAGTACATG CTTTAAATCA AAAGGCAATA 
 
pE_CD0113-insert  GCAAGAAGAT ATGCTAGAGA AATAAACAAG AAATATGAAG ATATAAATCT 
      CD0113-buk  GCAAGAAGAT ATGCTAGAGA AATAAACAAG AAATATGAAG ATATAAATCT 
 
pE_CD0113-insert  TATAGTTGCA CACATGGGTG GAGGAGTTTC TGTTGGAGCT CATAAAAATG 
      CD0113-buk  TATAGTTGCA CATATGGGTG GAGGAGTTTC TGTTGGAGCT CATAAAAATG 
 
pE_CD0113-insert  GTAAAATAGT AGATGTTGCA AACGCATTAG ATGGAGAAGG ACCTTTCTCT 
      CD0113-buk  GTAAAATAGT AGATGTTGCA AACGCATTAG ATGGAGAAGG ACCTTTCTCT 
 
pE_CD0113-insert  CCAGAAAGAA GTGGTGGACT ACCAGTAGGT GCATTAGTAA AAATGTGCTT 
      CD0113-buk  CCAGAAAGAA GTGGTGGACT ACCAGTAGGT GCATTAGTAA AAATGTGCTT 
 
pE_CD0113-insert  TAGTGGAAAA TATACTCAAG ATGAAATTAA AAAGAAAATA AAAGGTAATG 
      CD0113-buk  TAGTGGAAAA TATACTCAAG ATGAAATTAA AAAGAAAATA AAAGGTAATG 
 
pE_CD0113-insert  GCGGACTAGT TGCATACTTA AACACTAATG ATGCTAGAGA AGTTGAAGAA 
      CD0113-buk  GCGGATTAGT TGCATACTTA AACACTAATG ATGCTAGAGA AGTTGAAGAA 
 
pE_CD0113-insert  AGAATTGAAG CTGGTGATGA AAAAGCTAAA TTAGTATATG AAGCTATGGC 
      CD0113-buk  AGAATTGAAG CTGGTGATGA AAAAGCTAAA TTAGTATATG AAGCTATGGC 
 
pE_CD0113-insert  ATATCAAATC TCTAAAGAAA TAGGAGCTAG TGCTGCAGTT CTTAAGGGAG 
      CD0113-buk  ATATCAAATC TCTAAAGAAA TAGGAGCTAG TGCTGCAGTT CTTAAGGGAG 
 
pE_CD0113-insert  ATGTAAAAGC AATATTATTA ACTGGTGGAA TCGCATATTC AAAAATGTTT 
      CD0113-buk  ATGTAAAAGC AATATTATTA ACTGGTGGAA TCGCATATTC AAAAATGTTT 
 pE_CD0113-insert  ACAGAAATG
      CD0113-buk  ACAGAAATGA TTGCAGATAG AGTTAAATTT ATAGCAGATG TAAAAGTTTA
 
pE_CD0113-insert  TCCAGGTGAA GATGAAATGA TTGCATTAGC TCAAGGTGGA CTTAGAGTTT
      CD0113-buk  TCCAGGTGAA GATGAAATGA TTGCATTAGC TCAAGGTGGA 
 
pE_CD0113-insert  TAACTGGTGA AGAAGAGGCT CAAGTTTATG ATAAC
      CD0113-buk  TAACTGGTGA AGAAGAGGCT CAAGTTTATG ATAAC
 
App.32: Sequence alignment for the cloned 
genes from strain 630 
highlighted with red.     
 
      pE_CD0113  MSKIFKILTI NPGSTSTKIA VFDNEDLVFE KTLRHSSEEI GKYEKVSDQF
            Buk  MSKIFKILTI NPGSTSTKIA 
 
      pE_CD0113  EFRKQVIEEA LKEGGVKTSE LDAVVGRGGL LKPIKGGTYS VSAAMIEDLK
            Buk  EFRKQVIEEA LKEGGVKTSE LDAVVGRGGL LKPIKGGTYS VSAAMIEDLK
 
      pE_CD0113  VGVLGEHASN LGGIIAKQIG EEVNVPSYIV DPVVVDELED VARISGMPEI
            Buk  VGVLGEHASN LGGIIAKQIG EEVNVPSYIV DPVVVDELED VARISGMPEI
 
      pE_CD0113  SRASVVHALN 
            Buk  SRASVVHALN QKAIARRYAR EINKKYEDIN LIVAHMGGGV SVGAHKNGKI
 
      pE_CD0113  VDVANALDGE GPFSPERSGG LPVG
            Buk  VDVANALDGE GPFSPERSGG LPVGALVKMC FSGKYTQDEI KKKIKGNGGL
 
      pE_CD0113  VAYLNTNDAR EVEERIEAGD EKAKLVYEAM AYQISKEIGA SAAVLKGDVK
            Buk  VAYLNTNDAR EVEERIEAGD EKAKLVYEAM AYQISKEIGA SAAVLKGDVK
 
      pE_CD0113  AILLTGGIAY SKMFTEMIAD RVKFIADVKV YPGEDEMIAL AQGGLRVLTG
            Buk  AILLTGGIAY SKMFTEMIAD RVKFIADVKV YPGEDEMIAL AQGGLRVLTG
 
      pE_CD0113  EEEAQVYDN
            Buk  EEEAQVYDN
 
App.33: Amino acid alignment for the cloned 
genes from strain 630 [131
was replaced with glycin. 
 
 
 
App.34: Analysis of pE_buk (CD0113)
right hand, there is electropherogram for the plasmid. On the left hand, there is pDRAW file shows the 
recognition sites of NlaIII as well as the sequencing primers positions. 
 
pE_buk (CD0113)
2817 bp
1   - 1
NlaIII - 20
NlaIII - 1220NlaIII - 1565
NlaIII - 1607
NlaIII - 2165
NlaIII - 2251
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A TTGCAGATAG AGTTAAATTT ATAGCAGATG TAAAAGTTTA
GGGAG
TAA--
buk from C. difficile DSMZ 1296T and the genome derived 
[131] (GeneBank accession number CD0113). There are two mutations 
VFDNEDLVFE KTLRHSSEEI GKYEKVSDQF
QKAIARRYAR EINKKYEDIN LIVAHMGGGV SVGAHKNGKI
ALVKMC FSGKYTQDEI KKKIKGNGGL
G 
. 
buk from C. difficile DSMZ 1296T  and the genome derived 
]. No mutation was observed in the amino acid sequence
 with MultiNA after digestion with NlaIII restriction enzyme.
 
NlaIII - 740
NlaIII - 977
NlaIII - 1003
NlaIII - 1034
 42 86 186 237 345 558
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>pE_CA_C2711-insert 
        1 CGTCTCCAAT GGATTTTAAT TTAACAAGAG AACAAGAATT AGTAAGACAG ATGGTTAGAG 
       61 AATTTGCTGA AAATGAAGTT AAACCTATAG CAGCAGAAAT TGATGAAACA GAAAGATTTC 
      121 CAATGGAAAA TGTAAAGAAA ATGGGTCAGT ATGGTATGAT GGGAATTCCA TTTTCAAAAG 
      181 AGTATGGTGG CGCAGGTGGA GATGTATTAT CTTATATAAT CGCCGTTGAG GAATTATCAA 
      241 AGGTTTGCGG TACTACAGGA GTTATTCTTT CAGCACATAC ATCACTTTGT GCTTCATTAA 
      301 TAAATGAACA TGGTACAGAA GAACAAAAAC AAAAATATTT AGTACCTTTA GCTAAAGGTG 
      361 AAAAAATAGG TGCTTATGGA TTGACTGAGC CAAATGCAGG AACAGATTCT GGAGCACAAC 
      421 AAACAGTAGC TGTACTTGAA GGAGATCATT ATGTAATTAA TGGTTCAAAA ATATTCATAA 
      481 CTAATGGAGG AGTTGCAGAT ACTTTTGTTA TATTTGCAAT GACTGACAGA ACTAAAGGAA 
      541 CAAAAGGTAT ATCAGCATTT ATAATAGAAA AAGGCTTCAA AGGTTTCTCT ATTGGTAAAG 
      601 TTGAACAAAA GCTTGGAATA AGAGCTTCAT CAACAACTGA ACTTGTATTT GAAGATATGA 
      661 TAGTACCAGT AGAAAACATG ATTGGTAAAG AAGGAAAAGG CTTCCCTATA GCAATGAAAA 
      721 CTCTTGATGG AGGAAGAATT GGTATAGCAG CTCAAGCTTT AGGTATAGCT GAAGGTGCTT 
      781 TCAACGAAGC AAGAGCTTAC ATGAAGGAGA GAAAACAATT TGGAAGAAGC CTTGACAAAT 
      841 TCCAAGGTCT TGCATGGATG ATGACAGATA TGGATGTAGC TATAGAATCA GCTAGATATT 
      901 TAGTATATAA AGCAGCATAT CTTAAACAAG CAGGACTTCC ATACACAGTT GATGCTGCAA 
      961 GAGCTAAGCT TCATGCTGCA AATGTAGCAA TGGATGTAAC AACTAAGGCA GTACAATTAT 
     1021 TTGGTGGATA CGGATATACA AAAGATTATC CAGTTGAAAG AATGATGAGA GATGCTAAGA 
     1081 TAACTGAAAT ATATGAAGGA ACTTCAGAAG TTCAGAAATT AGTTATTTCA GGAAAAATTT 
     1141 TTAGAGGGAG GAGACG 
 
App.35: The nucleotide sequence of bcd cloned from C. acetobutylicum DSMZ 792T. The gray highlighted 
sequences refer to the Esp3I restriction site. There are two mutations highlighted with red. 
 
pE-CA_C2711-insert  CGTCTCCAAT GGATTTTAAT TTAACAAGAG AACAAGAATT AGTAAGACAG 
      CA_C2711-bcd  --------AT GGATTTTAAT TTAACAAGAG AACAAGAATT AGTAAGACAG 
 
pE-CA_C2711-insert  ATGGTTAGAG AATTTGCTGA AAATGAAGTT AAACCTATAG CAGCAGAAAT 
      CA_C2711-bcd  ATGGTTAGAG AATTTGCTGA AAATGAAGTT AAACCTATAG CAGCAGAAAT 
 
pE-CA_C2711-insert  TGATGAAACA GAAAGATTTC CAATGGAAAA TGTAAAGAAA ATGGGTCAGT 
      CA_C2711-bcd  TGATGAAACA GAAAGATTTC CAATGGAAAA TGTAAAGAAA ATGGGTCAGT 
 
pE-CA_C2711-insert  ATGGTATGAT GGGAATTCCA TTTTCAAAAG AGTATGGTGG CGCAGGTGGA 
      CA_C2711-bcd  ATGGTATGAT GGGAATTCCA TTTTCAAAAG AGTATGGTGG CGCAGGTGGA 
 
pE-CA_C2711-insert  GATGTATTAT CTTATATAAT CGCCGTTGAG GAATTATCAA AGGTTTGCGG 
      CA_C2711-bcd  GATGTATTAT CTTATATAAT CGCCGTTGAG GAATTATCAA AGGTTTGCGG 
 
pE-CA_C2711-insert  TACTACAGGA GTTATTCTTT CAGCACATAC ATCACTTTGT GCTTCATTAA 
      CA_C2711-bcd  TACTACAGGA GTTATTCTTT CAGCACATAC ATCACTTTGT GCTTCATTAA 
 
pE-CA_C2711-insert  TAAATGAACA TGGTACAGAA GAACAAAAAC AAAAATATTT AGTACCTTTA 
      CA_C2711-bcd  TAAATGAACA TGGTACAGAA GAACAAAAAC AAAAATATTT AGTACCTTTA 
 
pE-CA_C2711-insert  GCTAAAGGTG AAAAAATAGG TGCTTATGGA TTGACTGAGC CAAATGCAGG 
      CA_C2711-bcd  GCTAAAGGTG AAAAAATAGG TGCTTATGGA TTGACTGAGC CAAATGCAGG 
 
pE-CA_C2711-insert  AACAGATTCT GGAGCACAAC AAACAGTAGC TGTACTTGAA GGAGATCATT 
      CA_C2711-bcd  AACAGATTCT GGAGCACAAC AAACAGTAGC TGTACTTGAA GGAGATCATT 
 
pE-CA_C2711-insert  ATGTAATTAA TGGTTCAAAA ATATTCATAA CTAATGGAGG AGTTGCAGAT 
      CA_C2711-bcd  ATGTAATTAA TGGTTCAAAA ATATTCATAA CTAATGGAGG AGTTGCAGAT 
 
pE-CA_C2711-insert  ACTTTTGTTA TATTTGCAAT GACTGACAGA ACTAAAGGAA CAAAAGGTAT 
      CA_C2711-bcd  ACTTTTGTTA TATTTGCAAT GACTGACAGA ACTAAAGGAA CAAAAGGTAT 
 
pE-CA_C2711-insert  ATCAGCATTT ATAATAGAAA AAGGCTTCAA AGGTTTCTCT ATTGGTAAAG 
      CA_C2711-bcd  ATCAGCATTT ATAATAGAAA AAGGCTTCAA AGGTTTCTCT ATTGGTAAAG 
 
pE-CA_C2711-insert  TTGAACAAAA GCTTGGAATA AGAGCTTCAT CAACAACTGA ACTTGTATTT 
      CA_C2711-bcd  TTGAACAAAA GCTTGGAATA AGAGCTTCAT CAACAACTGA ACTTGTATTT 
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pE-CA_C2711-insert  GAAGATATGA TAGTACCAGT AGAAAACATG ATTGGTAAAG AAGGAAAAGG 
      CA_C2711-bcd  GAAGATATGA TAGTACCAGT AGAAAACATG ATTGGTAAAG AAGGAAAAGG 
 
pE-CA_C2711-insert  CTTCCCTATA GCAATGAAAA CTCTTGATGG AGGAAGAATT GGTATAGCAG 
      CA_C2711-bcd  CTTCCCTATA GCAATGAAAA CTCTTGATGG AGGAAGAATT GGTATAGCAG 
 
pE-CA_C2711-insert  CTCAAGCTTT AGGTATAGCT GAAGGTGCTT TCAACGAAGC AAGAGCTTAC 
      CA_C2711-bcd  CTCAAGCTTT AGGTATAGCT GAAGGTGCTT TCAACGAAGC AAGAGCTTAC 
 
pE-CA_C2711-insert  ATGAAGGAGA GAAAACAATT TGGAAGAAGC CTTGACAAAT TCCAAGGTCT 
      CA_C2711-bcd  ATGAAGGAGA GAAAACAATT TGGAAGAAGC CTTGACAAAT TCCAAGGTCT 
 
pE-CA_C2711-insert  TGCATGGATG ATGACAGATA TGGATGTAGC TATAGAATCA GCTAGATATT 
      CA_C2711-bcd  TGCATGGATG ATGGCAGATA TGGATGTAGC TATAGAATCA GCTAGATATT 
 
pE-CA_C2711-insert  TAGTATATAA AGCAGCATAT CTTAAACAAG CAGGACTTCC ATACACAGTT 
      CA_C2711-bcd  TAGTATATAA AGCAGCATAT CTTAAACAAG CAGGACTTCC ATACACAGTT 
 
pE-CA_C2711-insert  GATGCTGCAA GAGCTAAGCT TCATGCTGCA AATGTAGCAA TGGATGTAAC 
      CA_C2711-bcd  GATGCTGCAA GAGCTAAGCT TCATGCTGCA AATGTAGCAA TGGATGTAAC 
 
pE-CA_C2711-insert  AACTAAGGCA GTACAATTAT TTGGTGGATA CGGATATACA AAAGATTATC 
      CA_C2711-bcd  AACTAAGGCA GTACAATTAT TTGGTGGATA CGGATATACA AAAGATTATC 
 
pE-CA_C2711-insert  CAGTTGAAAG AATGATGAGA GATGCTAAGA TAACTGAAAT ATATGAAGGA 
      CA_C2711-bcd  CAGTTGAAAG AATGATGAGA GATGCTAAGA TAACTGAAAT ATATGAAGGA 
 
pE-CA_C2711-insert  ACTTCAGAAG TTCAGAAATT AGTTATTTCA GGAAAAATTT TTAGAGGGAG 
      CA_C2711-bcd  ACTTCAGAAG TTCAGAAATT AGTTATTTCA GGAAAAATTT TTAGATAA— 
 
pE-CA_C2711-insert  GAGACG 
      CA_C2711-bcd  ------ 
App.36: Sequence alignment for the cloned bcd from C. acetobutylicum DSMZ 792T and the genome 
derived genes from strain ATCC 824 (CA_C2711) [107]. One mutation was observed.     
 
    pE-CA_C2711  MDFNLTREQE LVRQMVREFA ENEVKPIAAE IDETERFPME NVKKMGQYGM 
            Bcd  MDFNLTREQE LVRQMVREFA ENEVKPIAAE IDETERFPME NVKKMGQYGM 
 
    pE-CA_C2711  MGIPFSKEYG GAGGDVLSYI IAVEELSKVC GTTGVILSAH TSLCASLINE 
            Bcd  MGIPFSKEYG GAGGDVLSYI IAVEELSKVC GTTGVILSAH TSLCASLINE 
 
    pE-CA_C2711  HGTEEQKQKY LVPLAKGEKI GAYGLTEPNA GTDSGAQQTV AVLEGDHYVI 
            Bcd  HGTEEQKQKY LVPLAKGEKI GAYGLTEPNA GTDSGAQQTV AVLEGDHYVI 
 
    pE-CA_C2711  NGSKIFITNG GVADTFVIFA MTDRTKGTKG ISAFIIEKGF KGFSIGKVEQ 
            Bcd  NGSKIFITNG GVADTFVIFA MTDRTKGTKG ISAFIIEKGF KGFSIGKVEQ 
 
    pE-CA_C2711  KLGIRASSTT ELVFEDMIVP VENMIGKEGK GFPIAMKTLD GGRIGIAAQA 
            Bcd  KLGIRASSTT ELVFEDMIVP VENMIGKEGK GFPIAMKTLD GGRIGIAAQA 
 
    pE-CA_C2711  LGIAEGAFNE ARAYMKERKQ FGRSLDKFQG LAWMMTDMDV AIESARYLVY 
            Bcd  LGIAEGAFNE ARAYMKERKQ FGRSLDKFQG LAWMMADMDV AIESARYLVY 
 
    pE-CA_C2711  KAAYLKQAGL PYTVDAARAK LHAANVAMDV TTKAVQLFGG YGYTKDYPVE 
            Bcd  KAAYLKQAGL PYTVDAARAK LHAANVAMDV TTKAVQLFGG YGYTKDYPVE 
 
    pE-CA_C2711  RMMRDAKITE IYEGTSEVQK LVISGKIFRG 
            Bcd  RMMRDAKITE IYEGTSEVQK LVISGKIFR. 
App.37: Amino acid alignment for the cloned bcd from C. acetobutylicum DSMZ 792T and the genome 
derived genes from strain ATCC 824 (CA_C2711) [107]. Only one conservative amino acid 
exchange was observed, which is also found in the donor strain. The stop codon was replaced with 
glycin. 
  
App.38: Analysis of pE_bcd (CA_C2711
the right hand, there is electropherogram for the plasmid. On the left hand, there is pDRAW file 
shows the recognition sites of 
 
>pE_CA_C2710-insert 
        1 CGTCTCCAAT GAATATAGTT 
       61 TAGATCCAGT TAAGGGAACA CTTATAAGAG AAGGAGTTCC ATCAATAATA AATCCAGATG
      121 ATAAAAACGC ACTTGAGGAA GCTTTAGTAT TAAAAGATAA TTATGGTGCA CATGTAACAG
      181 TTATAAGTAT GGGACCTCCA CAAGCTAAAA ATGCTTTAGT AGAAGC
      241 CTGATGAAGC TGTACTTTTA ACAGATAGAG CATTTGGAGG AGCAGATACA CTTGCGACTT
      301 CACATACAAT TGCAGCAGGA ATTAAGAAGC TAAAATATGA TATAGTTTTT GCTGGAAGGC
      361 AGGCTATAGA TGGAGATACA GCTCAGGTTG GACCAGAAAT AGCTGAGCAT CTTGGAATAC
      421 CTCAAGTAAC TTATGTTGAG AAAGTTGAAG TTGATGGAGA TACTTTAAAG ATTAGAAAAG
      481 CTTGGGAAGA TGGATATGAA GTTGTTGAAG TTAAGACACC AGTTCTTTTA ACAGCAATTA
      541 AAGAATTAAA TGTTCCAAGA TATATGAGTG TAGAAAAAAT ATTCGGAGCA TTTGATAAAG
      601 AAGTAAAAAT GTGGACTGCC GATGATATAG ATGTAGATAA GGCTAATTTA GGTCTTAAAG
      661 GTTCACCAAC TAAAGTTAAG AAGTCATCAA CTAAAGAAGT TAAAGGACAG GGAGAAGTTA
      721 TTGATAAGCC TGTTAAGGAA GCAGCTGCAT ATGTTGTCTC AAAATTAAAA GAAGAACACT
      781 ATATTGGGAG GAGACG
 
App.39: The nucleotide sequence of 
sequences refer to the Esp3I
 
pE-CA_C2710-insert  CGTCTCCA
     CA_C2710-etfB  --------
   
pE-CA_C2710-insert  GAAGTTAGAA TAGATCCAGT TAAGGGAACA CTTATAAGAG AAGGAGTTCC
     CA_C2710-etfB  GAAGTTAGAA TAGATCCAGT TAAGGGAACA CTTATAAGAG AAGGAGTTCC
  
pE-CA_C2710-insert  ATCAAT
     CA_C2710-etfB  ATCAATAATA AATCCAGATG ATAAAAACGC ACTTGAGGAA GCTTTAGTAT
 
pE-CA_C2710-insert  TAAAAGATAA TTATGGTGCA CATGTAACAG TTATAAGTAT GGGACCTCCA
     CA_C2710-etfB  TAAAAGATAA TTATGGTGCA CATGTAACAG TTA
 
pE-CA_C2710-insert  CAAGCTAAAA ATGCTTTAGT AGAAGCTTTG GCTATGGGTG CTGATGAAGC
     CA_C2710-etfB  CAAGCTAAAA ATGCTTTAGT AGAAGCTTTG GCTATGGGTG CTGATGAAGC
 
pE-CA_C2710-insert  TGTACTTTTA ACAGATAGAG CATTTGGAGG AGCAGATACA CTTGCGACTT
     CA_C2710-etfB  TGTACTTTTA ACAGATAGAG CATTTGGAGG AGCAGATACA CTTGCGACTT
 
pE-CA_C2710-insert  CACATACAAT TGCAGCAGGA ATTAAGAAGC TAAAATATGA TATAGTTTTT
     CA_C2710-etfB  CACATACAAT TGCAGCAGGA ATTAAGAAGC TAAAATATGA TATAGTTTTT
pE_bcd (CA_C2711) 
2877 bp
1   - 1
HinfI - 2090
HinfI - 2570
HinfI - 2868
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) with MultiNA after digestion with HinfI restriction enzyme.
HinfI as well as the sequencing primers positions.
GTTTGTTTAA AACAAGTTCC AGATACAGCG GAAGTTAGAA
 
etfB cloned from C. acetobutylicum DSMZ 792T. 
 restriction site. No difference was obtained. 
AT GAATATAGTT GTTTGTTTAA AACAAGTTCC AGATACAGCG
AT GAATATAGTT GTTTGTTTAA AACAAGTTCC AGATACAGCG
AATA AATCCAGATG ATAAAAACGC ACTTGAGGAA GCTTTAGTAT
TAAGTAT GGGACCTCCA
HinfI - 387
HinfI - 813
HinfI - 947
ori
134 298 396 426 
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TTTG GCTATGGGTG 
 
 
 
 
 
 
 
 
 
The gray highlighted 
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pE-CA_C2710-insert  GCTGGAAGGC AGGCTATAGA TGGAGATACA GCTCAGGTTG GACCAGAAAT 
     CA_C2710-etfB  GCTGGAAGGC AGGCTATAGA TGGAGATACA GCTCAGGTTG GACCAGAAAT 
 
pE-CA_C2710-insert  AGCTGAGCAT CTTGGAATAC CTCAAGTAAC TTATGTTGAG AAAGTTGAAG 
     CA_C2710-etfB  AGCTGAGCAT CTTGGAATAC CTCAAGTAAC TTATGTTGAG AAAGTTGAAG 
 
pE-CA_C2710-insert  TTGATGGAGA TACTTTAAAG ATTAGAAAAG CTTGGGAAGA TGGATATGAA 
     CA_C2710-etfB  TTGATGGAGA TACTTTAAAG ATTAGAAAAG CTTGGGAAGA TGGATATGAA 
 
pE-CA_C2710-insert  GTTGTTGAAG TTAAGACACC AGTTCTTTTA ACAGCAATTA AAGAATTAAA 
     CA_C2710-etfB  GTTGTTGAAG TTAAGACACC AGTTCTTTTA ACAGCAATTA AAGAATTAAA 
 
pE-CA_C2710-insert  TGTTCCAAGA TATATGAGTG TAGAAAAAAT ATTCGGAGCA TTTGATAAAG 
     CA_C2710-etfB  TGTTCCAAGA TATATGAGTG TAGAAAAAAT ATTCGGAGCA TTTGATAAAG 
 
pE-CA_C2710-insert  AAGTAAAAAT GTGGACTGCC GATGATATAG ATGTAGATAA GGCTAATTTA 
     CA_C2710-etfB  AAGTAAAAAT GTGGACTGCC GATGATATAG ATGTAGATAA GGCTAATTTA 
 
pE-CA_C2710-insert  GGTCTTAAAG GTTCACCAAC TAAAGTTAAG AAGTCATCAA CTAAAGAAGT 
     CA_C2710-etfB  GGTCTTAAAG GTTCACCAAC TAAAGTTAAG AAGTCATCAA CTAAAGAAGT 
 
pE-CA_C2710-insert  TAAAGGACAG GGAGAAGTTA TTGATAAGCC TGTTAAGGAA GCAGCTGCAT 
     CA_C2710-etfB  TAAAGGACAG GGAGAAGTTA TTGATAAGCC TGTTAAGGAA GCAGCTGCAT 
 
pE-CA_C2710-insert  ATGTTGTCTC AAAATTAAAA GAAGAACACT ATATTGGGAG GAGACG 
     CA_C2710-etfB  ATGTTGTCTC AAAATTAAAA GAAGAACACT ATATTTAA-- ------ 
 
App.40: Sequence alignment for the cloned etfB from C. acetobutylicum DSMZ 792T and the genome 
derived genes from strain ATCC 824 (CA_C2710) [107]. No mutation was observed.   
   
    pE-CA_C2710  MNIVVCLKQV PDTAEVRIDP VKGTLIREGV PSIINPDDKN ALEEALVLKD 
           etfB  MNIVVCLKQV PDTAEVRIDP VKGTLIREGV PSIINPDDKN ALEEALVLKD 
 
    pE-CA_C2710  NYGAHVTVIS MGPPQAKNAL VEALAMGADE AVLLTDRAFG GADTLATSHT 
           etfB  NYGAHVTVIS MGPPQAKNAL VEALAMGADE AVLLTDRAFG GADTLATSHT 
 
    pE-CA_C2710  IAAGIKKLKY DIVFAGRQAI DGDTAQVGPE IAEHLGIPQV TYVEKVEVDG 
           etfB  IAAGIKKLKY DIVFAGRQAI DGDTAQVGPE IAEHLGIPQV TYVEKVEVDG 
 
    pE-CA_C2710  DTLKIRKAWE DGYEVVEVKT PVLLTAIKEL NVPRYMSVEK IFGAFDKEVK 
           etfB  DTLKIRKAWE DGYEVVEVKT PVLLTAIKEL NVPRYMSVEK IFGAFDKEVK 
 
    pE-CA_C2710  MWTADDIDVD KANLGLKGSP TKVKKSSTKE VKGQGEVIDK PVKEAAAYVV 
           etfB  MWTADDIDVD KANLGLKGSP TKVKKSSTKE VKGQGEVIDK PVKEAAAYVV 
 
    pE-CA_C2710  SKLKEEHYIG  
           etfB  SKLKEEHYI.  
 
App.41: Amino acid alignment for the cloned etfB from C. acetobutylicum DSMZ 792T and the genome 
derived genes from strain ATCC 824 (CA_C2710) [107]. No mutation was observed. The stop codon 
was replaced with glycin. 
 
  
Expected fragments sizes (bp) 
App.42: Analysis of digest pE_etfB(CA_C2710) 
enzyme. On the right hand, there is electropherogram for the plasmid. On the left hand, there is 
pDRAW file shows the recognition sites of 
 
>pE_CA_C2709-insert 
        1 CGTCTCCAAT GAATAAAGCA GATTACAAGG GCGTATGGGT GTTTGCTGAA CAAAGAGA
       61 GAGAATTACA AAAGGTATCA TTGGAATTAT TAGGTAAAGG TAAGGAAATG GCTGAGAAAT
      121 TAGGCGTTGA ATTAACAGCT GTTTTACTTG GACATAATAC TGAAAAAATG TCAAAGGATT
      181 TATTATCTCA TGGAGCAGAT AAGGTTTTAG CAGCAGATAA TGAACTTTTA GCACATTTTT
      241 CAACAGATGG ATATGCTAAA GTTATATGTG ATTTAGTTAA TGAAAGAAAG CCAGAAATAT
      301 TATTCATAGG AGCTACT
      361 CTACTGGTTT AACTGCTGAT TGTACATCAC TTGACATAGA TGTAGAAAAT AGAGATTTAT
      421 TGGCTACAAG ACCAGCGTTT GGTGGAAATT TGATAGCTAC AATAGTTTGT TCAGACCACA
      481 GACCACAAAT GGCTACAGTA AGACCTGGTG TGTTTGAAAA AT
      541 ATGTTTCTGA TGATAAAATA GAAAAAGTTG CAATTAAATT AACAGCATCA GACATAAGAA
      601 CAAAAGTTTC AAAAGTTGTT AAGCTTGCTA AAGATATTGC AGATATCGGA GAAGCTAAGG
      661 TATTAGTTGC TGGTGGTAGA GGAGTTGGAA GCAAAGAAAA CTTTGAAAAA CTTGAAGAGT
      721 TAGCAAGTTT ACTTGGTGGA ACAATAGCCG CTTCAAGAGC AGCAATAGAA AAAGAATGGG
      781 TTGATAAGGA CCTTCAAGTA GGTCAAACTG GTAAAACTGT AAGACCAACT CTTTATATTG
      841 CATGTGGTAT ATCAGGAGCT ATCCAGCATT TAGCAGGTAT GCAAGATTCA GATTACATAA
      901 TTGCTATAAA TAAAGATGTA GAAG
      961 GTGATGTAAA TAAAGTTGTA CCAGAATTAA TAGCTCAAGT TAAAGCTGCT AATAAT
     1021 GGAGACG 
 
App.43: The nucleotide sequence of 
sequences refer to the Esp3I
restriction site and it is green
 
pE-CA_C2709-insert  CGTCTCCA
     CA_C2709-etfA  --------
 
pE-CA_C2709-insert  CAAAGAGA
     CA_C2709-etfA  CAAAGAGA
 
pE-CA_C2709-insert  TAAGGAAAT
     CA_C2709-etfA  TAAGGAAATG GCTGAGAAAT TAGGCGTTGA ATTAACAGCT GTTTTACTTG
 
pE-CA_C2709-insert  GACATAATAC TGAAAAAATG TCAAAGGATT TATTATCTCA TGGAGCAGAT
     CA_C2709-etfA  GACATAATAC TGAAAAAATG TCAAAGGATT TATTAT
 
pE-CA_C2709-insert  AAGGTTTTAG CAGCAGATAA TGAACTTTTA GCACATTTTT CAACAGATGG
     CA_C2709-etfA  AAGGTTTTAG CAGCAGATAA TGAACTTTTA GCACATTTTT CAACAGATGG
 
pE-CA_C2709-insert  ATATGCTAAA GTTATATGTG ATTTAGTTAA TGAAAGAAAG CCAGAAATAT
     CA_C2709-etfA  ATATGCTAAA GTTATATGTG ATTTAGTTAA TGAAAGAAAG CCAGAAATAT
pE_etfB (CA_C2710)
2517 bp
1   - 1
HinfI - 387
HinfI - 813
HinfI - 947
HinfI - 2508
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tfB
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134 396 426
with MultiNA after digestion with 
HinfI as well as the sequencing primers positions.
TTC ATAGGAAGAG ATTTAGGACC AAGAATAGCA GCAAGACTTT
TACCTGTT AATGATGCAA
CCCCAA TAATGAAGGT AGCAGATTTG GCTATAGTTG
etfA cloned from C. acetobutylicum DSMZ 792T. 
 restriction site. A silent mutation was introduced to remove the 
 highlighted. 
AT GAATAAAGCA GATTACAAGG GCGTATGGGT GTTTGCTGAA
AT GAATAAAGCA GATTACAAGG GCGTATGGGT GTTTGCTGAA
TG GAGAATTACA AAAGGTATCA TTGGAATTAT TAGGTAAAGG
CG GAGAATTACA AAAGGTATCA TTGGAATTAT TAGGTAAAGG
G GCTGAGAAAT TAGGCGTTGA ATTAACAGCT GTTTTACTTG
CTCA TGGAGCAGAT
 
 1561 
HinfI restriction 
 
TG 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
GGGA 
The gray highlighted 
LguI 
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pE-CA_C2709-insert  TATTCATAGG AGCTACTTTC ATAGGAAGAG ATTTAGGACC AAGAATAGCA 
     CA_C2709-etfA  TATTCATAGG AGCTACTTTC ATAGGAAGAG ATTTAGGACC AAGAATAGCA 
 
pE-CA_C2709-insert  GCAAGACTTT CTACTGGTTT AACTGCTGAT TGTACATCAC TTGACATAGA 
     CA_C2709-etfA  GCAAGACTTT CTACTGGTTT AACTGCTGAT TGTACATCAC TTGACATAGA 
 
pE-CA_C2709-insert  TGTAGAAAAT AGAGATTTAT TGGCTACAAG ACCAGCGTTT GGTGGAAATT 
     CA_C2709-etfA  TGTAGAAAAT AGAGATTTAT TGGCTACAAG ACCAGCGTTT GGTGGAAATT 
 
pE-CA_C2709-insert  TGATAGCTAC AATAGTTTGT TCAGACCACA GACCACAAAT GGCTACAGTA 
     CA_C2709-etfA  TGATAGCTAC AATAGTTTGT TCAGACCACA GACCACAAAT GGCTACAGTA 
 
pE-CA_C2709-insert  AGACCTGGTG TGTTTGAAAA ATTACCTGTT AATGATGCAA ATGTTTCTGA 
     CA_C2709-etfA  AGACCTGGTG TGTTTGAAAA ATTACCTGTT AATGATGCAA ATGTTTCTGA 
 
pE-CA_C2709-insert  TGATAAAATA GAAAAAGTTG CAATTAAATT AACAGCATCA GACATAAGAA 
     CA_C2709-etfA  TGATAAAATA GAAAAAGTTG CAATTAAATT AACAGCATCA GACATAAGAA 
 
pE-CA_C2709-insert  CAAAAGTTTC AAAAGTTGTT AAGCTTGCTA AAGATATTGC AGATATCGGA 
     CA_C2709-etfA  CAAAAGTTTC AAAAGTTGTT AAGCTTGCTA AAGATATTGC AGATATCGGA 
 
pE-CA_C2709-insert  GAAGCTAAGG TATTAGTTGC TGGTGGTAGA GGAGTTGGAA GCAAAGAAAA 
     CA_C2709-etfA  GAAGCTAAGG TATTAGTTGC TGGTGGTAGA GGAGTTGGAA GCAAAGAAAA 
 
pE-CA_C2709-insert  CTTTGAAAAA CTTGAAGAGT TAGCAAGTTT ACTTGGTGGA ACAATAGCCG 
     CA_C2709-etfA  CTTTGAAAAA CTTGAAGAGT TAGCAAGTTT ACTTGGTGGA ACAATAGCCG 
 
pE-CA_C2709-insert  CTTCAAGAGC AGCAATAGAA AAAGAATGGG TTGATAAGGA CCTTCAAGTA 
     CA_C2709-etfA  CTTCAAGAGC AGCAATAGAA AAAGAATGGG TTGATAAGGA CCTTCAAGTA 
 
pE-CA_C2709-insert  GGTCAAACTG GTAAAACTGT AAGACCAACT CTTTATATTG CATGTGGTAT 
     CA_C2709-etfA  GGTCAAACTG GTAAAACTGT AAGACCAACT CTTTATATTG CATGTGGTAT 
 
pE-CA_C2709-insert  ATCAGGAGCT ATCCAGCATT TAGCAGGTAT GCAAGATTCA GATTACATAA 
     CA_C2709-etfA  ATCAGGAGCT ATCCAGCATT TAGCAGGTAT GCAAGATTCA GATTACATAA 
 
pE-CA_C2709-insert  TTGCTATAAA TAAAGATGTA GAAGCCCCAA TAATGAAGGT AGCAGATTTG 
     CA_C2709-etfA  TTGCTATAAA TAAAGATGTA GAAGCCCCAA TAATGAAGGT AGCAGATTTG 
 
pE-CA_C2709-insert  GCTATAGTTG GTGATGTAAA TAAAGTTGTA CCAGAATTAA TAGCTCAAGT 
     CA_C2709-etfA  GCTATAGTTG GTGATGTAAA TAAAGTTGTA CCAGAATTAA TAGCTCAAGT 
 
pE-CA_C2709-insert  TAAAGCTGCT AATAATGGGA GGAGACG 
     CA_C2709-etfA  TAAAGCTGCT AATAATTAA- ------- 
 
App.44: Sequence alignment for the cloned etfA from C. acetobutylicum DSMZ 792T and the genome 
derived genes from strain ATCC 824 (CA_C2709) [107]. A silent mutation was introduced to 
remove the LguI restriction site and it is green highlighted     
 
 
    pE-CA_C2709  MNKADYKGVW VFAEQRDGEL QKVSLELLGK GKEMAEKLGV ELTAVLLGHN 
           etfA  MNKADYKGVW VFAEQRDGEL QKVSLELLGK GKEMAEKLGV ELTAVLLGHN 
 
    pE-CA_C2709  TEKMSKDLLS HGADKVLAAD NELLAHFSTD GYAKVICDLV NERKPEILFI 
           etfA  TEKMSKDLLS HGADKVLAAD NELLAHFSTD GYAKVICDLV NERKPEILFI 
 
    pE-CA_C2709  GATFIGRDLG PRIAARLSTG LTADCTSLDI DVENRDLLAT RPAFGGNLIA 
           etfA  GATFIGRDLG PRIAARLSTG LTADCTSLDI DVENRDLLAT RPAFGGNLIA 
 
    pE-CA_C2709  TIVCSDHRPQ MATVRPGVFE KLPVNDANVS DDKIEKVAIK LTASDIRTKV 
           etfA  TIVCSDHRPQ MATVRPGVFE KLPVNDANVS DDKIEKVAIK LTASDIRTKV 
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    pE-CA_C2709  SKVVKLAKDI ADIGEAKVLV AGGRGVGSKE NFEKLEELAS LLGGTIAASR 
           etfA  SKVVKLAKDI ADIGEAKVLV AGGRGVGSKE NFEKLEELAS LLGGTIAASR 
 
    pE-CA_C2709  AAIEKEWVDK DLQVGQTGKT VRPTLYIACG ISGAIQHLAG MQDSDYIIAI 
           etfA  AAIEKEWVDK DLQVGQTGKT VRPTLYIACG ISGAIQHLAG MQDSDYIIAI 
 
    pE-CA_C2709  NKDVEAPIMK VADLAIVGDV NKVVPELIAQ VKAANNG 
           etfA  NKDVEAPIMK VADLAIVGDV NKVVPELIAQ VKAANN. 
 
App.45: Amino acid alignment for the cloned etfA from C. acetobutylicum DSMZ 792T and the genome 
derived genes from strain ATCC 824 (CA_C2709) [107]. No mutation was observed. The stop codon 
was replaced with glycin. 
 
 
 
App.46: Analysis of digest pE_etfA(CA_C2709) with MultiNA after digestion with HinfI.  
pE_etfA (CA_C2709)
2748 bp
1   - 1
HinfI - 387
HinfI - 813
HinfI - 947
HinfI - 2570
HinfI - 2739
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Expected fragments size (bp) 134 169 396 426 1623 
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App.47: Analysis of digest pASG_BUTAC with MultiNA after digestion with HindIII restriction enzyme. 
The above diagram is a pDRAW file shows the recognition sites of HindIII and the below one is 
electropherogram for the digested plasmid. 
pASG.wt_BUTAC
11014 bp
1   - 1
tetP - 2939
HindIII - 3662
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App.48: Analyze of digest pASG_BUTAC with MultiNA after digestion with HinfI restriction enzyme. The 
above diagram is a pDRAW file shows the recognition sites of HinfI and the below one is 
electropherogram for the digested plasmid.   
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App.49: Analysis of digest pASG_BUTD with MultiNA after digestion with HindIII restriction enzyme.  
The above diagram is a pDRAW file shows the recognition sites of HindIII and the below one is 
electropherogram for the digested plasmid.   
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App.50: Analysis of digest pASG_BUTD with MultiNA after digestion with HinfI restriction enzyme. The 
above diagram is a pDRAW file shows the recognition sites of HinfI and the below one is 
electropherogram for the digested plasmid.  
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